<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Nat Commun</journal-id><journal-id journal-id-type="iso-abbrev">Nat Commun</journal-id><journal-id journal-id-type="pmc-domain-id">2873</journal-id><journal-id journal-id-type="pmc-domain">ncomms</journal-id><journal-title-group><journal-title>Nature Communications</journal-title></journal-title-group><issn pub-type="epub">2041-1723</issn><publisher><publisher-name>Nature Publishing Group</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12475061</article-id><article-id pub-id-type="pmcid-ver">PMC12475061.1</article-id><article-id pub-id-type="pmcaid">12475061</article-id><article-id pub-id-type="pmcaiid">12475061</article-id><article-id pub-id-type="pmid">41006271</article-id><article-id pub-id-type="doi">10.1038/s41467-025-63501-3</article-id><article-id pub-id-type="publisher-id">63501</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Advances in biomonitoring technologies for women&#8217;s health</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Moghimikandelousi</surname><given-names initials="S">Shaghayegh</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Najm</surname><given-names initials="L">Lubna</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0009-0008-6774-1125</contrib-id><name name-style="western"><surname>Lee</surname><given-names initials="Y">Yerim</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-8868-1650</contrib-id><name name-style="western"><surname>Bayat</surname><given-names initials="F">Fereshteh</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-2636-5097</contrib-id><name name-style="western"><surname>Prasad</surname><given-names initials="A">Akansha</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Khan</surname><given-names initials="S">Shadman</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bhavan</surname><given-names initials="A">Aishwarya</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-8503-4562</contrib-id><name name-style="western"><surname>Gao</surname><given-names initials="W">Wei</given-names></name><address><email>weigao@caltech.edu</email></address><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Hosseinidoust</surname><given-names initials="Z">Zeinab</given-names></name><address><email>doust@mcmaster.ca</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff5">5</xref><xref ref-type="aff" rid="Aff6">6</xref><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-8757-8002</contrib-id><name name-style="western"><surname>Didar</surname><given-names initials="TF">Tohid F.</given-names></name><address><email>didart@mcmaster.ca</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff7">7</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02fa3aq29</institution-id><institution-id institution-id-type="GRID">grid.25073.33</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8227</institution-id><institution>School of Biomedical Engineering, </institution><institution>McMaster University, </institution></institution-wrap>Hamilton, ON Canada </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02fa3aq29</institution-id><institution-id institution-id-type="GRID">grid.25073.33</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8227</institution-id><institution>Department of Mechanical Engineering, </institution><institution>McMaster University, </institution></institution-wrap>Hamilton, ON Canada </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05dxps055</institution-id><institution-id institution-id-type="GRID">grid.20861.3d</institution-id><institution-id institution-id-type="ISNI">0000 0001 0706 8890</institution-id><institution>Andrew and Peggy Cherng Department of Medical Engineering, Division of Engineering and Applied Science, </institution><institution>California Institute of Technology, </institution></institution-wrap>Pasadena, CA USA </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02fa3aq29</institution-id><institution-id institution-id-type="GRID">grid.25073.33</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8227</institution-id><institution>Department of Biochemistry and Biomedical Sciences, </institution><institution>McMaster University, </institution></institution-wrap>Hamilton, ON Canada </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02fa3aq29</institution-id><institution-id institution-id-type="GRID">grid.25073.33</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8227</institution-id><institution>Department of Chemical Engineering, </institution><institution>McMaster University, </institution></institution-wrap>Hamilton, ON Canada </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02fa3aq29</institution-id><institution-id institution-id-type="GRID">grid.25073.33</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8227</institution-id><institution>Farncombe Family Digestive Health Research Institute, </institution><institution>McMaster University, </institution></institution-wrap>Hamilton, ON Canada </aff><aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02fa3aq29</institution-id><institution-id institution-id-type="GRID">grid.25073.33</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8227</institution-id><institution>Michael DeGroote Institute for Infectious Disease Research, </institution><institution>McMaster University, </institution></institution-wrap>Hamilton, ON Canada </aff></contrib-group><pub-date pub-type="epub"><day>26</day><month>9</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>16</volume><issue-id pub-id-type="pmc-issue-id">478256</issue-id><elocation-id>8507</elocation-id><history><date date-type="received"><day>12</day><month>12</month><year>2024</year></date><date date-type="accepted"><day>21</day><month>8</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>26</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>28</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-28 16:25:18.507"><day>28</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="41467_2025_Article_63501.pdf"/><abstract id="Abs1"><p id="Par1">In global healthcare systems, sex and gender biases have favored cisgender males, which has led women and transgender individuals to be understudied and underrepresented in medical literature. Thus, these populations are largely overlooked in health policy making. Persistent gender inequalities, socioeconomic divides, and racial-ethnic discrimination, particularly in low-resource communities, have exacerbated women&#8217;s health concerns, delaying advancements in care and accessibility. However, recent years have seen the emergence of tracking technologies and wearable devices that enable long-term biomonitoring of key health biomarkers which promise to facilitate early disease diagnosis for women from all walks of life. These innovations value education and accessibility, which can break down barriers to health care access and management that has affected generations of women around the world. This review discusses emerging biomonitoring technologies for diagnosing and managing critical women&#8217;s health conditions as defined by the World Health Organization, including breast and gynecological cancers, vaginal infections, fertility, pregnancy and post-menopausal osteoporosis. Additionally, we examine the current commercial landscape of women&#8217;s health technologies, highlighting barriers to adoption, such as medical insurance access and socioeconomic status, as well as discuss opportunities for future innovation.</p></abstract><abstract id="Abs2" abstract-type="web-summary"><p id="Par2">In global healthcare systems, sex and gender biases have led to a health gap that affects diverse populations of women. This review highlights emerging wearable, biomonitoring, and diagnostic technologies to address this health gap, examines the commercial landscape and barriers to adoption, and discusses opportunities for future innovation.</p></abstract><kwd-group kwd-group-type="npg-subject"><title>Subject terms</title><kwd>Biomedical engineering</kwd><kwd>Health care</kwd><kwd>Biomaterials</kwd><kwd>Materials for devices</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/100000002</institution-id><institution>U.S. Department of Health &amp; Human Services | National Institutes of Health (NIH)</institution></institution-wrap></funding-source><award-id>ARPA-H-ICHUB-24-101-504</award-id><principal-award-recipient><name name-style="western"><surname>Gao</surname><given-names>Wei</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100001348</institution-id><institution>Agency for Science, Technology and Research (A*STAR)</institution></institution-wrap></funding-source></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100000038</institution-id><institution>Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (Conseil de Recherches en Sciences Naturelles et en G&#233;nie du Canada)</institution></institution-wrap></funding-source></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100005877</institution-id><institution>Suomen Akatemia | Luonnontieteiden ja Tekniikan Tutkimuksen Toimikunta (Research Council for Natural Sciences and Engineering)</institution></institution-wrap></funding-source></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; Springer Nature Limited 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p id="Par3">Despite many achievements in women&#8217;s civil rights over the past century, gaps in healthcare, medical research, sociocultural standing and economic power continue to affect women&#8217;s lives in the modern day<sup><xref ref-type="bibr" rid="CR1">1</xref>,<xref ref-type="bibr" rid="CR2">2</xref></sup>.</p><p id="Par4">From an economic perspective, women have struggled with attaining equal resources to men because of barriers in accessing education, job opportunities, safe housing, and healthcare services<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>. For instance, women&#8217;s opportunities in receiving medical insurance coverage and healthcare infrastructure resources are limited and often do not fully encompass women&#8217;s health needs<sup><xref ref-type="bibr" rid="CR3">3</xref></sup>. This leads to nearly 10.8 million women remaining medically uninsured in the USA, and 1.5 billion women and girls worldwide lacking access to healthcare facilities or resources<sup><xref ref-type="bibr" rid="CR3">3</xref>,<xref ref-type="bibr" rid="CR4">4</xref></sup>. The healthcare gap is exacerbated amongst populations of women in middle to low-income communities and transgender people<sup><xref ref-type="bibr" rid="CR5">5</xref>,<xref ref-type="bibr" rid="CR6">6</xref></sup>. In addition, funding and investment for health research and medical innovation has a biological sex bias<sup><xref ref-type="bibr" rid="CR7">7</xref></sup>. Despite $198 billion USD being invested in health research in the USA, only 4% is allocated to women&#8217;s cancer and 1% for all other female conditions<sup><xref ref-type="bibr" rid="CR7">7</xref></sup>. Additionally, conditions such as hepatitis B, which affects men 2<inline-formula id="IEq1"><alternatives><tex-math id="d33e344">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\times$$\end{document}</tex-math><mml:math id="d33e349"><mml:mo>&#215;</mml:mo></mml:math><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="41467_2025_63501_Article_IEq1.gif"/></alternatives></inline-formula> more than women, receive 41<inline-formula id="IEq2"><alternatives><tex-math id="d33e353">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\times$$\end{document}</tex-math><mml:math id="d33e358"><mml:mo>&#215;</mml:mo></mml:math><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="41467_2025_63501_Article_IEq1.gif"/></alternatives></inline-formula> more attention and funding in clinical or health research compared to conditions predominantly affecting women<sup><xref ref-type="bibr" rid="CR7">7</xref></sup>. This disparity stems from the viewpoint that &#8216;women&#8217;s health&#8217; is niche, resulting in women-prevalent conditions being neglected and understudied by funding agencies, policy makers and researchers<sup><xref ref-type="bibr" rid="CR7">7</xref></sup>.</p><p id="Par5">Other than research funding, biological sex biases affect clinical and medical studies<sup><xref ref-type="bibr" rid="CR8">8</xref></sup>. Historically, biological male participants, animal models and cell lines have been the bases of medical studies, which become generalized to women. These studies do not consider biological sex differences present in genetics, hormones, symptomology and bodily functions<sup><xref ref-type="bibr" rid="CR8">8</xref></sup>. This bias results from the fear of negatively impacting women&#8217;s fertility and pregnancy, resulting in only 37% of women representation amongst academic journals<sup><xref ref-type="bibr" rid="CR8">8</xref></sup>. Furthermore, amongst in vitro cell studies, 70% of cell lines used are derived from biological males<sup><xref ref-type="bibr" rid="CR8">8</xref></sup>. Consequently, the lack of sex considerations and limited health research is highly associated with increased incidence of harmful, ineffective or inappropriate treatment strategies implemented for females<sup><xref ref-type="bibr" rid="CR8">8</xref></sup>.</p><p id="Par6">The presence of these gaps leads to women often feeling limited in their understanding of their own bodies and unaware of their health choices<sup><xref ref-type="bibr" rid="CR2">2</xref></sup>. Personalized, cost-effective and reliable technologies can address the concerns that women face regarding the overall limited medical data on women-prevalent conditions<sup><xref ref-type="bibr" rid="CR7">7</xref></sup>. Women themselves have also shown interest in adopting wearable and wireless technologies for tracking their own health. For instance, there is a 77% acceptability rate towards using ovulation tracking via bracelet wearables<sup><xref ref-type="bibr" rid="CR9">9</xref></sup>. Transgender individuals also express interest in leveraging technologies for understanding their health. In qualitative studies conducted amongst transgender individuals, key factors listed for these technologies include the promotion of fluidity and gender identity, ability to support different kinds of transitions, and easy-to-manage user interfaces for data concerning transition and gender identity<sup><xref ref-type="bibr" rid="CR6">6</xref>,<xref ref-type="bibr" rid="CR10">10</xref></sup>.</p><p id="Par7">The World Health Organization (WHO) and various government agencies have reported that the most prevalent diseases and concerns amongst women are cancer, reproductive health, maternal health, and osteoporosis (Fig.&#160;<xref rid="Fig1" ref-type="fig">1a&#8211;e</xref>)<sup><xref ref-type="bibr" rid="CR11">11</xref>,<xref ref-type="bibr" rid="CR12">12</xref></sup>. Moreover, biomonitoring technologies, such as wearable devices and point-of-care (POC) diagnostic tools, have gained attention due their ability to enable early detection and long-term health management of these conditions. This is done by measuring and analyzing personalized vitals, hormones and biomarkers<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>. In this review, we discuss the emerging and accessible technologies for the diagnosis and monitoring of women&#8217;s health amongst diverse populations, based on the WHO&#8217;s reports. We describe the advantages and limitations of these emerging technologies, identifying gaps and areas in need of more attention or development. Furthermore, we highlight how artificial intelligence (AI) and machine learning (ML) algorithms present an unparalleled opportunity for improving women&#8217;s health diagnostics by enhancing the accuracy of current tools in predicting health problems<sup><xref ref-type="bibr" rid="CR13">13</xref></sup>.<fig id="Fig1" position="float" orientation="portrait"><label>Fig. 1</label><caption><title>Overview of women&#8217;s health conditions.</title><p><bold>a</bold> Depiction of conditions over-represented in women. <bold>b</bold> Schematics are shown for the progression of gynecological conditions. <bold>c</bold> Depiction of breast health conditions, including breast tumors, adenomas, mammary duct abnormalities, and fibrocystic tissues. <bold>d</bold> Illustration of the monthly female hormonal cycle, highlighting the different phases of menstrual cycle. <bold>e</bold> The role of female hormones in the progression of postmenopausal osteoporosis and the activity of bone-related cells. Created in BioRender. Hosseinidoust, Z. (2025) <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://BioRender.com/t20f565">https://BioRender.com/t20f565</ext-link>.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e459" position="float" orientation="portrait" xlink:href="41467_2025_63501_Fig1_HTML.jpg"/></fig></p></sec><sec id="Sec2"><title>Wearable technologies for biomonitoring</title><p id="Par8">Advancements in bioengineered wearable technologies have enabled real-time, long-term self-monitoring, providing women with reliable health data and gaining traction in both research and clinical practice (Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>)<sup><xref ref-type="bibr" rid="CR14">14</xref></sup>. This section focuses on wearable technologies for monitoring female prevalent conditions recommended by the WHO (Supplementary Table&#160;<xref rid="MOESM1" ref-type="media">1</xref>)<sup><xref ref-type="bibr" rid="CR11">11</xref>,<xref ref-type="bibr" rid="CR12">12</xref></sup>. Additionally, critical conditions that remain underrepresented in wearable health monitoring solutions are discussed, such as cardiovascular disease (CVD) and chronic pain, because of the limited experimental data available on these conditions to inform wearable technology design parameters for women<sup><xref ref-type="bibr" rid="CR15">15</xref>,<xref ref-type="bibr" rid="CR16">16</xref></sup>. Literature on these conditions mainly report observational studies and qualitative assessments from small pools of women<sup><xref ref-type="bibr" rid="CR16">16</xref></sup>.<fig id="Fig2" position="float" orientation="portrait"><label>Fig. 2</label><caption><title>Depiction of wearable biomonitoring technologies.</title><p><bold>a</bold> Nocturnal BBT monitoring with wrist wearable and intravaginal temperature monitoring with wireless logger. <bold>b</bold> Components of adhesive patches in hormonal monitoring. <bold>c</bold> Adhesive patches in microfluidics for oestradiol and cortisol monitoring. <bold>d</bold> Antenna pair system in healthy breast tissues compared to malignant tumor tissue. <bold>e</bold> Smart clothing and textiles, such as smart bras for breast cancer monitoring, conductive yarn for sweat cortisol monitoring and in-sole sensors for osteoporosis gait monitoring. <bold>f</bold> Wireless biosensor using pH sensitive chips embedded in underwear, vaginal rings and tampon surfaces. Created in BioRender. Hosseinidoust, Z. (2025) <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://BioRender.com/t20f565">https://BioRender.com/t20f565</ext-link>.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e523" position="float" orientation="portrait" xlink:href="41467_2025_63501_Fig2_HTML.jpg"/></fig></p><sec id="Sec3"><title>Biometric monitoring for fertility and pregnancy health</title><p id="Par9">Monitoring fertility and maternal health is crucial for both the mother and child, as 810 and 6700 maternal and fetal deaths, respectively, occur every day<sup><xref ref-type="bibr" rid="CR17">17</xref>,<xref ref-type="bibr" rid="CR18">18</xref></sup>. Additionally, the WHO reports that, annually, 40 million women develop long-term health conditions during pregnancy<sup><xref ref-type="bibr" rid="CR19">19</xref></sup>. If left improperly diagnosed or unaddressed, these conditions negatively impact women&#8217;s lives for years after giving birth, showing a need for health monitoring solutions<sup><xref ref-type="bibr" rid="CR19">19</xref>,<xref ref-type="bibr" rid="CR20">20</xref></sup>. Women in low-income and low-middle income countries can especially benefit, as 92% of maternal deaths in these countries are preventable by addressing the lack of access to high-quality healthcare resources, well-informed clinical guidelines and reliable data on women&#8217;s reproductive health<sup><xref ref-type="bibr" rid="CR20">20</xref></sup>.</p><p id="Par10">Biometric parameter changes, trackable with wearable devices, are characterized by physiological fluctuations throughout the menstrual cycle and pregnancy<sup><xref ref-type="bibr" rid="CR21">21</xref></sup>. These parameters include basal body temperature (BBT)<sup><xref ref-type="bibr" rid="CR22">22</xref></sup>, peripheral temperature on the skin<sup><xref ref-type="bibr" rid="CR23">23</xref></sup>, sweat rate<sup><xref ref-type="bibr" rid="CR24">24</xref></sup>, and heart rate<sup><xref ref-type="bibr" rid="CR25">25</xref></sup>. Some wearables offer a non-invasive alternative for measuring these parameters compared to traditional clinical assessments that require physician facilitation. These include temperature measurements recorded with a thermometer either orally, rectally or intravaginally<sup><xref ref-type="bibr" rid="CR26">26</xref>&#8211;<xref ref-type="bibr" rid="CR28">28</xref></sup>, thermocouple or infrared sensor heat mapping conducted in clinics<sup><xref ref-type="bibr" rid="CR23">23</xref></sup>, and off-body sweat sample analyses performed in laboratories<sup><xref ref-type="bibr" rid="CR29">29</xref></sup>.</p><p id="Par11">Wearable devices for BBT monitoring should be capable of detecting fluctuations in the range of 0.5&#8211;0.8&#8201;&#176;C, as this is the typical variation observed throughout the menstrual cycle<sup><xref ref-type="bibr" rid="CR30">30</xref>,<xref ref-type="bibr" rid="CR31">31</xref></sup>. Generally, estradiol levels increase throughout the follicular phase, peaking at ovulation, which is associated with increased vasodilation and body cooling<sup><xref ref-type="bibr" rid="CR32">32</xref></sup>. Subsequently, after ovulation, high progesterone levels lead to body heating by affecting the hypothalamus and central nervous system to increase the body&#8217;s thermoregulatory setpoint<sup><xref ref-type="bibr" rid="CR27">27</xref>,<xref ref-type="bibr" rid="CR33">33</xref></sup>. The most common BBT monitoring wearables are wrist-worn activity trackers. However, the challenges with measuring daily BBT through smart activity watches and bracelets are that fluctuations throughout the day, depending on level of activity, lead to fluctuating accuracy<sup><xref ref-type="bibr" rid="CR31">31</xref></sup>. These trackers are best suited for detecting biometric changes at night, when the body is at rest<sup><xref ref-type="bibr" rid="CR31">31</xref></sup>.</p><p id="Par12">BBT monitoring via wearable technologies for intravaginal temperature tracking offers a stable and accurate method for continuous reproductive health assessment, compared to manual or wrist-worn recorded temperature measurements at specific timepoints each day (Fig.&#160;<xref rid="Fig2" ref-type="fig">2a</xref>)<sup><xref ref-type="bibr" rid="CR34">34</xref></sup>. Intravaginal loggers, once inserted, provide automated real-time temperature measurements over multiple days without the need for removal<sup><xref ref-type="bibr" rid="CR35">35</xref></sup>. These devices, such as OvuSense, show 69.2% acceptability rate amongst women, with 76.9% reporting convenience and comfort during use over three menstrual cycles<sup><xref ref-type="bibr" rid="CR36">36</xref></sup>.</p><p id="Par13">Wearable devices that monitor biometrics specific to pregnancy can provide an overall surveillance of the pregnancy&#8217;s trajectory<sup><xref ref-type="bibr" rid="CR37">37</xref></sup>. Pregnancy-specific biometrics include maternal heart rate (interchangeable with pulse rate but focused on mother rather than fetus)<sup><xref ref-type="bibr" rid="CR38">38</xref></sup>, maternal cardiac function (traditionally monitored via electrocardiogram (ECG) or transthoracic echocardiogram (TTE))<sup><xref ref-type="bibr" rid="CR39">39</xref></sup>, uterine contractions<sup><xref ref-type="bibr" rid="CR40">40</xref></sup>, blood oxygenation<sup><xref ref-type="bibr" rid="CR39">39</xref></sup> and sleep patterns<sup><xref ref-type="bibr" rid="CR41">41</xref></sup>. For instance, wearable soft sensor systems leveraging traditional methods, such as ECG, electrohysterogram (EHG), and Doppler ultrasound, that can be worn over the abdomen provide a comprehensive solution for maternal biometrics tracking<sup><xref ref-type="bibr" rid="CR42">42</xref></sup>. Moreover, sensors integrated into conductive clothing, referred to as smart textiles, offer a non-invasive approach to monitoring uterine contractions, maternal heart rate, and respiration<sup><xref ref-type="bibr" rid="CR43">43</xref>,<xref ref-type="bibr" rid="CR44">44</xref></sup>. Although still in early development, large-scale clinical testing is required to refine smart textiles for broader adoption.</p><p id="Par14">Gestational diabetes mellitus (GDM) is a common complication developed during pregnancy that can benefit from biometric-based wearable technologies. GDM affects ~14% of pregnant women worldwide and leads to 10<inline-formula id="IEq3"><alternatives><tex-math id="d33e673">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\times$$\end{document}</tex-math><mml:math id="d33e678"><mml:mo>&#215;</mml:mo></mml:math><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="41467_2025_63501_Article_IEq1.gif"/></alternatives></inline-formula> increase in the risk of postpartum type 2 diabetes<sup><xref ref-type="bibr" rid="CR45">45</xref>&#8211;<xref ref-type="bibr" rid="CR48">48</xref></sup>. GDM is characterized by an intolerance towards glucose that develops during the second or third trimester of pregnancy, with lifestyle being the number one risk factor<sup><xref ref-type="bibr" rid="CR45">45</xref>,<xref ref-type="bibr" rid="CR49">49</xref></sup>. Lifestyle factors impacting the likelihood of developing GDM include activity levels, body mass index (BMI), stress levels, nutrition, and sleep patterns<sup><xref ref-type="bibr" rid="CR45">45</xref>,<xref ref-type="bibr" rid="CR50">50</xref>,<xref ref-type="bibr" rid="CR51">51</xref></sup>. Wearable technologies are designed to continuously track and record pregnancy and diabetes biometric parameters, such as physical activity indicators (e.g., number of steps, sitting and standing occurrences, actigraphy, heart rate), blood and interstitial glucose levels, renal function, and circadian rhythm<sup><xref ref-type="bibr" rid="CR41">41</xref>,<xref ref-type="bibr" rid="CR45">45</xref>,<xref ref-type="bibr" rid="CR50">50</xref>&#8211;<xref ref-type="bibr" rid="CR53">53</xref></sup>.</p><p id="Par15">Commercial wearable tracking devices worn on the hips and wrists capture specific biometric data over long time frames, sufficient for second and third trimester monitoring and GDM detection<sup><xref ref-type="bibr" rid="CR45">45</xref></sup>. Such devices include the Abbott FreeStyle Libre Pro<sup><xref ref-type="bibr" rid="CR45">45</xref></sup> (interstitial glucose levels), Medtronic Guardian Connect<sup><xref ref-type="bibr" rid="CR50">50</xref></sup> (tissue glucose under the skin), CamNTech ActiHeart device<sup><xref ref-type="bibr" rid="CR45">45</xref></sup> and Firstbeat Bodyguard 2<sup><xref ref-type="bibr" rid="CR50">50</xref></sup> (focused on heart rate variability to detect abnormalities), GENEActiv<sup><xref ref-type="bibr" rid="CR45">45</xref></sup> (focused on sleep analysis), Exsed from UKK-Institute<sup><xref ref-type="bibr" rid="CR50">50</xref></sup> (focused on tracking movement), Vivosmart 3<sup><xref ref-type="bibr" rid="CR50">50</xref></sup> and Fitbit Charge 3<sup><xref ref-type="bibr" rid="CR53">53</xref></sup> (step count and speed). Combining these data onto one wearable device can provide a comprehensive lifestyle profile for pregnant women. For instance, Ava Bracelet trackers capture data on movement during sleep, sleep duration, pulse rate, breathing rate and skin peripheral temperature<sup><xref ref-type="bibr" rid="CR41">41</xref></sup>. These biometrics, collectively, provide results on sleep analysis, emotional states and stress levels throughout pregnancy and postpartum<sup><xref ref-type="bibr" rid="CR41">41</xref></sup>.</p><p id="Par16">On the research front, miniaturized electrochemical biosensors or immunosensors targeting biomarkers associated with disease progression show promise for GDM monitoring<sup><xref ref-type="bibr" rid="CR50">50</xref>,<xref ref-type="bibr" rid="CR54">54</xref></sup>. For instance, an electrochemical wearable technology, combining miniaturized circuitry, cost-effective material and microneedle sample collection, has been proposed for detecting &#946;-hydroxybutyrate and/or lactate alongside glucose. The former two being key components for the diabetes ketosis pathway seen in GDM<sup><xref ref-type="bibr" rid="CR55">55</xref>,<xref ref-type="bibr" rid="CR56">56</xref></sup>. This technology achieved a LOD of 50&#8201;&#956;M with 95% stability over 6&#8201;h in artificial interstitial fluid<sup><xref ref-type="bibr" rid="CR56">56</xref></sup>. Cystatin C (Cys-C) is another such biomarker shown to increase severity in the presence of GDM. Cys-C is associated with multiple metabolic and physiological mechanisms as well as adverse immunological, renal and fetal growth effects<sup><xref ref-type="bibr" rid="CR52">52</xref></sup>. In a label-free miniaturized electrochemical immunosensor wearable, leveraging screen-printed electrodes coated with MXene and gold nanoparticles, Cys-C ranges of 50&#8211;5000&#8201;ng/mL were monitored over 30 days when placed on skin<sup><xref ref-type="bibr" rid="CR52">52</xref>,<xref ref-type="bibr" rid="CR57">57</xref></sup>. Multiplex detection with dopamine and uric acid was also used to provide comprehensive insight into the renal function during GDM<sup><xref ref-type="bibr" rid="CR57">57</xref></sup>.</p><p id="Par17">Another important aspect of GDM management is reducing reported feelings of failure, anxiety, and powerlessness many pregnant women face after receiving a diagnosis of GDM<sup><xref ref-type="bibr" rid="CR50">50</xref></sup>. By tracking both self-reported and wearable monitored biometrics on accessible mobile health (mHealth) applications, pregnant women can remain informed about their own health and lifestyle decisions<sup><xref ref-type="bibr" rid="CR46">46</xref>,<xref ref-type="bibr" rid="CR58">58</xref></sup>. mHealth applications tracking nutritional health and blood glucose levels, inputted manually 3&#8211;6 times a day, are amongst the most used worldwide, such as GDm-Health (UK), Dnurse (China), MoTHER (Australia), MyDiabby (France), Diamond (Australia), and Pregnant+ (Norway)<sup><xref ref-type="bibr" rid="CR58">58</xref></sup>.</p><p id="Par18">Despite the notable advancements on this front, the main barrier faced is the need for accurate data interpretation to direct proper management of GDM<sup><xref ref-type="bibr" rid="CR49">49</xref></sup>. Currently, even with proper utilization of wearables and smartphone applications, many women seek healthcare provider support to understand the significance of collected mHealth data. These women report hesitance in making health decisions or behavioral changes without professional feedback<sup><xref ref-type="bibr" rid="CR50">50</xref></sup>. As such, wearable and mHealth technology are implemented as an enhancement to the clinical care for pregnant women rather than as a complete substitute<sup><xref ref-type="bibr" rid="CR46">46</xref></sup>.</p><p id="Par19">Next generation designs of these mHealth technologies are expected to leverage remote professional feedback tools built into user interfaces, which can increase adoption amongst different demographics<sup><xref ref-type="bibr" rid="CR50">50</xref>,<xref ref-type="bibr" rid="CR51">51</xref>,<xref ref-type="bibr" rid="CR58">58</xref></sup>. One example of such emerging wearable devices includes the Fitbit Flex activity and nutrition tracker, which incorporated a feedback and encouragement text messaging system to promote positive behaviors and lifestyle change goals<sup><xref ref-type="bibr" rid="CR48">48</xref></sup>. Another step for wearable pregnancy monitoring involves launching community outreach and education initiatives focused on the wearables technologies in clinics and healthcare systems, amongst pregnant women and their healthcare providers. Such initiatives will bridge digital literacy gaps and encourage users to adopt these technologies<sup><xref ref-type="bibr" rid="CR59">59</xref></sup>. Wireless and remote communication is also key, as it enables remote monitoring between pregnant women and their clinicians, allowing for telemedicine application in pregnancy care<sup><xref ref-type="bibr" rid="CR60">60</xref></sup>. Telemedicine has the advantage of allowing pregnant mothers to monitor their health alongside a health professional from the comfort of their home, reducing need for clinic visits<sup><xref ref-type="bibr" rid="CR60">60</xref></sup>. However, for these initiatives and communication platforms, diverse populations of women need to be considered, including those from different cultural backgrounds, age groups, socioeconomic standings and those with limited internet access<sup><xref ref-type="bibr" rid="CR61">61</xref>,<xref ref-type="bibr" rid="CR62">62</xref></sup>.</p></sec><sec id="Sec4"><title>Hormonal monitoring wearables</title><p id="Par20">While general biometric wearables, such as smartwatches and fitness trackers, provide useful data, they fail to capture the complexity of menstrual cycles, hormone therapies, and their physiological implications. Integrating hormone biosensors into existing platforms could enhance diagnostic capabilities and lead to more personalized healthcare solutions.</p><p id="Par21">Hormonal fluctuations play a central role in the menstrual cycle, influencing the fertility window and ovulation<sup><xref ref-type="bibr" rid="CR63">63</xref></sup>. In addition to progesterone and estradiol, other key hormones of the menstrual cycle include follicle-stimulating hormone (FSH), estrone-3-glucuronide (E1G), cortisol and pregnanediol glucuronide (PdG), which dip and peak at different phase of menstrual cycle<sup><xref ref-type="bibr" rid="CR64">64</xref></sup>. For example, sweat-based nanobiosensors integrated into microfluidic wearable devices show promise in detecting hormones non-invasively (Fig.&#160;<xref rid="Fig2" ref-type="fig">2b, c</xref>)<sup><xref ref-type="bibr" rid="CR63">63</xref>,<xref ref-type="bibr" rid="CR65">65</xref></sup>. Aptamers functionalized onto gold nanoparticle-MXene (AuNP-MXene) electrodes enable highly sensitive hormone detection at picomolar concentrations, significantly enhancing predictive accuracy<sup><xref ref-type="bibr" rid="CR66">66</xref></sup>.</p><p id="Par22">Cortisol is also a key biomarker of reduced bone health as it influences calcium absorption and bone metabolism leading to osteoporosis<sup><xref ref-type="bibr" rid="CR67">67</xref>,<xref ref-type="bibr" rid="CR68">68</xref></sup>. Electrochemical detection of osteoporosis using sweat-based wearables, including microfluidics, microneedles, and textiles, enable non-invasive cortisol detection (Fig.&#160;<xref rid="Fig2" ref-type="fig">2b,c</xref>)<sup><xref ref-type="bibr" rid="CR66">66</xref>,<xref ref-type="bibr" rid="CR69">69</xref>,<xref ref-type="bibr" rid="CR70">70</xref></sup>. Smart textiles incorporating modified carbon yarn fibers coated with iron oxide (Fe&#8322;O&#8323;)-based conductive nanomaterials can selectively detect cortisol via chemically crosslinked monoclonal antibodies in a miniaturized nanobiosensor platform (Fig.&#160;<xref rid="Fig2" ref-type="fig">2e</xref>)<sup><xref ref-type="bibr" rid="CR69">69</xref>,<xref ref-type="bibr" rid="CR71">71</xref></sup>. In addition, during pregnancy, cortisol monitoring is essential, as cortisol levels are 2&#8211;4<inline-formula id="IEq4"><alternatives><tex-math id="d33e931">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\times$$\end{document}</tex-math><mml:math id="d33e936"><mml:mo>&#215;</mml:mo></mml:math><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="41467_2025_63501_Article_IEq1.gif"/></alternatives></inline-formula> higher when pregnant <italic toggle="yes">vs</italic>. non-pregnant, which has been correlated with bone loss<sup><xref ref-type="bibr" rid="CR72">72</xref>,<xref ref-type="bibr" rid="CR73">73</xref></sup>. One device that has the potential to address this risk by targeting cortisol monitoring in pregnant women is U-RHYTHM, which can monitor 24-hr ultradian rhythm fluctuations of cortisol and its derivates in the serum of pregnant women with different body weights<sup><xref ref-type="bibr" rid="CR25">25</xref>,<xref ref-type="bibr" rid="CR74">74</xref></sup>. By collecting data on multiple hormonal signals, devices such as U-RHYTHM enable deeper investigations of underlying biological mechanisms associated with changes in these signals<sup><xref ref-type="bibr" rid="CR25">25</xref>,<xref ref-type="bibr" rid="CR74">74</xref></sup>.</p><p id="Par23">Despite established correlations between hormonal changes and women-prevalent conditions, for chronic pain<sup><xref ref-type="bibr" rid="CR75">75</xref></sup>, endometriosis<sup><xref ref-type="bibr" rid="CR76">76</xref></sup>, polycystic ovarian syndrome (PCOS)<sup><xref ref-type="bibr" rid="CR77">77</xref></sup>, osteoarthritis<sup><xref ref-type="bibr" rid="CR78">78</xref></sup>, CVD<sup><xref ref-type="bibr" rid="CR79">79</xref></sup>, and lung cancer<sup><xref ref-type="bibr" rid="CR80">80</xref></sup>, no wearable technologies currently exist target these conditions<sup><xref ref-type="bibr" rid="CR81">81</xref></sup>. For instance, endometriosis, characterized by chronic menstrual pain, is associated with abnormal hormone levels<sup><xref ref-type="bibr" rid="CR76">76</xref></sup>. Gonadotropin-releasing hormone (GnRH) agonists, commonly used for treatment, ultimately suppress FSH, LH, and estrogen levels, leading to temporary menopause-like states and reducing bone density<sup><xref ref-type="bibr" rid="CR82">82</xref></sup>. However, no wearable devices exist for real-time hormone tracking before, during, or after endometriosis treatment. Similarly, testosterone is the key biomarker for PCOS diagnosis, yet there are no at-home biomonitoring solutions for its detection<sup><xref ref-type="bibr" rid="CR83">83</xref></sup>. Estrogen is also particularly relevant for various health conditions, including migraines, fibromyalgia, CVD, and lung cancer<sup><xref ref-type="bibr" rid="CR80">80</xref>,<xref ref-type="bibr" rid="CR84">84</xref>&#8211;<xref ref-type="bibr" rid="CR86">86</xref></sup>.</p><sec id="Sec5"><title>Transgender considerations in wearables design</title><p id="Par24">The literature on women&#8217;s health wearable technologies focuses disproportionately on design parameters, usability and experiences of cisgender women. However, a gender identity gap is also present in medical practice<sup><xref ref-type="bibr" rid="CR87">87</xref></sup>. Little consideration in medical literature has been given to transgender experiences, before, during and after undergoing transition<sup><xref ref-type="bibr" rid="CR88">88</xref></sup>. Fertility is another consideration regarding this health gap, as 76% of transgender individuals consider fertility preservation before transitioning. Yet only 12% successfully preserve their fertility, due to limited health guidelines<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>. As well, there is almost no collected and reported medical data for monitoring transgender health conditions, with little information on the potential effects of gender affirming hormone therapy on the body<sup><xref ref-type="bibr" rid="CR89">89</xref>,<xref ref-type="bibr" rid="CR90">90</xref></sup>. Wearables for hormone-based monitoring of gender affirming therapy can allow transgender individuals to feel confident in how their body is transitioning through tangible, accessible data<sup><xref ref-type="bibr" rid="CR91">91</xref></sup>.</p><p id="Par25">For transgender women, undergoing male-to-female transition, estrogen therapy requires the reduction of testosterone from 200&#8201;ng/dL (biological male levels) to 75&#8201;ng/dL (biological female levels), by intaking estrogen promoting drugs, thereby increasing estrogen and progesterone levels in the body<sup><xref ref-type="bibr" rid="CR89">89</xref>,<xref ref-type="bibr" rid="CR90">90</xref></sup>. When monitoring male-to-female transition, estrogen hormone therapy is a key factor for wearables design as it can lead to increased risk of disease by which estrogen is an underlying mechanism<sup><xref ref-type="bibr" rid="CR92">92</xref></sup>. Additionally, one of the main side effects of estrogen promoting drugs, such as cyproterone acetate, includes increased depression and hyperprolactinemia<sup><xref ref-type="bibr" rid="CR90">90</xref></sup>.</p><p id="Par26">Outside of hormone therapy, lifestyle factors play a key role in the development of long-term health conditions amongst the transgender population<sup><xref ref-type="bibr" rid="CR88">88</xref>,<xref ref-type="bibr" rid="CR93">93</xref></sup>. For instance, lifestyle habits such as drinking alcohol, smoking and diet, influences the chances of developing breast cancer for transgender individuals<sup><xref ref-type="bibr" rid="CR88">88</xref>,<xref ref-type="bibr" rid="CR93">93</xref></sup>. Additionally, gender dysphoria, experienced by transgender women and men, often leads to anxiety, depression and substance abuse, which can in turn affect biometrics like heart rate and sleep patterns<sup><xref ref-type="bibr" rid="CR94">94</xref>&#8211;<xref ref-type="bibr" rid="CR97">97</xref></sup>. As such, a combined biometric and hormonal wearable device that takes gender identity into account would greatly improve experiences of transition<sup><xref ref-type="bibr" rid="CR91">91</xref></sup>. Other challenges to overcome for transgender health technologies are the scarcity of health professionals knowledgeable in transgender health to assist in data interpretation, limited healthcare infrastructure to inform device design and integration into transgender lives, and lack of medical insurance plans supporting gender identity to receive high quality health care<sup><xref ref-type="bibr" rid="CR88">88</xref>,<xref ref-type="bibr" rid="CR91">91</xref></sup>.</p></sec></sec><sec id="Sec6"><title>Wearables tracking abnormal tissues using imaging modalities</title><p id="Par27">For various female-prevalent diseases, the clinical gold standard for diagnostics is imaging abnormal tissue growth or rapid tissue loss<sup><xref ref-type="bibr" rid="CR98">98</xref>&#8211;<xref ref-type="bibr" rid="CR100">100</xref></sup>. For imaging tissue growths amongst women, the breast is an organ of concern as 50% of women develop fibro cysts<sup><xref ref-type="bibr" rid="CR98">98</xref></sup>, and 25% develop benign tumors<sup><xref ref-type="bibr" rid="CR100">100</xref></sup>, referred to as fibroadenomas, over their lifetime. Mammography and ultrasound are the international standard of screening and diagnosing patients<sup><xref ref-type="bibr" rid="CR101">101</xref>&#8211;<xref ref-type="bibr" rid="CR103">103</xref></sup>. Similarly, osteoporosis in women is correlated with low estrogen levels that occur after menopause, resulting in lack of estrogen binding to osteoblasts and increased secretion of cytokines that promote osteoclast differentiation of progenitor cells. Ultimately, this leads to overactivity of bone resorption by high numbers of active osteoclasts (Fig.&#160;<xref rid="Fig1" ref-type="fig">1e</xref>)<sup><xref ref-type="bibr" rid="CR104">104</xref></sup>. For this objective, women aged over 50 years old, tissue loss particularly in bones, leads to 4<inline-formula id="IEq5"><alternatives><tex-math id="d33e1129">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\times$$\end{document}</tex-math><mml:math id="d33e1134"><mml:mo>&#215;</mml:mo></mml:math><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="41467_2025_63501_Article_IEq1.gif"/></alternatives></inline-formula> higher occurrences of osteoporosis compared to men<sup><xref ref-type="bibr" rid="CR105">105</xref></sup>. Regarding bone loss, x-ray-based imaging in hospitals, such as dual-energy x-ray or computed tomography, is the most common diagnostic method<sup><xref ref-type="bibr" rid="CR106">106</xref></sup>.</p><p id="Par28">While effective, these gold standard diagnostic methods are limited in accessibility, relying on highly expensive equipment and healthcare systems<sup><xref ref-type="bibr" rid="CR107">107</xref></sup>. In communities and countries with limited resources and funding for medical equipment, wearable imaging modality technologies, in comparison, provide cost-effective and resource-efficient alternatives<sup><xref ref-type="bibr" rid="CR108">108</xref>,<xref ref-type="bibr" rid="CR109">109</xref></sup>. Also, early onset diagnostics are limited, but having these conditions determined at early stages can prevent worsening disease symptomology<sup><xref ref-type="bibr" rid="CR110">110</xref></sup>. Additionally, many reports from women indicate feelings of discomfort, fear and anxiety before and after undergoing diagnostic imaging because of prolonged wait times to receive results<sup><xref ref-type="bibr" rid="CR107">107</xref></sup>. To address these concerns, emerging literature points to miniaturizing and integrating of imaging modalities into wearable devices for a faster result<sup><xref ref-type="bibr" rid="CR107">107</xref></sup>.</p><p id="Par29">Sensing antenna development is a promising component of breast imaging wearables<sup><xref ref-type="bibr" rid="CR111">111</xref>&#8211;<xref ref-type="bibr" rid="CR113">113</xref></sup>. Antennas transmit electromagnetic waves (e.g., microwaves, ultrasound, or infrared) into breast tissue, with reflection analyzed to differentiate healthy from malignant tissue based on stiffness and density differences (109&#8211;167&#8201;kPa for cancerous vs. 10.9&#8211;12.4&#8201;kPa for normal tissue) (Fig.&#160;<xref rid="Fig2" ref-type="fig">2d</xref>)<sup><xref ref-type="bibr" rid="CR113">113</xref>,<xref ref-type="bibr" rid="CR114">114</xref></sup>. While sensing antenna systems can provide full breast imaging, high probe counts (16&#8211;512 antennas) complicate user adoption. Recent developments in omnidirectional antennas, which allow simultaneous signal transmission and acquisition, have reduced probe requirements, improving user comfort<sup><xref ref-type="bibr" rid="CR115">115</xref></sup>. Regardless, these systems remain technically complex and require clinical expertise for data interpretation.</p><p id="Par30">Ultrasound breast patches offer better structural flexibility and compatibility with existing ultrasound imaging techniques and have thus been proposed as a preferred alternative for breast diagnostics and screening<sup><xref ref-type="bibr" rid="CR115">115</xref></sup>. Full breast monitoring and deep tissue imaging of cysts as small as 0.3&#8201;cm has been reported with ultrasound breast patches composed of crystalline materials, making them a viable option for early-onset detection<sup><xref ref-type="bibr" rid="CR115">115</xref></sup>. An additional advantage of crystal-based patches is their ability to detect electromagnetic waves in the terahertz frequency range, which is safer for patients and more compatible with current clinical workflows than microwave or infrared imaging<sup><xref ref-type="bibr" rid="CR116">116</xref>,<xref ref-type="bibr" rid="CR117">117</xref></sup>. However, these patches are typically single-use and require clinical evaluation, limiting their application for continuous at-home monitoring<sup><xref ref-type="bibr" rid="CR115">115</xref>,<xref ref-type="bibr" rid="CR116">116</xref></sup>.</p><p id="Par31">Smart textiles provide a practical solution for everyday breast health monitoring by incorporating wireless sensors into fabrics like cotton, polyester, nylon, and denim (Fig.&#160;<xref rid="Fig2" ref-type="fig">2e</xref>)<sup><xref ref-type="bibr" rid="CR112">112</xref>,<xref ref-type="bibr" rid="CR118">118</xref>,<xref ref-type="bibr" rid="CR119">119</xref></sup>. Textile-based antennas, either stand-alone or embedded into smart bras, can be implemented to measure tumor size and detect tissue abnormalities<sup><xref ref-type="bibr" rid="CR120">120</xref></sup>. These antennas leverage scalable textile manufacturing techniques, such as high-throughput weaving, making them viable for commercial production<sup><xref ref-type="bibr" rid="CR121">121</xref></sup>. Wireless connectivity allows real-time data transmission to smartphone applications, allowing women to monitor their breast health autonomously<sup><xref ref-type="bibr" rid="CR119">119</xref></sup>. Currently, most wearable breast health technologies and smart bras focus exclusively on breast cancer detection. However, conditions such as fibroadenomas and fibrocystic breasts, which involve benign tissue growths, could also benefit from similar wearable monitoring approaches. Future iterations of smart textiles and biosensors should be adapted to differentiate between benign and malignant tissue, expanding their diagnostic and preventative monitoring capabilities<sup><xref ref-type="bibr" rid="CR122">122</xref></sup>.</p><p id="Par32">Imaging and tracking wearables can also help in early management of osteoporosis. Osteoporosis is a musculoskeletal condition characterized by bone mineral density (BMD) loss due to heightened osteoclast activity<sup><xref ref-type="bibr" rid="CR123">123</xref></sup>. The decline in estrogen levels and high potential of developing osteoporosis during menopause accelerates bone resorption, increasing the risk of falls, fracture, sarcopenia and total hip arthroplasty (THA)<sup><xref ref-type="bibr" rid="CR124">124</xref>,<xref ref-type="bibr" rid="CR125">125</xref></sup>. Gait pattern can be assessed through motion sensors-based mapping and accelerometry, in combination with biometrics such as oximetry and cardiac monitoring, incorporated into wearable devices<sup><xref ref-type="bibr" rid="CR126">126</xref></sup>. Optical polymer fibers in textiles and walking devices track gait through heart rate, respiration, and gait cadence<sup><xref ref-type="bibr" rid="CR127">127</xref></sup>. Meanwhile, in-sole gait monitoring sensors utilizing inertial measurement units (IMUs) offer a discreet, real-time assessment (Fig.&#160;<xref rid="Fig2" ref-type="fig">2e</xref>)<sup><xref ref-type="bibr" rid="CR125">125</xref></sup>. For postmenopausal women, wearable sensors embedded in textiles or shoes are easily adoptable and can enhance compliance for more accurate monitoring. Regardless, these gait sensors primarily focus on regular walking patterns, with limited data on dynamic movements like exercise or abnormal walking patterns.</p><p id="Par33">Wearables measuring BMD provide a more direct strategy for monitoring osteoporosis compared to gait. For instance, emerging wearable armbands use ultrasonic transduction to measure BMD, detecting femoral ultrasonic velocity (3404.46&#8201;m&#8201;s<sup>&#8722;1</sup>) and identifying osteoporosis through T-score testing (T-score&#8201;&#8804;&#8201;&#8722;2.5)<sup><xref ref-type="bibr" rid="CR128">128</xref></sup>. Regardless, BMD abnormalities can also indicate conditions like rheumatoid arthritis, osteoarthritis, and Parkinson&#8217;s Disease, requiring BMD monitoring to be paired with electrochemical biosensing to enhance diagnostic precision<sup><xref ref-type="bibr" rid="CR129">129</xref>&#8211;<xref ref-type="bibr" rid="CR131">131</xref></sup>. These wearables, while promising, have not been assessed with large participant populations of elderly, menopausal women, and will require preclinical and clinical trials before being brought to market.</p></sec><sec id="Sec7"><title>Wireless wearable technologies for vaginal infection</title><p id="Par34">Vaginitis, or vaginal infection, one of the most common reasons women seek medical attention, impacts sexual and reproductive health<sup><xref ref-type="bibr" rid="CR132">132</xref></sup>. Symptoms include itching, pain, abnormal discharge, and odor, often leading to feelings of embarrassment, anxiety, and reduced quality of life<sup><xref ref-type="bibr" rid="CR133">133</xref>,<xref ref-type="bibr" rid="CR134">134</xref></sup>. The three most common types of vaginitis are bacterial vaginosis (BV), vulvovaginal candidiasis (VVC), and trichomoniasis<sup><xref ref-type="bibr" rid="CR135">135</xref>,<xref ref-type="bibr" rid="CR136">136</xref></sup>.</p><p id="Par35">BV, the most frequent vaginal infection among reproductive-age women, is characterized by microbiome imbalances, particularly a loss of <italic toggle="yes">Lactobacilli</italic> and an overgrowth of anaerobic bacteria such as <italic toggle="yes">Gardnerella</italic>, <italic toggle="yes">Prevotella</italic>, and <italic toggle="yes">Mobiluncus</italic><sup><xref ref-type="bibr" rid="CR132">132</xref>,<xref ref-type="bibr" rid="CR134">134</xref></sup>. Diagnosis traditionally relies on microscopy-based Nugent scoring and Amsel&#8217;s criteria, assessing discharge appearance, odor, and vaginal pH (pH&#8201;&gt;&#8201;4.5). However, these methods suffer from poor sensitivity, inter-observer variability, and reliance on skilled personnel<sup><xref ref-type="bibr" rid="CR132">132</xref></sup>. Similarly, VVC and trichomoniasis are diagnosed through microscopy, and in vitro pH assessment, both of which have limited accuracy<sup><xref ref-type="bibr" rid="CR136">136</xref></sup>. Polymerase Chain Reaction (PCR) diagnostic techniques enhance the specificity and sensitivity of detection by leveraging molecular mechanisms through microorganism DNA detection in biological samples<sup><xref ref-type="bibr" rid="CR137">137</xref></sup>. Regardless, current PCR platforms are only used for clinical and laboratory testing as equipment is costly and requires trained personnel, making it difficult for at-home monitoring<sup><xref ref-type="bibr" rid="CR137">137</xref></sup>.</p><p id="Par36">Research on wearable vaginal infection diagnostics remains limited, underscoring the need for further innovation. Several pH-based biosensors have been developed for BV and VVC detection. For example, intravaginal biosensing rings monitor pH levels continuously using a fluorescent polyelectrolyte-coated porous silica sensor on a PDMS ring<sup><xref ref-type="bibr" rid="CR138">138</xref></sup>. Similarly, a startup company, ALMA, reported the development of biosensing underwear that integrates potentiometric and amperometric sensors into the gusset to track vaginal pH and lactate levels<sup><xref ref-type="bibr" rid="CR139">139</xref></sup>. Additionally, waterproof electronic decals (WPEDs) mounted on tampons measure vaginal fluid pH, transmitting data wirelessly to a smartphone (Fig.&#160;<xref rid="Fig2" ref-type="fig">2f</xref>)<sup><xref ref-type="bibr" rid="CR140">140</xref></sup>.</p><p id="Par37">These biosensors provide cost-effective, real-time data, but they also face design challenges related to comfort, durability, safety, and hygiene. Issues with adhesion, connectivity, and interference from biological fluids (e.g., menstrual blood) further complicate their adoption. Additionally, pH monitoring alone is insufficient for definitive diagnosis, as abnormal pH is common to both BV and trichomoniasis, necessitating supplementary diagnostic methods<sup><xref ref-type="bibr" rid="CR141">141</xref></sup>.</p><p id="Par38">Beyond pH sensing, innovative biosensors targeting specific vaginal pathogens could enhance diagnostic accuracy. For instance, a thiolated aptamer-based AuNP sensor detects glucans on <italic toggle="yes">Candida albicans</italic>, triggering a colorimetric change from pink to blue upon pathogen detection. Compared to pH-based approaches, this method has increased specificity for VVC<sup><xref ref-type="bibr" rid="CR142">142</xref></sup>. However, its usability may be hindered by both the subjective interpretation of results by non-experts and the complexity of the device&#8217;s assembly process, such as calibration and user interface navigation<sup><xref ref-type="bibr" rid="CR143">143</xref></sup>.</p><p id="Par39">Despite advances in BV and VVC detection, wearable diagnostics for trichomoniasis remain unexplored. Expanding biosensor technologies to include pathogen-specific markers and multi-analyte detection could facilitate at-home vaginal health monitoring, offering more accurate, accessible, and user-friendly solutions.</p></sec></sec><sec id="Sec8"><title>Portable diagnostics of women-prevalent conditions</title><p id="Par40">Portable diagnostic devices have notable advantages including POC, real-time results, and minimal infrastructure requirements, making them particularly beneficial for women&#8217;s health. However, research and development efforts have largely focused on vaginitis and cancer, leaving many other conditions unexplored. Expanding existing POC technology could substantially improve diagnostic accessibility and quality of life. WHO emphasizes that POC devices should align with ASSURED criteria&#8212;affordable, sensitive, specific, user-friendly, rapid, equipment-free, and deliverable<sup><xref ref-type="bibr" rid="CR144">144</xref></sup>.</p><sec id="Sec9"><title>Point-of-care technologies for vaginal infection detection</title><p id="Par41">Timely and accurate detection of vaginitis is crucial, particularly in pregnancy, to prevent complications<sup><xref ref-type="bibr" rid="CR145">145</xref></sup>. Recent efforts have focused on low-cost microfluidic, paper-based, and electrochemical POC devices. The two most common approaches for vaginal infection detection are enzyme-activity-based and DNA-based methods.</p><sec id="Sec10"><title>Enzyme-activity-based technology for POC devices</title><p id="Par42">Bacterial enzymes such as vaginolysin (VLY) and sialidase (SLD) are key virulence factors in BV<sup><xref ref-type="bibr" rid="CR146">146</xref></sup>. SLDs, found commonly in vaginal discharge, play a crucial role in cleaving sialic acid from cervicovaginal mucus and epithelial cells, promoting bacterial growth, biofilm formation, and toxin formation (Fig.&#160;<xref rid="Fig3" ref-type="fig">3a</xref>). Bacterial SLDs also is associated with undesirable pregnancy outcomes and preterm birth<sup><xref ref-type="bibr" rid="CR146">146</xref>&#8211;<xref ref-type="bibr" rid="CR149">149</xref></sup>.<fig id="Fig3" position="float" orientation="portrait"><label>Fig. 3</label><caption><title>Diagnostic devices for women-prevalent conditions.</title><p><bold>a</bold> The mechanism of SLD activity, whereby disialylation of sialoglycon improves bacterial adhesion and biofilm formation. <bold>b</bold> LAMP-based lateral flow strips steps: DNA amplification accrues during the 1&#8201;h at isothermal condition; the test line of strip immobilized with anti-FAM antibody; conjugation with biotin/FAM-modified DNA; capturing streptavidin-modified AuNPs; test line signal. Copyright 2022 Frontiers<sup><xref ref-type="bibr" rid="CR158">158</xref></sup>. <bold>c</bold> Biomarker enrichment methods used for breast and gynecological cancer detection. <bold>d</bold> Microfluidic platform technology such as lateral displacement, &#181;-sieving, and channel surface modifications can be used for enrichment based on physical properties such as size and surface charges. Created in BioRender. Hosseinidoust, Z. (2025) <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://BioRender.com/t20f565">https://BioRender.com/t20f565</ext-link>.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e1452" position="float" orientation="portrait" xlink:href="41467_2025_63501_Fig3_HTML.jpg"/></fig></p><p id="Par43">SLD has been the target of numerous colorimetric and fluorescent biosensors. A reported colorimetric biosensor uses 20-(5-bromo-4-chloroindol-3-yl)-a-D-N-acetyl-neuraminic acid (BCIN), which changes color upon contact with vaginal fluid containing SLD<sup><xref ref-type="bibr" rid="CR150">150</xref></sup>. To enhance reaction speed and enzyme absorption, poly(ethyleneimine) is used as a catalyst<sup><xref ref-type="bibr" rid="CR150">150</xref>,<xref ref-type="bibr" rid="CR151">151</xref></sup>. Although colorimetric biosensors are user-friendly, they often lack quantitative precision. To improve sensitivity, fluorescent SLD detection can be leveraged alongside colorimetric methods. Disposable Y-shaped paper-based biosensors or well-plate sensing platforms incorporate cadmium selenide zinc sulfide (CdSe@ZnS) quantum dots (QDs) or fluorescein isothiocyanate (FITC)-modified antibodies can achieve quantifiable results through fluorescence<sup><xref ref-type="bibr" rid="CR148">148</xref>,<xref ref-type="bibr" rid="CR152">152</xref></sup>.</p></sec><sec id="Sec11"><title>LAMP-based POC devices</title><p id="Par44">In the diagnosis of VVC, chlamydia trachomatis (CT), and neisseria gonorrhoeae (NG), current gold standard tests include cell culture technology, enzyme-linked immunosorbent assays (ELISAs), nucleic acid amplification tests (NAATs), and PCR-based assays. Of these methods, PCR is the most clinically used as it has &gt;90% sensitivity and specificity<sup><xref ref-type="bibr" rid="CR153">153</xref>,<xref ref-type="bibr" rid="CR154">154</xref></sup>. These techniques, while effective in clinics, are time consuming, labor some and difficult to incorporate into at-home POC devices.</p><p id="Par45">More accessible POC-compatible alternatives to PCR are loop-mediated isothermal amplification (LAMP) and recombinase polymerase amplification (RPA). LAMP is a rapid, low-cost, and straightforward method for nucleic acid amplification, capable of amplifying the target gene within one hour under an isothermal cycle (50&#8211;60&#8201;&#176;C) (Fig.&#160;<xref rid="Fig3" ref-type="fig">3b</xref>)<sup><xref ref-type="bibr" rid="CR153">153</xref></sup>. In comparison, RPA operates at lower temperatures (37&#8211;42&#8201;&#176;C) and requires fewer primers. Although RPA is more temperature-flexible, LAMP is more widely used due to its resistance to inhibitors, making it ideal for complex clinical samples such as blood and vaginal fluids<sup><xref ref-type="bibr" rid="CR153">153</xref>,<xref ref-type="bibr" rid="CR155">155</xref>,<xref ref-type="bibr" rid="CR156">156</xref></sup>.</p><p id="Par46">While lateral flow assays (LFAs) are commonly used in BV POC biosensors, they lack the sensitivity and speed of NAATs<sup><xref ref-type="bibr" rid="CR137">137</xref>,<xref ref-type="bibr" rid="CR157">157</xref></sup>. To overcome this, LAMP-integrated lateral flow assays (LILFAs) have been developed for multiplex detection of NG and CT. LILFAs utilize biotin- and fluorescein-labeled DNA probes, forming a sandwich-like structure upon target binding, enhancing detection accuracy<sup><xref ref-type="bibr" rid="CR158">158</xref></sup>. However, LILFAs remain qualitative, and further research is needed to incorporate quantitative fluorescence-based detection for bacterial load analysis and infection staging<sup><xref ref-type="bibr" rid="CR157">157</xref>,<xref ref-type="bibr" rid="CR159">159</xref></sup>.</p></sec><sec id="Sec12"><title>Bacteriophage-based biosensing technologies</title><p id="Par47">Bacteriophage (phage)-based biosensing is an emerging tool for the detection of bacterial pathogens in various settings<sup><xref ref-type="bibr" rid="CR160">160</xref>,<xref ref-type="bibr" rid="CR161">161</xref></sup>. Phages selectively infect bacteria, injecting genetic material for replication, making them ideal for highly specific bio-probes in electrochemical and optical biosensors<sup><xref ref-type="bibr" rid="CR162">162</xref></sup>. While phage-based diagnostics have been applied in various medical fields, no studies have explored their use in vaginal infection detection. Given their specificity, low-cost, rapid detection, and low detection limits, phage biosensors hold promise for BV diagnostics and multi-pathogen detection in the future<sup><xref ref-type="bibr" rid="CR163">163</xref></sup>.</p></sec></sec><sec id="Sec13"><title>Diagnostic technologies for breast and gynecological cancers</title><p id="Par48">Early cancer detection significantly improves survival rates by enabling timely, less invasive treatment<sup><xref ref-type="bibr" rid="CR164">164</xref></sup>. However, 31% of breast cancer and 49% of cervical cancer diagnoses occur at late stages<sup><xref ref-type="bibr" rid="CR165">165</xref></sup>. As a result, five-year survival rates drastically lower, from 93% (stage 1) to 26.9% (stage 3) and 13.4% (stage 4)<sup><xref ref-type="bibr" rid="CR166">166</xref></sup>. Current detection methods&#8212;ultrasound, computed tomography, and magnetic resonance imaging (MRI)&#8212;lack sensitivity for early-stage diagnosis, are costly, or involve toxic chemicals<sup><xref ref-type="bibr" rid="CR164">164</xref></sup>. POC diagnostics can enhance early biomarker isolation and detection, as summarized in Supplementary Table&#160;<xref rid="MOESM1" ref-type="media">2</xref>.</p><sec id="Sec14"><title>Enrichment of early-stage women cancer biomarkers</title><p id="Par49">Serological biomarkers are commonly used in immunosensors, ELISAs, and PCR, with key breast and gynecological cancer biomarkers including breast cancer associated gene 1 and 2 (BRCA1 and BRCA2), cancer antigen-125 (CA-125), human epididymis protein 4 (HE-4), mesothelin alpha fetoprotein, osteopontin, human epidermal growth factor receptor 2 (HER2), and human papillomavirus (HPV) virus. However, these markers may overlap with non-cancerous conditions, leading to false negatives<sup><xref ref-type="bibr" rid="CR167">167</xref>,<xref ref-type="bibr" rid="CR168">168</xref></sup>. For instance, CA-125 is not detectable amongst 50% of women in the first stage of ovarian cancer<sup><xref ref-type="bibr" rid="CR169">169</xref></sup>. Moreover, traditional solid-tissue biopsies are invasive and fail to capture tumor heterogeneity in real time<sup><xref ref-type="bibr" rid="CR170">170</xref></sup>. In comparison, liquid biopsies offer a timely, non-invasive method for cancer detection of a diverse range of biomarkers, found in body fluids such as blood, urine, and saliva<sup><xref ref-type="bibr" rid="CR171">171</xref>,<xref ref-type="bibr" rid="CR172">172</xref></sup>.</p><p id="Par50">Alternative biomarkers for cancer detection focus on biomolecules secreted by breast and gynecological cancer cells into biological fluids, such as extracellular vehicles (EVs), circulating tumor DNA (ctDNA), microRNA (miRNA), and cancer-derived lipids or proteins. For example, exosomes, ranging from 30 to 200&#8201;nm in size, can also be secreted by cancer cells into body fluids at different stages of cancer development depending on the cancer type<sup><xref ref-type="bibr" rid="CR141">141</xref>,<xref ref-type="bibr" rid="CR142">142</xref></sup>. Additionally, circulating tumor cells (CTCs)&#8212;shed from tumors during early metastasis&#8212;serve as early-stage cancer biomarkers<sup><xref ref-type="bibr" rid="CR173">173</xref>,<xref ref-type="bibr" rid="CR174">174</xref></sup>. As all these biomarkers are found in fluid, future diagnostic methods will shift towards liquid biopsies, minimizing the reliance on more invasive solid tumor biopsy, which can severely alter the structure and function of female tissues<sup><xref ref-type="bibr" rid="CR175">175</xref></sup>.</p><p id="Par51">Despite their promise, CTC concentrations in biological fluids are extremely low (1&#8211;100 CTCs per million hemocytes), necessitating isolation and enrichment<sup><xref ref-type="bibr" rid="CR174">174</xref></sup>. Conventional methods (flow cytometry, ELISA, ultracentrifugation) are time-consuming, costly, and inefficient for detecting exosomes (&lt;200&#8201;nm)<sup><xref ref-type="bibr" rid="CR176">176</xref></sup>. Two key alternative techniques for biomarker isolation with minimal structural disruption and high size resolution are biochemical and biophysical separation<sup><xref ref-type="bibr" rid="CR175">175</xref>,<xref ref-type="bibr" rid="CR177">177</xref>,<xref ref-type="bibr" rid="CR178">178</xref></sup>.</p><p id="Par52">Biochemical enrichment relies on biomarker interaction with biorecognition molecules. Magnetic beads (MBs) functionalized with cancer-specific probes enhance biomarker isolation in liquid biopsies. In addition, folate receptors, overexpressed in breast and ovarian cancers, are ideal MB targets for CTC capture (Fig.&#160;<xref rid="Fig3" ref-type="fig">3c</xref>)<sup><xref ref-type="bibr" rid="CR179">179</xref>,<xref ref-type="bibr" rid="CR180">180</xref></sup>. However, biochemical methods are limited to singleplex detection, requiring multiple probes for multiplexing<sup><xref ref-type="bibr" rid="CR181">181</xref></sup>. Microfluidic chips, with micrometric channels for single-cell studies, reduce sample volume and costs, making them widely adopted for cancer detection<sup><xref ref-type="bibr" rid="CR182">182</xref>,<xref ref-type="bibr" rid="CR183">183</xref></sup>.</p><p id="Par53">Biophysical separation, a label-free approach, overcomes biochemical limitations by utilizing filtration, inertial forces, ultrasound, or electrical fields<sup><xref ref-type="bibr" rid="CR181">181</xref></sup>. Recent studies combine size, charge affinity, and surface modifications for enhanced isolation (Fig.&#160;<xref rid="Fig3" ref-type="fig">3d</xref>)<sup><xref ref-type="bibr" rid="CR184">184</xref>,<xref ref-type="bibr" rid="CR185">185</xref></sup>. For example, CTCs preferentially adhere to positively charged surfaces, such as lipid or polymer-modified surfaces, leveraging their stronger negative charge compared to normal cells<sup><xref ref-type="bibr" rid="CR181">181</xref>,<xref ref-type="bibr" rid="CR186">186</xref></sup>. CTCs can also be enriched through filtration or binding to antibody-functionalized polymeric nanoparticles (e.g., polystyrene), then collected downstream in a microfluidic chip<sup><xref ref-type="bibr" rid="CR156">156</xref>,<xref ref-type="bibr" rid="CR157">157</xref></sup>.</p><p id="Par54">Exosome isolation can also be achieved via surface charge manipulation. Chitosan-coated microfluidic channels, sensitive to pH changes, allow negatively charged exosomes to bind during sample flow. After capture and sample removal, pH modulation releases the exosomes, facilitating collection<sup><xref ref-type="bibr" rid="CR186">186</xref></sup>. This approach can be further enhanced by combining size and charge-based separation<sup><xref ref-type="bibr" rid="CR181">181</xref></sup>.</p></sec><sec id="Sec15"><title>POC technologies for breast and gynecological cancer</title><p id="Par55">Standard cancer diagnostics require trained personnel and hospital-based equipment, limiting accessibility, particularly for women with restricted healthcare access. At-home POC devices, such as LFAs, provide affordable, rapid screening that meets WHO&#8217;s ASSURED criteria<sup><xref ref-type="bibr" rid="CR141">141</xref></sup>.</p><p id="Par56">LFAs are paper-based POC devices composed of a sample pad that interacts with the sample fluid and transfers it to the conjugate pad for labeling. The labeled sample moves through the strip by capillary forces, towards the detection pad, modified with aptamers, antibodies and other biomolecules<sup><xref ref-type="bibr" rid="CR187">187</xref></sup>. To increase sample interaction time and increase sensitivity, promising approaches include using magnetic materials, such as probe-modified magnetic particles, which attach to biomarkers on the detection pad and extend interaction time under a magnetic field<sup><xref ref-type="bibr" rid="CR188">188</xref></sup>.</p><p id="Par57">However, conventional LFAs remain primarily qualitative or semi-quantitative, limiting their sensitivity compared to ELISA-based assays. To address sensitivity limitations, luminescent-based dual-mode LFAs incorporate fluorescent microspheres (FMs), QDs, and organic dyes, enabling both visual and quantitative detection<sup><xref ref-type="bibr" rid="CR189">189</xref>&#8211;<xref ref-type="bibr" rid="CR191">191</xref></sup>.</p><p id="Par58">While LFAs effectively detect abundant cancer biomarkers (e.g., CA-125, HER2, HE-4), CTCs and exosomes, due to their low concentrations, require preconcentration before detection. Achieving simultaneous preconcentration, signal amplification, and detection of CTCs and exosomes in LFAs remains a challenge, though emerging strategies have been reported. Pen-based LFAs, using a catalyzed hairpin assembly (CHA) technique, are especially promising in their ease of use and all-in-one design<sup><xref ref-type="bibr" rid="CR192">192</xref></sup>.</p></sec><sec id="Sec16"><title>Multiplex detection for women-prevalent cancers</title><p id="Par59">Relying on a single biomarker for cancer detection can lead to high false-positive rates, as some biomarkers for women&#8217;s cancers are associated with other women&#8217;s conditions. For example, CA-125, a key ovarian cancer biomarker, is also elevated during endometriosis<sup><xref ref-type="bibr" rid="CR193">193</xref>&#8211;<xref ref-type="bibr" rid="CR195">195</xref></sup>. Similarly, breast cancer subtypes&#8212;HER2-positive, Luminal A/B, and Basal-like&#8212;require distinct biomarker panels (HER2, estrogen receptor (ER), and progesterone receptor (PR)) to guide treatment selection<sup><xref ref-type="bibr" rid="CR196">196</xref>,<xref ref-type="bibr" rid="CR197">197</xref></sup>.</p><p id="Par60">Multiplex biosensors enhance diagnostic specificity by detecting multiple cancer biomarkers simultaneously. For instance, miRNA profiles (miR-21, miR-106a, miR-155) vary across breast cancer subtypes, necessitating multiplex detection strategies<sup><xref ref-type="bibr" rid="CR198">198</xref></sup>. Electrochemical biosensors are well-suited for the development of flexible sensors due to fast response, inherent miniaturization, convenient operation, portability, and integration of cost-effective electrodes. Unlike optical methods, electrochemical biosensors provide direct electrical readouts, enabling real-time biomarker analysis in complex biological samples<sup><xref ref-type="bibr" rid="CR199">199</xref></sup>. Enzyme-based electrochemical (EBEC) and electrochemiluminescence (ECL) biosensors enhance signal amplification and sensitivity, which can be achieved by labeling the probes with redox species such as methylene blue, horseradish peroxidase (HRP), and metal ions (e.g., gold, silver) for EBEC, or with fluorescent labels for ECL<sup><xref ref-type="bibr" rid="CR200">200</xref>,<xref ref-type="bibr" rid="CR201">201</xref></sup>.</p><p id="Par61">Multiplex LFA-based POC devices are particularly relevant for ovarian cancer, one of the most difficult cancers to detect in its early stages. Since HE-4 levels in urine vary depending on hydration status and urine concentration, creatinine levels are used as a normalizer for urinary biomarkers<sup><xref ref-type="bibr" rid="CR193">193</xref>,<xref ref-type="bibr" rid="CR202">202</xref></sup>. It is also essential to measure the HE-4/creatinine ratio for detecting ovarian cancer in urine. The cut-off value for HE-4 is 3.5, with the ratio range being around 2 for healthy individuals and up to 45 for late-stage cancer patients. For this purpose, a dual LFA system has been reported with signals quantified using a smartphone and scanner<sup><xref ref-type="bibr" rid="CR195">195</xref></sup>. One strip was designed to detect HE-4 using a sandwich-like system with antibodies and antibody-modified gold shells as reporters, while the other strip was designed for creatinine detection through a series of chemical reactions.</p><p id="Par62">Despite advancements, few LFAs are available for detecting multiple protein biomarkers. LFAs sensitivity, in both singleplex and multiplex detection, is often limited by the hook effect that prevents the formation of the antibody-antigen complex<sup><xref ref-type="bibr" rid="CR203">203</xref></sup>. This leads to false-negative results when targeting more than two protein biomarkers at high concentrations. Vertical flow assays overcome this limitation. Surface-enhanced Raman spectroscopy (SERS)-vertical flow assays have shown promise for the multiplex detection of exosome proteins (Mucin short variant S1 (MUC1), HER2, and CEA) which are useful for identifying breast cancer subtypes. This vertical flow assay contains a single aptamer-modified test pad that captures each biomarker on a specific spot, followed by detection using SERS probes that offer ultrasensitive, non-destructive analysis capabilities and minimal photobleaching<sup><xref ref-type="bibr" rid="CR204">204</xref></sup>.</p></sec></sec></sec><sec id="Sec17"><title>Commercialization, barriers to entry and future scopes</title><p id="Par63">Recent advancements in women&#8217;s health technologies&#8211;particularly in wearable biosensors and POC diagnostic devices&#8211;have accelerated the transition from conceptualization to clinical trials, driving increased stakeholder investment and introduction of these technologies into international markets (Supplementary Table&#160;<xref rid="MOESM1" ref-type="media">3</xref>)<sup><xref ref-type="bibr" rid="CR205">205</xref></sup>.</p><sec id="Sec18"><title>Barriers to entry of women&#8217;s wearable technologies</title><p id="Par64">A recent surge in technologies in the commercial space of women&#8217;s health have advanced significantly in the product pipeline for new product development (NPD)<sup><xref ref-type="bibr" rid="CR205">205</xref></sup>. For instance, a majority of fertility wearable tracking devices are readily available for clinicians, researchers and consumers to purchase and use<sup><xref ref-type="bibr" rid="CR206">206</xref>&#8211;<xref ref-type="bibr" rid="CR210">210</xref></sup>. Additionally, companies such as Dexcom and Freestyle Libre have led the development of continuous glucose monitoring wearables in the commercial space<sup><xref ref-type="bibr" rid="CR211">211</xref>,<xref ref-type="bibr" rid="CR212">212</xref></sup>. For highly specialized devices, such as those targeting women-prevalent cancer screening and osteoporosis monitoring, these technologies are not as advanced in the product development pipeline, with many going through clinical trials or the early stages of product scale up<sup><xref ref-type="bibr" rid="CR213">213</xref>&#8211;<xref ref-type="bibr" rid="CR220">220</xref></sup>. The success of these commercial devices relies on ease of integration into the currently existing infrastructure, where devices designed to be compatible with current medical best practices and mHealth applications have a higher chance of sucess<sup><xref ref-type="bibr" rid="CR221">221</xref>,<xref ref-type="bibr" rid="CR222">222</xref></sup>. On the other hand, devices that are costly in terms of manufacturing and materials are more likely to fail<sup><xref ref-type="bibr" rid="CR221">221</xref>,<xref ref-type="bibr" rid="CR222">222</xref></sup>. Women&#8217;s health is a rapidly growing commercial space, therefore intellectual property in the field is expected to grow and thus patenting new technologies becomes even more important for technologies geared towards commercialization<sup><xref ref-type="bibr" rid="CR223">223</xref></sup>. Bringing women&#8217;s health technologies from prototype to commercialization involves multiple challenges. This section highlights key barriers in usability, adoption, and policy-making that impact market success.</p><sec id="Sec19"><title>Usability, adoption and compliance for diverse women</title><p id="Par65">Women&#8217;s health technologies in commercialized spaces are most successful when they are designed for diverse populations of cisgender women and transgender people from different socioeconomic and cultural communities<sup><xref ref-type="bibr" rid="CR224">224</xref>,<xref ref-type="bibr" rid="CR225">225</xref></sup>. Age is also essential to consider when designing user interfaces for monitoring and diagnosing disease associated with menopause. Digital knowledge gaps may restrict usability for older generations of women<sup><xref ref-type="bibr" rid="CR226">226</xref>,<xref ref-type="bibr" rid="CR227">227</xref></sup>. Meeting these considerations can ensure compliance and autonomy when using digital devices<sup><xref ref-type="bibr" rid="CR228">228</xref></sup>.</p><p id="Par66">Furthermore, women from low socioeconomic status or enfranchised communities adopt biomonitoring technologies less than women of high socioeconomic status<sup><xref ref-type="bibr" rid="CR229">229</xref></sup>. The reason for this is the lack of access to digital health platforms and internet needed for device function, as well as limited opportunities to partake in educational or policy decision making initiatives<sup><xref ref-type="bibr" rid="CR62">62</xref></sup>. Often, the voices of these women are not heard on the world political stage, and these women do not have expectations that wearable devices can be designed for them, creating a market barrier in a similar way as differences in age. This is because of poverty, cultural disparities and income inequality, as well as home or job insecurity<sup><xref ref-type="bibr" rid="CR62">62</xref>,<xref ref-type="bibr" rid="CR230">230</xref>,<xref ref-type="bibr" rid="CR231">231</xref></sup>. These experiences are exacerbated amongst transgender individuals, who are over twice as likely to experience low socioeconomic conditions compared to the cisgender population in the US<sup><xref ref-type="bibr" rid="CR232">232</xref>&#8211;<xref ref-type="bibr" rid="CR234">234</xref></sup>.</p></sec><sec id="Sec20"><title>Global policy making for women&#8217;s health technologies</title><p id="Par67">One challenge in the development of technologies is the lack of global policy making practices for women&#8217;s health. Within the past decade, a large positive shift towards the globalization of women&#8217;s health and sexual rights has taken place. On an international front, the United Nations (UN) and WHO acknowledged the lack of policy making and women&#8217;s sexual rights laws which has limited women&#8217;s access to healthcare and medical devices<sup><xref ref-type="bibr" rid="CR235">235</xref>,<xref ref-type="bibr" rid="CR236">236</xref></sup>. Many international governments have taken initiatives and measures to remove gender and sex discrimination, and promote women&#8217;s self-autonomy, medical education and access to healthcare resources. This includes the United States (e.g., National Institutes of Health&#8217;s (NIH&#8217;s) Women Health Initiative), Canada (e.g., Health Canada&#8217;s National Women&#8217;s Health Research Initiative), Europe (e.g., European Union (EU) Manifesto for Women&#8217;s Health), and Australia (e.g., Australia&#8217;s National Women&#8217;s Health Strategy 2020&#8211;2030)<sup><xref ref-type="bibr" rid="CR237">237</xref>&#8211;<xref ref-type="bibr" rid="CR241">241</xref></sup>. Additionally, international organizations, such as United Nations (e.g., United Nations Population Fund) and WHO (e.g., Global Strategy for Women&#8217;s, Children&#8217;s and Adolescents&#8217; Health), are collaborating with countries in Africa, the Middle East, and Asia to initiate women&#8217;s health and equality policies by 2030<sup><xref ref-type="bibr" rid="CR242">242</xref>,<xref ref-type="bibr" rid="CR243">243</xref></sup>.</p></sec></sec><sec id="Sec21"><title>Artificial intelligence in women&#8217;s health technologies</title><p id="Par68">From a clinical perspective, AI and ML can be leveraged to significantly improve predictive capabilities and offer dynamic pattern recognition to enhance early-onset diagnostics, automate data collection and streamline care<sup><xref ref-type="bibr" rid="CR244">244</xref></sup>. Examples of AI and ML algorithms of interest include convolutional neural networks (CNNs)<sup><xref ref-type="bibr" rid="CR245">245</xref></sup>, artificial neural networks (ANNs)<sup><xref ref-type="bibr" rid="CR18">18</xref></sup>, support vector machine (SVM)<sup><xref ref-type="bibr" rid="CR246">246</xref></sup>, multivariate logistic regression (LR), random forest (RF), extreme gradient boosting (XGBoost), and light gradient boosting machine (LightGBM)<sup><xref ref-type="bibr" rid="CR247">247</xref></sup>. In women&#8217;s health, AI and ML algorithms can enhance health outcomes for women facing pregnancy complications (e.g., preterm births, spontaneous abortion, GDM, preeclampsia, neonatal deaths, congenital anomalies)<sup><xref ref-type="bibr" rid="CR18">18</xref>,<xref ref-type="bibr" rid="CR246">246</xref></sup>, vaginal infections<sup><xref ref-type="bibr" rid="CR245">245</xref>,<xref ref-type="bibr" rid="CR248">248</xref></sup>, and cancers<sup><xref ref-type="bibr" rid="CR249">249</xref>&#8211;<xref ref-type="bibr" rid="CR256">256</xref></sup> (Supplementary Table&#160;<xref rid="MOESM1" ref-type="media">4</xref>).</p><p id="Par69">In diagnostics, new biomarker discovery using AI can introduce unique or more all-encompassing diagnostic strategies by providing more holistic understanding of disease mechanisms for conditions affecting women, thus bridging the knowledge gap<sup><xref ref-type="bibr" rid="CR246">246</xref></sup>. An example can be identifying new set of biomarkers in urine for determining GDM that affects many organ systems of pregnant women and has multiple disease mechanisms for different symptomologies<sup><xref ref-type="bibr" rid="CR246">246</xref>,<xref ref-type="bibr" rid="CR257">257</xref></sup>. AI and ML algorithms can also collect and compile a wide range of predictive values simultaneously, including EHG, metabolic biomarker levels, ultrasound images of abdomen and cervix, and demographic profiles, to predict complication occurrences in the first trimester<sup><xref ref-type="bibr" rid="CR246">246</xref></sup>. Additionally, AI-powered mHealth applications offer a valuable tool for assessing early symptoms and recommending timely interventions, an example includes AI-powered smart phone tools using MGH Perinatal Depression Scale (MGHPDS) for postpartum depression, which affects approximately 15% of mothers<sup><xref ref-type="bibr" rid="CR258">258</xref>,<xref ref-type="bibr" rid="CR259">259</xref></sup>. Identifying diseases by comparing hundreds of sample images is another capability, as AI and ML algorithms can quickly pick up discrepancies that can be missed by the human eye. For instance, CNNs can detect the presence of yeast hyphae from microscopy images for detecting VVC, exceeding expert diagnostics by 4.58%<sup><xref ref-type="bibr" rid="CR245">245</xref></sup>.</p><p id="Par70">Some mHealth applications and wearable technologies that leverage AI and ML have already been commercialized for women&#8217;s health applications or are close to commercialization<sup><xref ref-type="bibr" rid="CR260">260</xref></sup>. For example, the OvuSense platform, which has been incorporated into viO&#8217;s OvuFirst device, is a commercial device that obtains temperature data for fertility monitoring and utilizes algorithms for improved fertility predictions<sup><xref ref-type="bibr" rid="CR261">261</xref></sup>. Copan Diagnostics has also developed and released PhenoMatrix to detect multiple vaginal infections by comparing images of vaginal swab plate cultures<sup><xref ref-type="bibr" rid="CR248">248</xref></sup>. Select studies have shown how AI has been implemented for improving accuracy of cervical and breast cancer diagnosis; these technologies have received Food and Drug Administration (FDA) regulatory approval for commercial use<sup><xref ref-type="bibr" rid="CR249">249</xref>&#8211;<xref ref-type="bibr" rid="CR256">256</xref></sup>. One example is General Electric&#8217;s FDA approved AI-powered breast cancer prediction tool based on ultrasound data<sup><xref ref-type="bibr" rid="CR262">262</xref></sup>.</p><p id="Par71">In applying AI and ML for clinical practice, there is a dire need to understand the effects of generalized data and how we can shift away from it for reliable outputs<sup><xref ref-type="bibr" rid="CR263">263</xref></sup>. An untapped use of AI is in assessing the possibility of undetermined or undetected biological sex differences amongst diseases that affect both males and females<sup><xref ref-type="bibr" rid="CR264">264</xref></sup>. One example is the use of AI-powered statistical analyses comparing women with and without menstrual cycles, as well as males, to determine the variance of body temperature to overcome sex biases by including equal data on females and males<sup><xref ref-type="bibr" rid="CR265">265</xref></sup>. If trained on unbiased data sets, AI and ML have the power to distinguish factors that lead to predominance of diseases in women compared to men, such as CVD and osteoporosis<sup><xref ref-type="bibr" rid="CR264">264</xref></sup>. These algorithms also have the potential to identify other unknown conditions that predominantly affect women, providing insight and knowledge into unidentified health gaps<sup><xref ref-type="bibr" rid="CR264">264</xref></sup>. However, the main challenge in algorithm development is that they typically leverage historically reported biased medical data and biomedical research as part of their training processes<sup><xref ref-type="bibr" rid="CR264">264</xref>,<xref ref-type="bibr" rid="CR266">266</xref></sup>. As mentioned, a large biological sex bias and gender identity disparity exists in literature and medical records, which could translate to the model after training<sup><xref ref-type="bibr" rid="CR264">264</xref>,<xref ref-type="bibr" rid="CR267">267</xref></sup>. This barrier to entry for emerging AI and ML models necessitates the need for further biomedical research addressing this biological sex bias. It also highlights the importance of reporting unbiased data that includes equal representation of all sexes, genders and backgrounds<sup><xref ref-type="bibr" rid="CR268">268</xref></sup>.</p></sec></sec><sec id="Sec22"><title>Outlook</title><p id="Par72">This review highlights key bioengineering advancements in women&#8217;s health diagnostics and biomonitoring. As more prototypes and in vivo studies emerge, the field is progressing toward commercialization, transforming economic, healthcare, and societal perceptions of women&#8217;s health monitoring and diagnostics. One outstanding challenge in these emerging technologies is the limited data from underrepresented populations to inform device design and user interface accessibility. To ensure equitable healthcare solutions, future biomedical devices must be inclusive, addressing the needs of cisgender women and transgender individuals across diverse backgrounds.</p><p id="Par73">As more wearable technologies and detection platforms for women&#8217;s health are created, integrating wearable technologies with ML and AI will not only enhance detection accuracy but also reduce user error in data interpretation. AI-driven systems can personalize diagnostics, ensuring precise monitoring of cancers, infections, and reproductive health conditions. AI algorithms can predict bacterial imbalances before a full-blown infection develops, allowing for earlier intervention<sup><xref ref-type="bibr" rid="CR269">269</xref></sup>. Similarly, in cancer detection, AI can analyze biomarker fluctuations, predict cancer progression, metastasis risk, and immune responses (e.g., NK cell activation), leading to earlier and more targeted treatments.</p><p id="Par74">The future of women&#8217;s health technologies is shifting toward wireless, AI-integrated wearables that provide real-time predictive feedback, enhanced user interfaces, and seamless remote monitoring. These innovations will assist women by enabling personalized, proactive healthcare management. By bridging bioengineering, AI, and digital health, the next generation of wearable diagnostics will transform women&#8217;s health monitoring into a more accessible, data-driven, and patient-centered paradigm.</p></sec><sec id="Sec23" sec-type="supplementary-material"><title>Supplementary information</title><p>
<supplementary-material content-type="local-data" id="MOESM1" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="41467_2025_63501_MOESM1_ESM.pdf" position="float" orientation="portrait"><caption><p>Supplementary Information</p></caption></media></supplementary-material>
</p></sec></body><back><fn-group><fn><p><bold>Publisher&#8217;s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>These authors contributed equally: Shaghayegh Moghimikandelousi, Lubna Najm, Yerim Lee.</p></fn></fn-group><sec><title>Supplementary information</title><p>The online version contains supplementary material available at 10.1038/s41467-025-63501-3.</p></sec><ack><title>Acknowledgements</title><p>W.G. acknowledges the support from the Advanced Research Projects Agency for Health (ARPA-H) Sprint for Women&#8217;s Health (award no. ARPA-H-ICHUB-24-101-504) and the American Cancer Society Research Scholar Grant RSG-21-181-01-CTPS. Y.L. acknowledges the National Science Scholarship from the Agency for Science, Technology and Research (A*STAR), Singapore. T.F.D. and Z.H. acknowledge the support from the Canada Research Chairs Program. T.F.D. and Z.H. also acknowledge the support from Natural Sciences and Engineering Research Council (NSERC) of Canada through the Canada Discovery Grant and the Ontario Early Researcher Award.A.P.&#160;is a recipient of the Vanier Canada Graduate Scholarship awarded by&#160;NSERC of Canada.</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>T.F.D., Z.H., and W.G. conceived the idea of the review paper, designed the outline and scope, and provided funding for this project. Sh.M. and L.N. conducted the literature research, compiled the tables, and wrote the manuscript. Sh.M., L.N., and F.B. designed the figures. T.F.D., Z.H., W.G., Sh.M., L.N., Y.L., F.B., A.P., S.K., and A.B. edited the manuscript, references, figures and tables.</p></notes><notes notes-type="peer-review"><title>Peer review</title><sec id="FPar1"><title>Peer review information</title><p id="Par75"><italic toggle="yes">Nature Communications</italic> thanks Ramses Martinez, and the other, anonymous, reviewers for their contribution to the peer review of this work.</p></sec></notes><notes id="FPar2" notes-type="COI-statement"><title>Competing interests</title><p id="Par76">The authors declare the following competing interests: W.G. is co-founder and advisor at Persperity Health. T.F.D. and Z.H. are principal investigators on an NSERC Alliance grant with Women&#8217;s Global Health Innovations.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><mixed-citation publication-type="other">Shaw, L. J. et al. Quality and equitable health care gaps for women: attributions to sex differences in cardiovascular medicine. <italic toggle="yes">J. Am. College Cardiol.</italic><bold>70</bold>, 373&#8211;388 (2017).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jacc.2017.05.051</pub-id><pub-id pub-id-type="pmid">28705320</pub-id></mixed-citation></ref><ref id="CR2"><label>2.</label><mixed-citation publication-type="other">Benyamini, Y. &amp; Todorova, I. Women&#8217;s Reproductive Health in Sociocultural Context. <italic toggle="yes">Int. J. Behav. Med.</italic><bold>24</bold>, 799&#8211;802 (2017).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s12529-017-9695-7</pub-id><pub-id pub-id-type="pmid">29150752</pub-id></mixed-citation></ref><ref id="CR3"><label>3.</label><mixed-citation publication-type="other">Sutton, M. Y., Anachebe, N. F., Lee, R. &amp; Skanes, H. Racial and ethnic disparities in reproductive health services and outcomes, 2020. <italic toggle="yes">Obstet. Gynecol.</italic><bold>137</bold>, 225&#8211;233 (2021).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/AOG.0000000000004224</pub-id><pub-id pub-id-type="pmcid">PMC7813444</pub-id><pub-id pub-id-type="pmid">33416284</pub-id></mixed-citation></ref><ref id="CR4"><label>4.</label><mixed-citation publication-type="other">Women&#8217;s health got worse in 2021, global survey finds. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.cnn.com/2022/09/21/health/global-womens-health-index-2021/index.html">https://www.cnn.com/2022/09/21/health/global-womens-health-index-2021/index.html</ext-link> (2022).</mixed-citation></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Samson Enitan</surname><given-names>S</given-names></name></person-group><article-title>Improving women&#8217;s health in the 21st century: current challenges, medical advancements and future prospects</article-title><source>Women Health Care Issues</source><year>2023</year><volume>6</volume><fpage>01</fpage><lpage>07</lpage><pub-id pub-id-type="doi">10.31579/2642-9756/149</pub-id></element-citation><mixed-citation id="mc-CR5" publication-type="journal">Samson Enitan, S. Improving women&#8217;s health in the 21st century: current challenges, medical advancements and future prospects. <italic toggle="yes">Women Health Care Issues</italic><bold>6</bold>, 01&#8211;07 (2023).</mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Magnus</surname><given-names>M</given-names></name><etal/></person-group><article-title>Development of a telehealth intervention to promote care-seeking among transgender women of color in Washington, DC</article-title><source>Public Health Nurs.</source><year>2020</year><volume>37</volume><fpage>262</fpage><lpage>271</lpage><pub-id pub-id-type="doi">10.1111/phn.12709</pub-id><pub-id pub-id-type="pmid">32017202</pub-id></element-citation><mixed-citation id="mc-CR6" publication-type="journal">Magnus, M. et al. Development of a telehealth intervention to promote care-seeking among transgender women of color in Washington, DC. <italic toggle="yes">Public Health Nurs.</italic><bold>37</bold>, 262&#8211;271 (2020).<pub-id pub-id-type="pmid">32017202</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/phn.12709</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><mixed-citation publication-type="other">White, J. &amp; Clayton, J. The gender health innovation gap: a perspective from the NIH Office of Research on Women&#8217;s Health. <italic toggle="yes">Med.</italic><bold>3</bold>, 298&#8211;301 (2022).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.medj.2022.04.010</pub-id><pub-id pub-id-type="pmid">35584651</pub-id></mixed-citation></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Merone</surname><given-names>L</given-names></name><name name-style="western"><surname>Tsey</surname><given-names>K</given-names></name><name name-style="western"><surname>Russell</surname><given-names>D</given-names></name><name name-style="western"><surname>Nagle</surname><given-names>C</given-names></name></person-group><article-title>Sex inequalities in medical research: a systematic scoping review of the literature</article-title><source>Women&#8217;s Health Rep.</source><year>2022</year><volume>3</volume><fpage>49</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.1089/whr.2021.0083</pub-id><pub-id pub-id-type="pmcid">PMC8812498</pub-id><pub-id pub-id-type="pmid">35136877</pub-id></element-citation><mixed-citation id="mc-CR8" publication-type="journal">Merone, L., Tsey, K., Russell, D. &amp; Nagle, C. Sex inequalities in medical research: a systematic scoping review of the literature. <italic toggle="yes">Women&#8217;s Health Rep.</italic><bold>3</bold>, 49&#8211;59 (2022).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1089/whr.2021.0083</pub-id><pub-id pub-id-type="pmcid">PMC8812498</pub-id><pub-id pub-id-type="pmid">35136877</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><mixed-citation publication-type="other">Lyzwinski, L., Elgendi, M. &amp; Menon, C. Innovative approaches to menstruation and fertility tracking using wearable reproductive health technology: systematic review. <italic toggle="yes">J. Med. Internet Res.</italic><bold>26</bold>, e45139 (2024).<pub-id pub-id-type="doi" assigning-authority="pmc">10.2196/45139</pub-id><pub-id pub-id-type="pmcid">PMC10905339</pub-id><pub-id pub-id-type="pmid">38358798</pub-id></mixed-citation></ref><ref id="CR10"><label>10.</label><mixed-citation publication-type="other">Zuo, X., Yang, X., Dou, Z. &amp; Wen, J. R. RUCIR at TREC 2019: conversational assistance track. In <italic toggle="yes">28th Text REtrieval Conference, TREC 2019 - Proceedings</italic> (National Institute of Standards and Technology (NIST), 10.1145/1122445.1122456 2019).</mixed-citation></ref><ref id="CR11"><label>11.</label><mixed-citation publication-type="other">Common chronic diseases in women compared to men. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.canada.ca/en/public-health/services/publications/diseases-conditions/common-chronic-diseases-women-compared-men-aged-65-years-older.html">https://www.canada.ca/en/public-health/services/publications/diseases-conditions/common-chronic-diseases-women-compared-men-aged-65-years-older.html</ext-link> (2021).</mixed-citation></ref><ref id="CR12"><label>12.</label><mixed-citation publication-type="other">WHO. Ten top issues for women&#8217;s health. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.who.int/news-room/commentaries/detail/ten-top-issues-for-women">https://www.who.int/news-room/commentaries/detail/ten-top-issues-for-women&#8217;s-health</ext-link> (2015).</mixed-citation></ref><ref id="CR13"><label>13.</label><mixed-citation publication-type="other">Singh, V. AI, women&#8217;s health care, and trust: problems and prospects. <italic toggle="yes">Artif. Intell. Mach. Learn. Women&#8217;s Health Issues</italic> 235&#8211;254 10.1016/B978-0-443-21889-7.00002-6 (2024).</mixed-citation></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pan</surname><given-names>M</given-names></name><etal/></person-group><article-title>Effects of wearable physical activity tracking for breast cancer survivors: a systematic review and meta-analysis</article-title><source>Int J. Nurs. Knowl.</source><year>2024</year><volume>35</volume><fpage>117</fpage><lpage>129</lpage><pub-id pub-id-type="doi">10.1111/2047-3095.12418</pub-id><pub-id pub-id-type="pmid">36843066</pub-id></element-citation><mixed-citation id="mc-CR14" publication-type="journal">Pan, M. et al. Effects of wearable physical activity tracking for breast cancer survivors: a systematic review and meta-analysis. <italic toggle="yes">Int J. Nurs. Knowl.</italic><bold>35</bold>, 117&#8211;129 (2024).<pub-id pub-id-type="pmid">36843066</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/2047-3095.12418</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dhingra</surname><given-names>LS</given-names></name><etal/></person-group><article-title>Use of wearable devices in individuals with or at risk for cardiovascular disease in the US, 2019 to 2020</article-title><source>JAMA Netw. Open</source><year>2023</year><volume>6</volume><fpage>e2316634</fpage><pub-id pub-id-type="doi">10.1001/jamanetworkopen.2023.16634</pub-id><pub-id pub-id-type="pmid">37285157</pub-id><pub-id pub-id-type="pmcid">PMC10248745</pub-id></element-citation><mixed-citation id="mc-CR15" publication-type="journal">Dhingra, L. S. et al. Use of wearable devices in individuals with or at risk for cardiovascular disease in the US, 2019 to 2020. <italic toggle="yes">JAMA Netw. Open</italic><bold>6</bold>, e2316634 (2023).<pub-id pub-id-type="pmid">37285157</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamanetworkopen.2023.16634</pub-id><pub-id pub-id-type="pmcid">PMC10248745</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mattison</surname><given-names>G</given-names></name><etal/></person-group><article-title>The influence of wearables on health care outcomes in chronic disease: systematic review</article-title><source>J. Med Internet Res.</source><year>2022</year><volume>24</volume><fpage>e36690</fpage><pub-id pub-id-type="doi">10.2196/36690</pub-id><pub-id pub-id-type="pmid">35776492</pub-id><pub-id pub-id-type="pmcid">PMC9288104</pub-id></element-citation><mixed-citation id="mc-CR16" publication-type="journal">Mattison, G. et al. The influence of wearables on health care outcomes in chronic disease: systematic review. <italic toggle="yes">J. Med Internet Res.</italic><bold>24</bold>, e36690 (2022).<pub-id pub-id-type="pmid">35776492</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2196/36690</pub-id><pub-id pub-id-type="pmcid">PMC9288104</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Leung</surname><given-names>A</given-names></name><name name-style="western"><surname>Sakkas</surname><given-names>D</given-names></name><name name-style="western"><surname>Pang</surname><given-names>S</given-names></name><name name-style="western"><surname>Thornton</surname><given-names>K</given-names></name><name name-style="western"><surname>Resetkova</surname><given-names>N</given-names></name></person-group><article-title>Assisted reproductive technology outcomes in female-to-male transgender patients compared with cisgender patients: a new frontier in reproductive medicine</article-title><source>Fertil. Steril.</source><year>2019</year><volume>112</volume><fpage>858</fpage><lpage>865</lpage><pub-id pub-id-type="doi">10.1016/j.fertnstert.2019.07.014</pub-id><pub-id pub-id-type="pmid">31594633</pub-id></element-citation><mixed-citation id="mc-CR17" publication-type="journal">Leung, A., Sakkas, D., Pang, S., Thornton, K. &amp; Resetkova, N. Assisted reproductive technology outcomes in female-to-male transgender patients compared with cisgender patients: a new frontier in reproductive medicine. <italic toggle="yes">Fertil. Steril.</italic><bold>112</bold>, 858&#8211;865 (2019).<pub-id pub-id-type="pmid">31594633</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.fertnstert.2019.07.014</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><mixed-citation publication-type="other">Togunwa, T. O., Babatunde, A. O. &amp; Abdullah, K.-R. Deep hybrid model for maternal health risk classification in pregnancy: synergy of ANN and random forest. <italic toggle="yes">Front. Artif. Intell.</italic><bold>6</bold>, 1213436 (2023).<pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/frai.2023.1213436</pub-id><pub-id pub-id-type="pmcid">PMC10354509</pub-id><pub-id pub-id-type="pmid">37476504</pub-id></mixed-citation></ref><ref id="CR19"><label>19.</label><mixed-citation publication-type="other">World Health Organization. More than a third of women experience lasting health problems after childbirth, new research shows. <italic toggle="yes">World Health Organization</italic><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.who.int/news/item/07-12-2023-more-than-a-third-of-women-experience-lasting-health-problems-after-childbirth">https://www.who.int/news/item/07-12-2023-more-than-a-third-of-women-experience-lasting-health-problems-after-childbirth</ext-link> (2023).</mixed-citation></ref><ref id="CR20"><label>20.</label><mixed-citation publication-type="other">World Health Organization. Maternal mortality. World Health Organization <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.who.int/news-room/fact-sheets/detail/maternal-mortality">https://www.who.int/news-room/fact-sheets/detail/maternal-mortality</ext-link> (2025).</mixed-citation></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goodale</surname><given-names>BM</given-names></name><etal/></person-group><article-title>Wearable sensors reveal menses-driven changes in physiology and enable prediction of the fertile window: observational study</article-title><source>J. Med Internet Res.</source><year>2019</year><volume>21</volume><fpage>e13404</fpage><pub-id pub-id-type="doi">10.2196/13404</pub-id><pub-id pub-id-type="pmid">30998226</pub-id><pub-id pub-id-type="pmcid">PMC6495289</pub-id></element-citation><mixed-citation id="mc-CR21" publication-type="journal">Goodale, B. M. et al. Wearable sensors reveal menses-driven changes in physiology and enable prediction of the fertile window: observational study. <italic toggle="yes">J. Med Internet Res.</italic><bold>21</bold>, e13404 (2019).<pub-id pub-id-type="pmid">30998226</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2196/13404</pub-id><pub-id pub-id-type="pmcid">PMC6495289</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><mixed-citation publication-type="other">Shilaih, M. et al. Modern fertility awareness methods: wrist wearables capture the changes in temperature associated with the menstrual cycle. <italic toggle="yes">Biosci. Rep.</italic><bold>38</bold>, BSR20171279 (2018).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1042/BSR20171279</pub-id><pub-id pub-id-type="pmcid">PMC6265623</pub-id><pub-id pub-id-type="pmid">29175999</pub-id></mixed-citation></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vanmarkenlichtenbelt</surname><given-names>W</given-names></name><etal/></person-group><article-title>Evaluation of wireless determination of skin temperature using iButtons</article-title><source>Physiol. Behav.</source><year>2006</year><volume>88</volume><fpage>489</fpage><lpage>497</lpage><pub-id pub-id-type="doi">10.1016/j.physbeh.2006.04.026</pub-id><pub-id pub-id-type="pmid">16797616</pub-id></element-citation><mixed-citation id="mc-CR23" publication-type="journal">Vanmarkenlichtenbelt, W. et al. Evaluation of wireless determination of skin temperature using iButtons. <italic toggle="yes">Physiol. Behav.</italic><bold>88</bold>, 489&#8211;497 (2006).<pub-id pub-id-type="pmid">16797616</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.physbeh.2006.04.026</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Garcia</surname><given-names>AMC</given-names></name><etal/></person-group><article-title>Luteal phase of the menstrual cycle increases sweating rate during exercise</article-title><source>Braz. J. Med. Biol. Res.</source><year>2006</year><volume>39</volume><fpage>1255</fpage><lpage>1261</lpage><pub-id pub-id-type="doi">10.1590/S0100-879X2006005000007</pub-id><pub-id pub-id-type="pmid">16981051</pub-id></element-citation><mixed-citation id="mc-CR24" publication-type="journal">Garcia, A. M. C. et al. Luteal phase of the menstrual cycle increases sweating rate during exercise. <italic toggle="yes">Braz. J. Med. Biol. Res.</italic><bold>39</bold>, 1255&#8211;1261 (2006).<pub-id pub-id-type="pmid">16981051</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1590/s0100-879x2006005000007</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Upton</surname><given-names>TJ</given-names></name><etal/></person-group><article-title>High-resolution daily profiles of tissue adrenal steroids by portable automated collection</article-title><source>Sci. Transl. Med.</source><year>2023</year><volume>15</volume><fpage>eadg8464</fpage><pub-id pub-id-type="doi">10.1126/scitranslmed.adg8464</pub-id><pub-id pub-id-type="pmid">37343084</pub-id></element-citation><mixed-citation id="mc-CR25" publication-type="journal">Upton, T. J. et al. High-resolution daily profiles of tissue adrenal steroids by portable automated collection. <italic toggle="yes">Sci. Transl. Med.</italic><bold>15</bold>, eadg8464 (2023).<pub-id pub-id-type="pmid">37343084</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/scitranslmed.adg8464</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><mixed-citation publication-type="other">myHealth Alberta. Basal Body Temperature (BBT) Tracking. <italic toggle="yes">Government of Alberta</italic><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://myhealth.alberta.ca/Health/pages/conditions.aspx?hwid=hw202058">https://myhealth.alberta.ca/Health/pages/conditions.aspx?hwid=hw202058</ext-link> (2024).</mixed-citation></ref><ref id="CR27"><label>27.</label><mixed-citation publication-type="other">Steward, K. &amp; Raja, A. <italic toggle="yes">Physiology, Ovulation and Basal Body Temperature</italic>. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK546686/">https://www.ncbi.nlm.nih.gov/books/NBK546686/</ext-link> (2023).<pub-id pub-id-type="pmid">31536292</pub-id></mixed-citation></ref><ref id="CR28"><label>28.</label><mixed-citation publication-type="other">Williams, A. M. FAM basics: basal body temperature (BBT). <italic toggle="yes">Nat. Womanhood</italic><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://naturalwomanhood.org/fertility-awareness-method-basics-basal-body-temperature-bbt/?utm_source=chatgpt.com">https://naturalwomanhood.org/fertility-awareness-method-basics-basal-body-temperature-bbt/?utm_source=chatgpt.com</ext-link> (2021).</mixed-citation></ref><ref id="CR29"><label>29.</label><mixed-citation publication-type="other">Wei, L. et al. Wearable sweat management technologies. <italic toggle="yes">Adv. Mater Technol.</italic><bold>9</bold>, 2470031 (2024).</mixed-citation></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Charkoudian</surname><given-names>N</given-names></name><name name-style="western"><surname>Stachenfeld</surname><given-names>N</given-names></name></person-group><article-title>Sex hormone effects on autonomic mechanisms of thermoregulation in humans</article-title><source>Auton. Neurosci.</source><year>2016</year><volume>196</volume><fpage>75</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1016/j.autneu.2015.11.004</pub-id><pub-id pub-id-type="pmid">26674572</pub-id></element-citation><mixed-citation id="mc-CR30" publication-type="journal">Charkoudian, N. &amp; Stachenfeld, N. Sex hormone effects on autonomic mechanisms of thermoregulation in humans. <italic toggle="yes">Auton. Neurosci.</italic><bold>196</bold>, 75&#8211;80 (2016).<pub-id pub-id-type="pmid">26674572</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.autneu.2015.11.004</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baker</surname><given-names>FC</given-names></name><name name-style="western"><surname>Siboza</surname><given-names>F</given-names></name><name name-style="western"><surname>Fuller</surname><given-names>A</given-names></name></person-group><article-title>Temperature regulation in women: effects of the menstrual cycle</article-title><source>Temperature</source><year>2020</year><volume>7</volume><fpage>226</fpage><lpage>262</lpage><pub-id pub-id-type="doi">10.1080/23328940.2020.1735927</pub-id><pub-id pub-id-type="pmcid">PMC7575238</pub-id><pub-id pub-id-type="pmid">33123618</pub-id></element-citation><mixed-citation id="mc-CR31" publication-type="journal">Baker, F. C., Siboza, F. &amp; Fuller, A. Temperature regulation in women: effects of the menstrual cycle. <italic toggle="yes">Temperature</italic><bold>7</bold>, 226&#8211;262 (2020).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/23328940.2020.1735927</pub-id><pub-id pub-id-type="pmcid">PMC7575238</pub-id><pub-id pub-id-type="pmid">33123618</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Z</given-names></name><name name-style="western"><surname>DiVittorio</surname><given-names>JR</given-names></name><name name-style="western"><surname>Joseph</surname><given-names>AM</given-names></name><name name-style="western"><surname>Correa</surname><given-names>SM</given-names></name></person-group><article-title>The effects of estrogens on neural circuits that control temperature</article-title><source>Endocrinology</source><year>2021</year><volume>162</volume><fpage>bqab087</fpage><pub-id pub-id-type="doi">10.1210/endocr/bqab087</pub-id><pub-id pub-id-type="pmid">33939822</pub-id><pub-id pub-id-type="pmcid">PMC8237993</pub-id></element-citation><mixed-citation id="mc-CR32" publication-type="journal">Zhang, Z., DiVittorio, J. R., Joseph, A. M. &amp; Correa, S. M. The effects of estrogens on neural circuits that control temperature. <italic toggle="yes">Endocrinology</italic><bold>162</bold>, bqab087 (2021).<pub-id pub-id-type="pmid">33939822</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1210/endocr/bqab087</pub-id><pub-id pub-id-type="pmcid">PMC8237993</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Forman</surname><given-names>RG</given-names></name><name name-style="western"><surname>Chapman</surname><given-names>MC</given-names></name><name name-style="western"><surname>Steptoe</surname><given-names>PC</given-names></name></person-group><article-title>The effect of endogenous progesterone on basal body temperature in stimulated ovarian cycles</article-title><source>Hum. Reprod.</source><year>1987</year><volume>2</volume><fpage>631</fpage><lpage>634</lpage><pub-id pub-id-type="doi">10.1093/oxfordjournals.humrep.a136605</pub-id><pub-id pub-id-type="pmid">3125209</pub-id></element-citation><mixed-citation id="mc-CR33" publication-type="journal">Forman, R. G., Chapman, M. C. &amp; Steptoe, P. C. The effect of endogenous progesterone on basal body temperature in stimulated ovarian cycles. <italic toggle="yes">Hum. Reprod.</italic><bold>2</bold>, 631&#8211;634 (1987).<pub-id pub-id-type="pmid">3125209</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/oxfordjournals.humrep.a136605</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Evans-Hoeker</surname><given-names>E</given-names></name><etal/></person-group><article-title>Cervical mucus monitoring prevalence and associated fecundability in women trying to conceive</article-title><source>Fertil. Steril.</source><year>2013</year><volume>100</volume><fpage>1033</fpage><lpage>1038.e1</lpage><pub-id pub-id-type="doi">10.1016/j.fertnstert.2013.06.002</pub-id><pub-id pub-id-type="pmid">23850303</pub-id><pub-id pub-id-type="pmcid">PMC3787999</pub-id></element-citation><mixed-citation id="mc-CR34" publication-type="journal">Evans-Hoeker, E. et al. Cervical mucus monitoring prevalence and associated fecundability in women trying to conceive. <italic toggle="yes">Fertil. Steril.</italic><bold>100</bold>, 1033&#8211;1038.e1 (2013).<pub-id pub-id-type="pmid">23850303</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.fertnstert.2013.06.002</pub-id><pub-id pub-id-type="pmcid">PMC3787999</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boyd</surname><given-names>P</given-names></name><etal/></person-group><article-title>A temperature-monitoring vaginal ring for measuring adherence</article-title><source>PLoS One</source><year>2015</year><volume>10</volume><fpage>e0125682</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0125682</pub-id><pub-id pub-id-type="pmid">25965956</pub-id><pub-id pub-id-type="pmcid">PMC4429109</pub-id></element-citation><mixed-citation id="mc-CR35" publication-type="journal">Boyd, P. et al. A temperature-monitoring vaginal ring for measuring adherence. <italic toggle="yes">PLoS One</italic><bold>10</bold>, e0125682 (2015).<pub-id pub-id-type="pmid">25965956</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0125682</pub-id><pub-id pub-id-type="pmcid">PMC4429109</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Papaioannou</surname><given-names>S</given-names></name><name name-style="western"><surname>Aslam</surname><given-names>M</given-names></name><name name-style="western"><surname>Al Wattar</surname><given-names>BH</given-names></name><name name-style="western"><surname>Milnes</surname><given-names>RC</given-names></name><name name-style="western"><surname>Knowles</surname><given-names>TG</given-names></name></person-group><article-title>User&#8217;s acceptability of OvuSense: a novel vaginal temperature sensor for prediction of the fertile period</article-title><source>J. Obstet. Gynaecol. (Lahore)</source><year>2013</year><volume>33</volume><fpage>705</fpage><lpage>709</lpage><pub-id pub-id-type="doi">10.3109/01443615.2013.817984</pub-id><pub-id pub-id-type="pmid">24127960</pub-id></element-citation><mixed-citation id="mc-CR36" publication-type="journal">Papaioannou, S., Aslam, M., Al Wattar, B. H., Milnes, R. C. &amp; Knowles, T. G. User&#8217;s acceptability of OvuSense: a novel vaginal temperature sensor for prediction of the fertile period. <italic toggle="yes">J. Obstet. Gynaecol. (Lahore)</italic><bold>33</bold>, 705&#8211;709 (2013).<pub-id pub-id-type="doi" assigning-authority="pmc">10.3109/01443615.2013.817984</pub-id><pub-id pub-id-type="pmid">24127960</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Keeler Bruce</surname><given-names>L</given-names></name><name name-style="western"><surname>Gonz&#225;lez</surname><given-names>D</given-names></name><name name-style="western"><surname>Dasgupta</surname><given-names>S</given-names></name><name name-style="western"><surname>Smarr</surname><given-names>BL</given-names></name></person-group><article-title>Biometrics of complete human pregnancy recorded by wearable devices</article-title><source>NPJ Digit Med.</source><year>2024</year><volume>7</volume><fpage>207</fpage><pub-id pub-id-type="doi">10.1038/s41746-024-01183-9</pub-id><pub-id pub-id-type="pmid">39134787</pub-id><pub-id pub-id-type="pmcid">PMC11319646</pub-id></element-citation><mixed-citation id="mc-CR37" publication-type="journal">Keeler Bruce, L., Gonz&#225;lez, D., Dasgupta, S. &amp; Smarr, B. L. Biometrics of complete human pregnancy recorded by wearable devices. <italic toggle="yes">NPJ Digit Med.</italic><bold>7</bold>, 207 (2024).<pub-id pub-id-type="pmid">39134787</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41746-024-01183-9</pub-id><pub-id pub-id-type="pmcid">PMC11319646</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tarvonen</surname><given-names>M</given-names></name><etal/></person-group><article-title>Intrapartum cardiotocography with simultaneous maternal heart rate registration improves neonatal outcome</article-title><source>Am. J. Obstet. Gynecol.</source><year>2024</year><volume>230</volume><fpage>379.e1</fpage><lpage>379.e12</lpage><pub-id pub-id-type="doi">10.1016/j.ajog.2024.01.011</pub-id><pub-id pub-id-type="pmid">38272284</pub-id></element-citation><mixed-citation id="mc-CR38" publication-type="journal">Tarvonen, M. et al. Intrapartum cardiotocography with simultaneous maternal heart rate registration improves neonatal outcome. <italic toggle="yes">Am. J. Obstet. Gynecol.</italic><bold>230</bold>, 379.e1&#8211;379.e12 (2024).<pub-id pub-id-type="pmid">38272284</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ajog.2024.01.011</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Afari</surname><given-names>HA</given-names></name><name name-style="western"><surname>Davis</surname><given-names>EF</given-names></name><name name-style="western"><surname>Sarma</surname><given-names>AA</given-names></name></person-group><article-title>Echocardiography for the pregnant heart</article-title><source>Curr. Treat. Options Cardiovasc. Med.</source><year>2021</year><volume>23</volume><fpage>55</fpage><pub-id pub-id-type="doi">10.1007/s11936-021-00930-5</pub-id><pub-id pub-id-type="pmid">34075291</pub-id><pub-id pub-id-type="pmcid">PMC8160078</pub-id></element-citation><mixed-citation id="mc-CR39" publication-type="journal">Afari, H. A., Davis, E. F. &amp; Sarma, A. A. Echocardiography for the pregnant heart. <italic toggle="yes">Curr. Treat. Options Cardiovasc. Med.</italic><bold>23</bold>, 55 (2021).<pub-id pub-id-type="pmid">34075291</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11936-021-00930-5</pub-id><pub-id pub-id-type="pmcid">PMC8160078</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rosen</surname><given-names>H</given-names></name><name name-style="western"><surname>Yogev</surname><given-names>Y</given-names></name></person-group><article-title>Assessment of uterine contractions in labor and delivery</article-title><source>Am. J. Obstet. Gynecol.</source><year>2023</year><volume>228</volume><fpage>S1209</fpage><lpage>S1221</lpage><pub-id pub-id-type="doi">10.1016/j.ajog.2022.09.003</pub-id><pub-id pub-id-type="pmid">37164494</pub-id></element-citation><mixed-citation id="mc-CR40" publication-type="journal">Rosen, H. &amp; Yogev, Y. Assessment of uterine contractions in labor and delivery. <italic toggle="yes">Am. J. Obstet. Gynecol.</italic><bold>228</bold>, S1209&#8211;S1221 (2023).<pub-id pub-id-type="pmid">37164494</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ajog.2022.09.003</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Leeners</surname><given-names>B</given-names></name></person-group><article-title>Utilizing wearable biosensor technology for monitoring sleep duration patterns in pregnancy &#8211; a pilot study</article-title><source>Endocrinol. Disord.</source><year>2024</year><volume>8</volume><fpage>01</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.31579/2640-1045/196</pub-id></element-citation><mixed-citation id="mc-CR41" publication-type="journal">Leeners, B. Utilizing wearable biosensor technology for monitoring sleep duration patterns in pregnancy &#8211; a pilot study. <italic toggle="yes">Endocrinol. Disord.</italic><bold>8</bold>, 01&#8211;10 (2024).</mixed-citation></citation-alternatives></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ryu</surname><given-names>D</given-names></name><etal/></person-group><article-title>Comprehensive pregnancy monitoring with a network of wireless, soft, and flexible sensors in high-and low-resource health settings</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2021</year><volume>118</volume><fpage>e2100466118</fpage><pub-id pub-id-type="doi">10.1073/pnas.2100466118</pub-id><pub-id pub-id-type="pmid">33972445</pub-id><pub-id pub-id-type="pmcid">PMC8157941</pub-id></element-citation><mixed-citation id="mc-CR42" publication-type="journal">Ryu, D. et al. Comprehensive pregnancy monitoring with a network of wireless, soft, and flexible sensors in high-and low-resource health settings. <italic toggle="yes">Proc. Natl. Acad. Sci. USA</italic><bold>118</bold>, e2100466118 (2021).<pub-id pub-id-type="pmid">33972445</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.2100466118</pub-id><pub-id pub-id-type="pmcid">PMC8157941</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aggarwal</surname><given-names>G</given-names></name><name name-style="western"><surname>Wei</surname><given-names>Y</given-names></name></person-group><article-title>Non-invasive fetal electrocardiogram monitoring techniques: potential and future research opportunities in smart textiles</article-title><source>Signals</source><year>2021</year><volume>2</volume><fpage>392</fpage><lpage>412</lpage><pub-id pub-id-type="doi">10.3390/signals2030025</pub-id></element-citation><mixed-citation id="mc-CR43" publication-type="journal">Aggarwal, G. &amp; Wei, Y. Non-invasive fetal electrocardiogram monitoring techniques: potential and future research opportunities in smart textiles. <italic toggle="yes">Signals</italic><bold>2</bold>, 392&#8211;412 (2021).</mixed-citation></citation-alternatives></ref><ref id="CR44"><label>44.</label><mixed-citation publication-type="other">Mongan, W. et al. A multi-disciplinary framework for continuous biomedical monitoring using low-power passive RFID-based wireless wearable sensors. <italic toggle="yes">2016 IEEE International Conference on Smart Computing, SMARTCOMP 2016</italic>10.1109/SMARTCOMP.2016.7501674 (2016).</mixed-citation></ref><ref id="CR45"><label>45.</label><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Phillips</surname><given-names>NE</given-names></name><etal/></person-group><article-title>The metabolic and circadian signatures of gestational diabetes in the postpartum period characterised using multiple wearable devices</article-title><source>Diabetologia</source><year>2025</year><volume>68</volume><fpage>419</fpage><lpage>432</lpage><pub-id pub-id-type="doi">10.1007/s00125-024-06318-x</pub-id><pub-id pub-id-type="pmid">39531039</pub-id><pub-id pub-id-type="pmcid">PMC11732869</pub-id></element-citation><mixed-citation id="mc-CR45" publication-type="journal">Phillips, N. E. et al. The metabolic and circadian signatures of gestational diabetes in the postpartum period characterised using multiple wearable devices. <italic toggle="yes">Diabetologia</italic><bold>68</bold>, 419&#8211;432 (2025).<pub-id pub-id-type="pmid">39531039</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00125-024-06318-x</pub-id><pub-id pub-id-type="pmcid">PMC11732869</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR46"><label>46.</label><mixed-citation publication-type="other">Wei, H. X., Yang, Y. L., Luo, T. Y. &amp; Chen, W. Q. Effectiveness of mobile health interventions for pregnant women with gestational diabetes mellitus: a systematic review and meta-analysis. <italic toggle="yes">J. Obstet. Gynaecol. (Lahore)</italic><bold>43</bold>, 2245906 (2023).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/01443615.2023.2245906</pub-id><pub-id pub-id-type="pmid">37605977</pub-id></mixed-citation></ref><ref id="CR47"><label>47.</label><citation-alternatives><element-citation id="ec-CR47" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kyt&#246;</surname><given-names>M</given-names></name><etal/></person-group><article-title>Behavior change app for self-management of gestational diabetes: design and evaluation of desirable features</article-title><source>JMIR Hum. Factors</source><year>2022</year><volume>9</volume><fpage>e36987</fpage><pub-id pub-id-type="doi">10.2196/36987</pub-id><pub-id pub-id-type="pmid">36222806</pub-id><pub-id pub-id-type="pmcid">PMC9607927</pub-id></element-citation><mixed-citation id="mc-CR47" publication-type="journal">Kyt&#246;, M. et al. Behavior change app for self-management of gestational diabetes: design and evaluation of desirable features. <italic toggle="yes">JMIR Hum. Factors</italic><bold>9</bold>, e36987 (2022).<pub-id pub-id-type="pmid">36222806</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2196/36987</pub-id><pub-id pub-id-type="pmcid">PMC9607927</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR48"><label>48.</label><citation-alternatives><element-citation id="ec-CR48" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cheung</surname><given-names>NW</given-names></name><etal/></person-group><article-title>A pilot randomised controlled trial of a text messaging intervention with customisation using linked data from wireless wearable activity monitors to improve risk factors following gestational diabetes</article-title><source>Nutrients</source><year>2019</year><volume>11</volume><fpage>590</fpage><pub-id pub-id-type="doi">10.3390/nu11030590</pub-id><pub-id pub-id-type="pmid">30862052</pub-id><pub-id pub-id-type="pmcid">PMC6470941</pub-id></element-citation><mixed-citation id="mc-CR48" publication-type="journal">Cheung, N. W. et al. A pilot randomised controlled trial of a text messaging intervention with customisation using linked data from wireless wearable activity monitors to improve risk factors following gestational diabetes. <italic toggle="yes">Nutrients</italic><bold>11</bold>, 590 (2019).<pub-id pub-id-type="pmid">30862052</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/nu11030590</pub-id><pub-id pub-id-type="pmcid">PMC6470941</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR49"><label>49.</label><citation-alternatives><element-citation id="ec-CR49" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kyt&#246;</surname><given-names>M</given-names></name><etal/></person-group><article-title>Comprehensive self-tracking of blood glucose and lifestyle with a mobile application in the management of gestational diabetes: a study protocol for a randomised controlled trial (eMOM GDM study)</article-title><source>BMJ Open</source><year>2022</year><volume>12</volume><fpage>e066292</fpage><pub-id pub-id-type="doi">10.1136/bmjopen-2022-066292</pub-id><pub-id pub-id-type="pmid">36344008</pub-id><pub-id pub-id-type="pmcid">PMC9644362</pub-id></element-citation><mixed-citation id="mc-CR49" publication-type="journal">Kyt&#246;, M. et al. Comprehensive self-tracking of blood glucose and lifestyle with a mobile application in the management of gestational diabetes: a study protocol for a randomised controlled trial (eMOM GDM study). <italic toggle="yes">BMJ Open</italic><bold>12</bold>, e066292 (2022).<pub-id pub-id-type="pmid">36344008</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmjopen-2022-066292</pub-id><pub-id pub-id-type="pmcid">PMC9644362</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR50"><label>50.</label><citation-alternatives><element-citation id="ec-CR50" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kyt&#246;</surname><given-names>M</given-names></name><etal/></person-group><article-title>Supporting the management of gestational diabetes mellitus with comprehensive self-tracking: mixed methods study of wearable sensors</article-title><source>JMIR Diabetes</source><year>2023</year><volume>8</volume><fpage>e43979</fpage><pub-id pub-id-type="doi">10.2196/43979</pub-id><pub-id pub-id-type="pmid">37906216</pub-id><pub-id pub-id-type="pmcid">PMC10646680</pub-id></element-citation><mixed-citation id="mc-CR50" publication-type="journal">Kyt&#246;, M. et al. Supporting the management of gestational diabetes mellitus with comprehensive self-tracking: mixed methods study of wearable sensors. <italic toggle="yes">JMIR Diabetes</italic><bold>8</bold>, e43979 (2023).<pub-id pub-id-type="pmid">37906216</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2196/43979</pub-id><pub-id pub-id-type="pmcid">PMC10646680</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR51"><label>51.</label><citation-alternatives><element-citation id="ec-CR51" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Penders</surname><given-names>J</given-names></name><name name-style="western"><surname>Altini</surname><given-names>M</given-names></name><name name-style="western"><surname>Van Hoof</surname><given-names>C</given-names></name><name name-style="western"><surname>Dy</surname><given-names>E</given-names></name></person-group><article-title>Wearable sensors for healthier pregnancies</article-title><source>Proc. IEEE</source><year>2015</year><volume>103</volume><fpage>179</fpage><lpage>191</lpage><pub-id pub-id-type="doi">10.1109/JPROC.2014.2387017</pub-id></element-citation><mixed-citation id="mc-CR51" publication-type="journal">Penders, J., Altini, M., Van Hoof, C. &amp; Dy, E. Wearable sensors for healthier pregnancies. <italic toggle="yes">Proc. IEEE</italic><bold>103</bold>, 179&#8211;191 (2015).</mixed-citation></citation-alternatives></ref><ref id="CR52"><label>52.</label><citation-alternatives><element-citation id="ec-CR52" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jin</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Enhanced detection of Cystatin C for predicting adverse outcomes in gestational diabetes mellitus using a point-of-care immunosensor</article-title><source>Bioelectrochemistry</source><year>2025</year><volume>163</volume><fpage>108907</fpage><pub-id pub-id-type="doi">10.1016/j.bioelechem.2025.108907</pub-id><pub-id pub-id-type="pmid">39823996</pub-id></element-citation><mixed-citation id="mc-CR52" publication-type="journal">Jin, Y. et al. Enhanced detection of Cystatin C for predicting adverse outcomes in gestational diabetes mellitus using a point-of-care immunosensor. <italic toggle="yes">Bioelectrochemistry</italic><bold>163</bold>, 108907 (2025).<pub-id pub-id-type="pmid">39823996</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bioelechem.2025.108907</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR53"><label>53.</label><citation-alternatives><element-citation id="ec-CR53" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ehrlich</surname><given-names>SF</given-names></name><etal/></person-group><article-title>Using a consumer-based wearable activity tracker for physical activity goal setting and measuring steps in pregnant women with gestational diabetes mellitus: exploring acceptance and validity</article-title><source>BMC Pregnancy Childbirth</source><year>2021</year><volume>21</volume><fpage>420</fpage><pub-id pub-id-type="doi">10.1186/s12884-021-03900-8</pub-id><pub-id pub-id-type="pmid">34103002</pub-id><pub-id pub-id-type="pmcid">PMC8188700</pub-id></element-citation><mixed-citation id="mc-CR53" publication-type="journal">Ehrlich, S. F. et al. Using a consumer-based wearable activity tracker for physical activity goal setting and measuring steps in pregnant women with gestational diabetes mellitus: exploring acceptance and validity. <italic toggle="yes">BMC Pregnancy Childbirth</italic><bold>21</bold>, 420 (2021).<pub-id pub-id-type="pmid">34103002</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12884-021-03900-8</pub-id><pub-id pub-id-type="pmcid">PMC8188700</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR54"><label>54.</label><mixed-citation publication-type="other">Karnain Wadoo, O., Ahmad, I. &amp; Sayeed, S. I. Reduced lung function and progression to prediabetes: a prospective study. <italic toggle="yes">Iran. J. Diabetes Obes.</italic>10.18502/ijdo.v13i4.7994 (2021).</mixed-citation></ref><ref id="CR55"><label>55.</label><citation-alternatives><element-citation id="ec-CR55" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tehrani</surname><given-names>F</given-names></name><etal/></person-group><article-title>An integrated wearable microneedle array for the continuous monitoring of multiple biomarkers in interstitial fluid</article-title><source>Nat. Biomed. Eng.</source><year>2022</year><volume>6</volume><fpage>1214</fpage><lpage>1224</lpage><pub-id pub-id-type="doi">10.1038/s41551-022-00887-1</pub-id><pub-id pub-id-type="pmid">35534575</pub-id></element-citation><mixed-citation id="mc-CR55" publication-type="journal">Tehrani, F. et al. An integrated wearable microneedle array for the continuous monitoring of multiple biomarkers in interstitial fluid. <italic toggle="yes">Nat. Biomed. Eng.</italic><bold>6</bold>, 1214&#8211;1224 (2022).<pub-id pub-id-type="pmid">35534575</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41551-022-00887-1</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR56"><label>56.</label><citation-alternatives><element-citation id="ec-CR56" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Teymourian</surname><given-names>H</given-names></name><etal/></person-group><article-title>Microneedle-based detection of ketone bodies along with glucose and lactate: toward real-time continuous interstitial fluid monitoring of diabetic ketosis and ketoacidosis</article-title><source>Anal. Chem.</source><year>2020</year><volume>92</volume><fpage>2291</fpage><lpage>2300</lpage><pub-id pub-id-type="doi">10.1021/acs.analchem.9b05109</pub-id><pub-id pub-id-type="pmid">31874029</pub-id></element-citation><mixed-citation id="mc-CR56" publication-type="journal">Teymourian, H. et al. Microneedle-based detection of ketone bodies along with glucose and lactate: toward real-time continuous interstitial fluid monitoring of diabetic ketosis and ketoacidosis. <italic toggle="yes">Anal. Chem.</italic><bold>92</bold>, 2291&#8211;2300 (2020).<pub-id pub-id-type="pmid">31874029</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acs.analchem.9b05109</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR57"><label>57.</label><citation-alternatives><element-citation id="ec-CR57" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name><etal/></person-group><article-title>A gold nanoparticles and mxene nanocomposite based electrochemical sensor for point-of-care monitoring of serum biomarkers</article-title><source>ACS Nano</source><year>2025</year><volume>19</volume><fpage>16980</fpage><lpage>16994</lpage><pub-id pub-id-type="doi">10.1021/acsnano.5c03194</pub-id><pub-id pub-id-type="pmid">40262058</pub-id></element-citation><mixed-citation id="mc-CR57" publication-type="journal">Chen, Y. et al. A gold nanoparticles and mxene nanocomposite based electrochemical sensor for point-of-care monitoring of serum biomarkers. <italic toggle="yes">ACS Nano</italic><bold>19</bold>, 16980&#8211;16994 (2025).<pub-id pub-id-type="pmid">40262058</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acsnano.5c03194</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR58"><label>58.</label><citation-alternatives><element-citation id="ec-CR58" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smyth</surname><given-names>S</given-names></name><name name-style="western"><surname>Curtin</surname><given-names>E</given-names></name><name name-style="western"><surname>Tully</surname><given-names>E</given-names></name><name name-style="western"><surname>Molphy</surname><given-names>Z</given-names></name><name name-style="western"><surname>Breathnach</surname><given-names>F</given-names></name></person-group><article-title>Smartphone apps for surveillance of gestational diabetes: scoping review</article-title><source>JMIR Diabetes</source><year>2022</year><volume>7</volume><fpage>e38910</fpage><pub-id pub-id-type="doi">10.2196/38910</pub-id><pub-id pub-id-type="pmid">36409549</pub-id><pub-id pub-id-type="pmcid">PMC9723973</pub-id></element-citation><mixed-citation id="mc-CR58" publication-type="journal">Smyth, S., Curtin, E., Tully, E., Molphy, Z. &amp; Breathnach, F. Smartphone apps for surveillance of gestational diabetes: scoping review. <italic toggle="yes">JMIR Diabetes</italic><bold>7</bold>, e38910 (2022).<pub-id pub-id-type="pmid">36409549</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2196/38910</pub-id><pub-id pub-id-type="pmcid">PMC9723973</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR59"><label>59.</label><citation-alternatives><element-citation id="ec-CR59" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Asadollahi</surname><given-names>F</given-names></name><name name-style="western"><surname>Zagami</surname><given-names>SE</given-names></name><name name-style="western"><surname>Eslami</surname><given-names>S</given-names></name><name name-style="western"><surname>Roudsari</surname><given-names>RL</given-names></name></person-group><article-title>Barriers and facilitators for mHealth utilization in pregnancy care: a qualitative analysis of pregnant women and stakeholder&#8217;s perspectives</article-title><source>BMC Pregnancy Childbirth</source><year>2025</year><volume>25</volume><fpage>141</fpage><pub-id pub-id-type="doi">10.1186/s12884-025-07244-5</pub-id><pub-id pub-id-type="pmid">39934681</pub-id><pub-id pub-id-type="pmcid">PMC11817079</pub-id></element-citation><mixed-citation id="mc-CR59" publication-type="journal">Asadollahi, F., Zagami, S. E., Eslami, S. &amp; Roudsari, R. L. Barriers and facilitators for mHealth utilization in pregnancy care: a qualitative analysis of pregnant women and stakeholder&#8217;s perspectives. <italic toggle="yes">BMC Pregnancy Childbirth</italic><bold>25</bold>, 141 (2025).<pub-id pub-id-type="pmid">39934681</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12884-025-07244-5</pub-id><pub-id pub-id-type="pmcid">PMC11817079</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR60"><label>60.</label><citation-alternatives><element-citation id="ec-CR60" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Walter</surname><given-names>JR</given-names></name><etal/></person-group><article-title>The future of remote monitoring for pregnancy</article-title><source>Bridge (Wash. D. C.)</source><year>2022</year><volume>52</volume><fpage>16</fpage><pub-id pub-id-type="pmid">38111590</pub-id><pub-id pub-id-type="pmcid">PMC10727511</pub-id></element-citation><mixed-citation id="mc-CR60" publication-type="journal">Walter, J. R. et al. The future of remote monitoring for pregnancy. <italic toggle="yes">Bridge (Wash. D. C.)</italic><bold>52</bold>, 16 (2022).<pub-id pub-id-type="pmid">38111590</pub-id><pub-id pub-id-type="pmcid">PMC10727511</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR61"><label>61.</label><citation-alternatives><element-citation id="ec-CR61" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Veinot</surname><given-names>TC</given-names></name><name name-style="western"><surname>Mitchell</surname><given-names>H</given-names></name><name name-style="western"><surname>Ancker</surname><given-names>JS</given-names></name></person-group><article-title>Good intentions are not enough: how informatics interventions can worsen inequality</article-title><source>J. Am. Med. Inform. Assoc.</source><year>2018</year><volume>25</volume><fpage>1080</fpage><lpage>1088</lpage><pub-id pub-id-type="doi">10.1093/jamia/ocy052</pub-id><pub-id pub-id-type="pmid">29788380</pub-id><pub-id pub-id-type="pmcid">PMC7646885</pub-id></element-citation><mixed-citation id="mc-CR61" publication-type="journal">Veinot, T. C., Mitchell, H. &amp; Ancker, J. S. Good intentions are not enough: how informatics interventions can worsen inequality. <italic toggle="yes">J. Am. Med. Inform. Assoc.</italic><bold>25</bold>, 1080&#8211;1088 (2018).<pub-id pub-id-type="pmid">29788380</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/jamia/ocy052</pub-id><pub-id pub-id-type="pmcid">PMC7646885</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR62"><label>62.</label><citation-alternatives><element-citation id="ec-CR62" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Girmay</surname><given-names>M</given-names></name></person-group><article-title>Digital health divide: opportunities for reducing health disparities and promoting equitable care for maternal and child health populations</article-title><source>Int. J. Matern. Child Health AIDS</source><year>2024</year><volume>13</volume><fpage>e026</fpage><pub-id pub-id-type="doi">10.25259/IJMA_41_2024</pub-id><pub-id pub-id-type="pmcid">PMC11705165</pub-id><pub-id pub-id-type="pmid">39776789</pub-id></element-citation><mixed-citation id="mc-CR62" publication-type="journal">Girmay, M. Digital health divide: opportunities for reducing health disparities and promoting equitable care for maternal and child health populations. <italic toggle="yes">Int. J. Matern. Child Health AIDS</italic><bold>13</bold>, e026 (2024).<pub-id pub-id-type="doi" assigning-authority="pmc">10.25259/IJMA_41_2024</pub-id><pub-id pub-id-type="pmcid">PMC11705165</pub-id><pub-id pub-id-type="pmid">39776789</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR63"><label>63.</label><citation-alternatives><element-citation id="ec-CR63" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Avila-Varela</surname><given-names>DS</given-names></name><etal/></person-group><article-title>Whole-brain dynamics across the menstrual cycle: the role of hormonal fluctuations and age in healthy women</article-title><source>npj Women&#8217;s Health</source><year>2024</year><volume>2</volume><fpage>8</fpage><pub-id pub-id-type="doi">10.1038/s44294-024-00012-4</pub-id></element-citation><mixed-citation id="mc-CR63" publication-type="journal">Avila-Varela, D. S. et al. Whole-brain dynamics across the menstrual cycle: the role of hormonal fluctuations and age in healthy women. <italic toggle="yes">npj Women&#8217;s Health</italic><bold>2</bold>, 8 (2024).</mixed-citation></citation-alternatives></ref><ref id="CR64"><label>64.</label><mixed-citation publication-type="other">Kumar, P. &amp; Sait, S. Luteinizing hormone and its dilemma in ovulation induction. <italic toggle="yes">J. Hum. Reprod. Sci.</italic><bold>4</bold>, 2&#8211;7 (2011).<pub-id pub-id-type="doi" assigning-authority="pmc">10.4103/0974-1208.82351</pub-id><pub-id pub-id-type="pmcid">PMC3136063</pub-id><pub-id pub-id-type="pmid">21772731</pub-id></mixed-citation></ref><ref id="CR65"><label>65.</label><mixed-citation publication-type="other">Lee, Y. &amp; Gao, W. Non-invasive hormone monitoring with a wearable sweat biosensor. <italic toggle="yes">Nat. Rev. Bioeng.</italic>10.1038/s44222-025-00276-8 (2025).</mixed-citation></ref><ref id="CR66"><label>66.</label><citation-alternatives><element-citation id="ec-CR66" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ye</surname><given-names>C</given-names></name><etal/></person-group><article-title>A wearable aptamer nanobiosensor for non-invasive female hormone monitoring</article-title><source>Nat. Nanotechnol.</source><year>2023</year><volume>19</volume><fpage>330</fpage><lpage>337</lpage><pub-id pub-id-type="doi">10.1038/s41565-023-01513-0</pub-id><pub-id pub-id-type="pmid">37770648</pub-id><pub-id pub-id-type="pmcid">PMC10954395</pub-id></element-citation><mixed-citation id="mc-CR66" publication-type="journal">Ye, C. et al. A wearable aptamer nanobiosensor for non-invasive female hormone monitoring. <italic toggle="yes">Nat. Nanotechnol.</italic><bold>19</bold>, 330&#8211;337 (2023).<pub-id pub-id-type="pmid">37770648</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41565-023-01513-0</pub-id><pub-id pub-id-type="pmcid">PMC10954395</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR67"><label>67.</label><citation-alternatives><element-citation id="ec-CR67" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Altindag</surname><given-names>O</given-names></name><etal/></person-group><article-title>Relation of cortisol levels and bone mineral density among premenopausal women with major depression</article-title><source>Int. J. Clin. Pract.</source><year>2007</year><volume>61</volume><fpage>416</fpage><lpage>420</lpage><pub-id pub-id-type="doi">10.1111/j.1742-1241.2006.01276.x</pub-id><pub-id pub-id-type="pmid">17313608</pub-id></element-citation><mixed-citation id="mc-CR67" publication-type="journal">Altindag, O. et al. Relation of cortisol levels and bone mineral density among premenopausal women with major depression. <italic toggle="yes">Int. J. Clin. Pract.</italic><bold>61</bold>, 416&#8211;420 (2007).<pub-id pub-id-type="pmid">17313608</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1742-1241.2006.01276.x</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR68"><label>68.</label><citation-alternatives><element-citation id="ec-CR68" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Qiao</surname><given-names>L</given-names></name><name name-style="western"><surname>Benzigar</surname><given-names>MR</given-names></name><name name-style="western"><surname>Subramony</surname><given-names>JA</given-names></name><name name-style="western"><surname>Lovell</surname><given-names>NH</given-names></name><name name-style="western"><surname>Liu</surname><given-names>G</given-names></name></person-group><article-title>Advances in sweat wearables: sample extraction, real-time biosensing, and flexible platforms</article-title><source>ACS Appl Mater. Interfaces</source><year>2020</year><volume>12</volume><fpage>34337</fpage><lpage>34361</lpage><pub-id pub-id-type="doi">10.1021/acsami.0c07614</pub-id><pub-id pub-id-type="pmid">32579332</pub-id></element-citation><mixed-citation id="mc-CR68" publication-type="journal">Qiao, L., Benzigar, M. R., Subramony, J. A., Lovell, N. H. &amp; Liu, G. Advances in sweat wearables: sample extraction, real-time biosensing, and flexible platforms. <italic toggle="yes">ACS Appl Mater. Interfaces</italic><bold>12</bold>, 34337&#8211;34361 (2020).<pub-id pub-id-type="pmid">32579332</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acsami.0c07614</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR69"><label>69.</label><citation-alternatives><element-citation id="ec-CR69" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>HB</given-names></name><name name-style="western"><surname>Meeseepong</surname><given-names>M</given-names></name><name name-style="western"><surname>Trung</surname><given-names>TQ</given-names></name><name name-style="western"><surname>Kim</surname><given-names>BY</given-names></name><name name-style="western"><surname>Lee</surname><given-names>NE</given-names></name></person-group><article-title>A wearable lab-on-a-patch platform with stretchable nanostructured biosensor for non-invasive immunodetection of biomarker in sweat</article-title><source>Biosens. Bioelectron.</source><year>2020</year><volume>156</volume><fpage>112133</fpage><pub-id pub-id-type="doi">10.1016/j.bios.2020.112133</pub-id><pub-id pub-id-type="pmid">32174559</pub-id></element-citation><mixed-citation id="mc-CR69" publication-type="journal">Lee, H. B., Meeseepong, M., Trung, T. Q., Kim, B. Y. &amp; Lee, N. E. A wearable lab-on-a-patch platform with stretchable nanostructured biosensor for non-invasive immunodetection of biomarker in sweat. <italic toggle="yes">Biosens. Bioelectron.</italic><bold>156</bold>, 112133 (2020).<pub-id pub-id-type="pmid">32174559</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bios.2020.112133</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR70"><label>70.</label><citation-alternatives><element-citation id="ec-CR70" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>Z</given-names></name><name name-style="western"><surname>Chen</surname><given-names>F</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>N</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name><name name-style="western"><surname>Xie</surname><given-names>Z</given-names></name></person-group><article-title>Tip-enhanced sub-femtomolar steroid immunosensing via micropyramidal flexible conducting polymer electrodes for at-home monitoring of salivary sex hormones</article-title><source>ACS Nano</source><year>2023</year><volume>17</volume><fpage>21935</fpage><lpage>21946</lpage><pub-id pub-id-type="doi">10.1021/acsnano.3c08315</pub-id><pub-id pub-id-type="pmid">37922489</pub-id></element-citation><mixed-citation id="mc-CR70" publication-type="journal">Li, Z., Chen, F., Zhu, N., Zhang, L. &amp; Xie, Z. Tip-enhanced sub-femtomolar steroid immunosensing via micropyramidal flexible conducting polymer electrodes for at-home monitoring of salivary sex hormones. <italic toggle="yes">ACS Nano</italic><bold>17</bold>, 21935&#8211;21946 (2023).<pub-id pub-id-type="pmid">37922489</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acsnano.3c08315</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR71"><label>71.</label><citation-alternatives><element-citation id="ec-CR71" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sekar</surname><given-names>M</given-names></name><name name-style="western"><surname>Pandiaraj</surname><given-names>M</given-names></name><name name-style="western"><surname>Bhansali</surname><given-names>S</given-names></name><name name-style="western"><surname>Ponpandian</surname><given-names>N</given-names></name><name name-style="western"><surname>Viswanathan</surname><given-names>C</given-names></name></person-group><article-title>Carbon fiber based electrochemical sensor for sweat cortisol measurement</article-title><source>Sci. Rep.</source><year>2019</year><volume>9</volume><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1038/s41598-018-37243-w</pub-id><pub-id pub-id-type="pmid">30674991</pub-id><pub-id pub-id-type="pmcid">PMC6344552</pub-id></element-citation><mixed-citation id="mc-CR71" publication-type="journal">Sekar, M., Pandiaraj, M., Bhansali, S., Ponpandian, N. &amp; Viswanathan, C. Carbon fiber based electrochemical sensor for sweat cortisol measurement. <italic toggle="yes">Sci. Rep.</italic><bold>9</bold>, 1&#8211;14 (2019).<pub-id pub-id-type="pmid">30674991</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-018-37243-w</pub-id><pub-id pub-id-type="pmcid">PMC6344552</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR72"><label>72.</label><citation-alternatives><element-citation id="ec-CR72" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zheng</surname><given-names>J</given-names></name><name name-style="western"><surname>Feng</surname><given-names>Q</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>S</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>X</given-names></name></person-group><article-title>Maternal nutrition and the developmental origins of osteoporosis in offspring: Potential mechanisms and clinical implications</article-title><source>Exp. Biol. Med.</source><year>2018</year><volume>243</volume><fpage>836</fpage><lpage>842</lpage><pub-id pub-id-type="doi">10.1177/1535370218779024</pub-id><pub-id pub-id-type="pmcid">PMC6022911</pub-id><pub-id pub-id-type="pmid">29792069</pub-id></element-citation><mixed-citation id="mc-CR72" publication-type="journal">Zheng, J., Feng, Q., Zheng, S. &amp; Xiao, X. Maternal nutrition and the developmental origins of osteoporosis in offspring: Potential mechanisms and clinical implications. <italic toggle="yes">Exp. Biol. Med.</italic><bold>243</bold>, 836&#8211;842 (2018).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/1535370218779024</pub-id><pub-id pub-id-type="pmcid">PMC6022911</pub-id><pub-id pub-id-type="pmid">29792069</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR73"><label>73.</label><citation-alternatives><element-citation id="ec-CR73" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Madigan</surname><given-names>JA</given-names></name><etal/></person-group><article-title>Perinatal hair cortisol concentrations linked to psychological distress and unpredicted birth complications</article-title><source>Psychoneuroendocrinology</source><year>2024</year><volume>161</volume><fpage>106921</fpage><pub-id pub-id-type="doi">10.1016/j.psyneuen.2023.106921</pub-id><pub-id pub-id-type="pmid">38141367</pub-id></element-citation><mixed-citation id="mc-CR73" publication-type="journal">Madigan, J. A. et al. Perinatal hair cortisol concentrations linked to psychological distress and unpredicted birth complications. <italic toggle="yes">Psychoneuroendocrinology</italic><bold>161</bold>, 106921 (2024).<pub-id pub-id-type="pmid">38141367</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.psyneuen.2023.106921</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR74"><label>74.</label><citation-alternatives><element-citation id="ec-CR74" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stirrat</surname><given-names>LI</given-names></name><etal/></person-group><article-title>Pulsatility of glucocorticoid hormones in pregnancy: Changes with gestation and obesity</article-title><source>Clin. Endocrinol. (Oxf.)</source><year>2018</year><volume>88</volume><fpage>592</fpage><lpage>600</lpage><pub-id pub-id-type="doi">10.1111/cen.13548</pub-id><pub-id pub-id-type="pmid">29314170</pub-id><pub-id pub-id-type="pmcid">PMC5887976</pub-id></element-citation><mixed-citation id="mc-CR74" publication-type="journal">Stirrat, L. I. et al. Pulsatility of glucocorticoid hormones in pregnancy: Changes with gestation and obesity. <italic toggle="yes">Clin. Endocrinol. (Oxf.)</italic><bold>88</bold>, 592&#8211;600 (2018).<pub-id pub-id-type="pmid">29314170</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/cen.13548</pub-id><pub-id pub-id-type="pmcid">PMC5887976</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR75"><label>75.</label><citation-alternatives><element-citation id="ec-CR75" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hassan</surname><given-names>S</given-names></name><name name-style="western"><surname>Muere</surname><given-names>A</given-names></name><name name-style="western"><surname>Einstein</surname><given-names>G</given-names></name></person-group><article-title>Ovarian hormones and chronic pain: a comprehensive review</article-title><source>Pain</source><year>2014</year><volume>155</volume><fpage>2448</fpage><lpage>2460</lpage><pub-id pub-id-type="doi">10.1016/j.pain.2014.08.027</pub-id><pub-id pub-id-type="pmid">25172822</pub-id></element-citation><mixed-citation id="mc-CR75" publication-type="journal">Hassan, S., Muere, A. &amp; Einstein, G. Ovarian hormones and chronic pain: a comprehensive review. <italic toggle="yes">Pain</italic><bold>155</bold>, 2448&#8211;2460 (2014).<pub-id pub-id-type="pmid">25172822</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.pain.2014.08.027</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR76"><label>76.</label><citation-alternatives><element-citation id="ec-CR76" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chantalat</surname><given-names>E</given-names></name><etal/></person-group><article-title>Estrogen receptors and endometriosis</article-title><source>Int. J. Mol. Sci.</source><year>2020</year><volume>21</volume><fpage>2815</fpage><pub-id pub-id-type="doi">10.3390/ijms21082815</pub-id><pub-id pub-id-type="pmid">32316608</pub-id><pub-id pub-id-type="pmcid">PMC7215544</pub-id></element-citation><mixed-citation id="mc-CR76" publication-type="journal">Chantalat, E. et al. Estrogen receptors and endometriosis. <italic toggle="yes">Int. J. Mol. Sci.</italic><bold>21</bold>, 2815 (2020).<pub-id pub-id-type="pmid">32316608</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms21082815</pub-id><pub-id pub-id-type="pmcid">PMC7215544</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR77"><label>77.</label><citation-alternatives><element-citation id="ec-CR77" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Patel</surname><given-names>S</given-names></name></person-group><article-title>Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy</article-title><source>J. Steroid Biochem Mol. Biol.</source><year>2018</year><volume>182</volume><fpage>27</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1016/j.jsbmb.2018.04.008</pub-id><pub-id pub-id-type="pmid">29678491</pub-id></element-citation><mixed-citation id="mc-CR77" publication-type="journal">Patel, S. Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy. <italic toggle="yes">J. Steroid Biochem Mol. Biol.</italic><bold>182</bold>, 27&#8211;36 (2018).<pub-id pub-id-type="pmid">29678491</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jsbmb.2018.04.008</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR78"><label>78.</label><citation-alternatives><element-citation id="ec-CR78" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hussain</surname><given-names>SM</given-names></name><name name-style="western"><surname>Cicuttini</surname><given-names>FM</given-names></name><name name-style="western"><surname>Alyousef</surname><given-names>B</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name></person-group><article-title>Female hormonal factors and osteoarthritis of the knee, hip and hand: a narrative review</article-title><source>Climacteric</source><year>2018</year><volume>21</volume><fpage>132</fpage><lpage>139</lpage><pub-id pub-id-type="doi">10.1080/13697137.2017.1421926</pub-id><pub-id pub-id-type="pmid">29378442</pub-id></element-citation><mixed-citation id="mc-CR78" publication-type="journal">Hussain, S. M., Cicuttini, F. M., Alyousef, B. &amp; Wang, Y. Female hormonal factors and osteoarthritis of the knee, hip and hand: a narrative review. <italic toggle="yes">Climacteric</italic><bold>21</bold>, 132&#8211;139 (2018).<pub-id pub-id-type="pmid">29378442</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/13697137.2017.1421926</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR79"><label>79.</label><citation-alternatives><element-citation id="ec-CR79" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>P&#233;rez-L&#243;pez</surname><given-names>FR</given-names></name><name name-style="western"><surname>Larrad-Mur</surname><given-names>L</given-names></name><name name-style="western"><surname>Kallen</surname><given-names>A</given-names></name><name name-style="western"><surname>Chedraui</surname><given-names>P</given-names></name><name name-style="western"><surname>Taylor</surname><given-names>HS</given-names></name></person-group><article-title>Gender differences in cardiovascular disease: hormonal and biochemical influences</article-title><source>Reprod. Sci.</source><year>2010</year><volume>17</volume><fpage>511</fpage><lpage>531</lpage><pub-id pub-id-type="doi">10.1177/1933719110367829</pub-id><pub-id pub-id-type="pmid">20460551</pub-id><pub-id pub-id-type="pmcid">PMC3107852</pub-id></element-citation><mixed-citation id="mc-CR79" publication-type="journal">P&#233;rez-L&#243;pez, F. R., Larrad-Mur, L., Kallen, A., Chedraui, P. &amp; Taylor, H. S. Gender differences in cardiovascular disease: hormonal and biochemical influences. <italic toggle="yes">Reprod. Sci.</italic><bold>17</bold>, 511&#8211;531 (2010).<pub-id pub-id-type="pmid">20460551</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/1933719110367829</pub-id><pub-id pub-id-type="pmcid">PMC3107852</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR80"><label>80.</label><citation-alternatives><element-citation id="ec-CR80" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chakraborty</surname><given-names>S</given-names></name><name name-style="western"><surname>Ganti</surname><given-names>AK</given-names></name><name name-style="western"><surname>Marr</surname><given-names>A</given-names></name><name name-style="western"><surname>Batra</surname><given-names>SK</given-names></name></person-group><article-title>Lung cancer in women: role of estrogens</article-title><source>Expert Rev. Respir. Med.</source><year>2010</year><volume>4</volume><fpage>509</fpage><lpage>518</lpage><pub-id pub-id-type="doi">10.1586/ers.10.50</pub-id><pub-id pub-id-type="pmid">20658912</pub-id><pub-id pub-id-type="pmcid">PMC2928145</pub-id></element-citation><mixed-citation id="mc-CR80" publication-type="journal">Chakraborty, S., Ganti, A. K., Marr, A. &amp; Batra, S. K. Lung cancer in women: role of estrogens. <italic toggle="yes">Expert Rev. Respir. Med.</italic><bold>4</bold>, 509&#8211;518 (2010).<pub-id pub-id-type="pmid">20658912</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1586/ers.10.50</pub-id><pub-id pub-id-type="pmcid">PMC2928145</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR81"><label>81.</label><mixed-citation publication-type="other">Meng, X., Li, Z., Yue, W., Zhang, L. &amp; Xie, Z. Toward at-home and wearable monitoring of female hormones: emerging nanotechnologies and clinical prospects. <italic toggle="yes">ACS Sens.</italic>10.1021/acssensors.4c02877 (2025).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acssensors.4c02877</pub-id><pub-id pub-id-type="pmid">39761986</pub-id></mixed-citation></ref><ref id="CR82"><label>82.</label><citation-alternatives><element-citation id="ec-CR82" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>DiVasta</surname><given-names>AD</given-names></name><etal/></person-group><article-title>Hormonal add-back therapy for females treated with gonadotropin-releasing hormone agonist for endometriosis</article-title><source>Obstet. Gynecol.</source><year>2015</year><volume>126</volume><fpage>617</fpage><lpage>627</lpage><pub-id pub-id-type="doi">10.1097/AOG.0000000000000964</pub-id><pub-id pub-id-type="pmid">26181088</pub-id><pub-id pub-id-type="pmcid">PMC4545413</pub-id></element-citation><mixed-citation id="mc-CR82" publication-type="journal">DiVasta, A. D. et al. Hormonal add-back therapy for females treated with gonadotropin-releasing hormone agonist for endometriosis. <italic toggle="yes">Obstet. Gynecol.</italic><bold>126</bold>, 617&#8211;627 (2015).<pub-id pub-id-type="pmid">26181088</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/AOG.0000000000000964</pub-id><pub-id pub-id-type="pmcid">PMC4545413</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR83"><label>83.</label><citation-alternatives><element-citation id="ec-CR83" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Karakas</surname><given-names>SE</given-names></name></person-group><article-title>New biomarkers for diagnosis and management of polycystic ovary syndrome</article-title><source>Clin. Chim. Acta</source><year>2017</year><volume>471</volume><fpage>248</fpage><lpage>253</lpage><pub-id pub-id-type="doi">10.1016/j.cca.2017.06.009</pub-id><pub-id pub-id-type="pmid">28624501</pub-id></element-citation><mixed-citation id="mc-CR83" publication-type="journal">Karakas, S. E. New biomarkers for diagnosis and management of polycystic ovary syndrome. <italic toggle="yes">Clin. Chim. Acta</italic><bold>471</bold>, 248&#8211;253 (2017).<pub-id pub-id-type="pmid">28624501</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cca.2017.06.009</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR84"><label>84.</label><citation-alternatives><element-citation id="ec-CR84" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Constantin</surname><given-names>A</given-names></name></person-group><article-title>Estradiol in systemic lupus erythematosus</article-title><source>Acta Endocrinol. (Buchar.)</source><year>2023</year><volume>19</volume><fpage>274</fpage><lpage>276</lpage><pub-id pub-id-type="doi">10.4183/aeb.2023.274</pub-id><pub-id pub-id-type="pmid">37908893</pub-id><pub-id pub-id-type="pmcid">PMC10614577</pub-id></element-citation><mixed-citation id="mc-CR84" publication-type="journal">Constantin, A. Estradiol in systemic lupus erythematosus. <italic toggle="yes">Acta Endocrinol. (Buchar.)</italic><bold>19</bold>, 274&#8211;276 (2023).<pub-id pub-id-type="pmid">37908893</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4183/aeb.2023.274</pub-id><pub-id pub-id-type="pmcid">PMC10614577</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR85"><label>85.</label><mixed-citation publication-type="other">Xiang, D., Liu, Y., Zhou, S., Zhou, E. &amp; Wang, Y. Protective effects of estrogen on cardiovascular disease mediated by oxidative stress. <italic toggle="yes">Oxid. Med. Cell Longev.</italic><bold>2021</bold>, 5523516 (2021).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2021/5523516</pub-id><pub-id pub-id-type="pmcid">PMC8260319</pub-id><pub-id pub-id-type="pmid">34257804</pub-id></mixed-citation></ref><ref id="CR86"><label>86.</label><mixed-citation publication-type="other">Javed, A. et al. The relationship between myocardial infarction and estrogen use: a literature review. <italic toggle="yes">Cureus</italic>10.7759/cureus.46134 (2023).<pub-id pub-id-type="doi" assigning-authority="pmc">10.7759/cureus.46134</pub-id><pub-id pub-id-type="pmcid">PMC10612533</pub-id><pub-id pub-id-type="pmid">37900417</pub-id></mixed-citation></ref><ref id="CR87"><label>87.</label><citation-alternatives><element-citation id="ec-CR87" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reisner</surname><given-names>SL</given-names></name><etal/></person-group><article-title>Global health burden and needs of transgender populations: a review</article-title><source> Lancet</source><year>2016</year><volume>388</volume><fpage>412</fpage><lpage>436</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(16)00684-X</pub-id><pub-id pub-id-type="pmid">27323919</pub-id><pub-id pub-id-type="pmcid">PMC7035595</pub-id></element-citation><mixed-citation id="mc-CR87" publication-type="journal">Reisner, S. L. et al. Global health burden and needs of transgender populations: a review. <italic toggle="yes"> Lancet</italic><bold>388</bold>, 412&#8211;436 (2016).<pub-id pub-id-type="pmid">27323919</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(16)00684-X</pub-id><pub-id pub-id-type="pmcid">PMC7035595</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR88"><label>88.</label><citation-alternatives><element-citation id="ec-CR88" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Safer</surname><given-names>JD</given-names></name><etal/></person-group><article-title>Barriers to healthcare for transgender individuals</article-title><source>Curr. Opin. Endocrinol. Diabetes Obes.</source><year>2016</year><volume>23</volume><fpage>168</fpage><lpage>171</lpage><pub-id pub-id-type="doi">10.1097/MED.0000000000000227</pub-id><pub-id pub-id-type="pmid">26910276</pub-id><pub-id pub-id-type="pmcid">PMC4802845</pub-id></element-citation><mixed-citation id="mc-CR88" publication-type="journal">Safer, J. D. et al. Barriers to healthcare for transgender individuals. <italic toggle="yes">Curr. Opin. Endocrinol. Diabetes Obes.</italic><bold>23</bold>, 168&#8211;171 (2016).<pub-id pub-id-type="pmid">26910276</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/MED.0000000000000227</pub-id><pub-id pub-id-type="pmcid">PMC4802845</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR89"><label>89.</label><citation-alternatives><element-citation id="ec-CR89" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tangpricha</surname><given-names>V</given-names></name><name name-style="western"><surname>den Heijer</surname><given-names>M</given-names></name></person-group><article-title>Oestrogen and anti-androgen therapy for transgender women</article-title><source>Lancet Diabetes Endocrinol.</source><year>2016</year><volume>5</volume><fpage>291</fpage><pub-id pub-id-type="doi">10.1016/S2213-8587(16)30319-9</pub-id><pub-id pub-id-type="pmid">27916515</pub-id><pub-id pub-id-type="pmcid">PMC5366074</pub-id></element-citation><mixed-citation id="mc-CR89" publication-type="journal">Tangpricha, V. &amp; den Heijer, M. Oestrogen and anti-androgen therapy for transgender women. <italic toggle="yes">Lancet Diabetes Endocrinol.</italic><bold>5</bold>, 291 (2016).<pub-id pub-id-type="pmid">27916515</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S2213-8587(16)30319-9</pub-id><pub-id pub-id-type="pmcid">PMC5366074</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR90"><label>90.</label><citation-alternatives><element-citation id="ec-CR90" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sudhakar</surname><given-names>D</given-names></name><name name-style="western"><surname>Huang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Zietkowski</surname><given-names>M</given-names></name><name name-style="western"><surname>Powell</surname><given-names>N</given-names></name><name name-style="western"><surname>Fisher</surname><given-names>AR</given-names></name></person-group><article-title>Feminizing gender-affirming hormone therapy for the transgender and gender diverse population: an overview of treatment modality, monitoring, and risks</article-title><source>Neurourol. Urodyn.</source><year>2023</year><volume>42</volume><fpage>903</fpage><lpage>920</lpage><pub-id pub-id-type="doi">10.1002/nau.25097</pub-id><pub-id pub-id-type="pmid">36403287</pub-id></element-citation><mixed-citation id="mc-CR90" publication-type="journal">Sudhakar, D., Huang, Z., Zietkowski, M., Powell, N. &amp; Fisher, A. R. Feminizing gender-affirming hormone therapy for the transgender and gender diverse population: an overview of treatment modality, monitoring, and risks. <italic toggle="yes">Neurourol. Urodyn.</italic><bold>42</bold>, 903&#8211;920 (2023).<pub-id pub-id-type="pmid">36403287</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/nau.25097</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR91"><label>91.</label><mixed-citation publication-type="other">Haimson, O. L., Gorrell, D., Starks, D. L. &amp; Weinger, Z. Designing trans technology. In <italic toggle="yes">Proceedings of the 2020 CHI Conference on Human Factors in Computing Systems</italic> 1&#8211;13 (ACM, New York, NY, USA, 2020). 10.1145/3313831.3376669.</mixed-citation></ref><ref id="CR92"><label>92.</label><mixed-citation publication-type="other">Johansson, T. et al. Contemporary menopausal hormone therapy and risk of cardiovascular disease: Swedish nationwide register based emulated target trial. <italic toggle="yes">BMJ</italic> e078784. 10.1136/bmj-2023-078784 (2024).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmj-2023-078784</pub-id><pub-id pub-id-type="pmcid">PMC11600536</pub-id><pub-id pub-id-type="pmid">39603704</pub-id></mixed-citation></ref><ref id="CR93"><label>93.</label><citation-alternatives><element-citation id="ec-CR93" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kidd</surname><given-names>JD</given-names></name><etal/></person-group><article-title>Prevalence of substance use and mental health problems among transgender and cisgender U.S. adults: Results from a national probability sample</article-title><source>Psychiatry Res.</source><year>2023</year><volume>326</volume><fpage>115339</fpage><pub-id pub-id-type="doi">10.1016/j.psychres.2023.115339</pub-id><pub-id pub-id-type="pmid">37429172</pub-id><pub-id pub-id-type="pmcid">PMC10528335</pub-id></element-citation><mixed-citation id="mc-CR93" publication-type="journal">Kidd, J. D. et al. Prevalence of substance use and mental health problems among transgender and cisgender U.S. adults: Results from a national probability sample. <italic toggle="yes">Psychiatry Res.</italic><bold>326</bold>, 115339 (2023).<pub-id pub-id-type="pmid">37429172</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.psychres.2023.115339</pub-id><pub-id pub-id-type="pmcid">PMC10528335</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR94"><label>94.</label><mixed-citation publication-type="other">Berliere, M. et al. Effects of hormones on breast development and breast cancer risk in transgender women. <italic toggle="yes">Cancers</italic><bold>15</bold>, 245 (2023).<pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/cancers15010245</pub-id><pub-id pub-id-type="pmcid">PMC9818520</pub-id><pub-id pub-id-type="pmid">36612241</pub-id></mixed-citation></ref><ref id="CR95"><label>95.</label><mixed-citation publication-type="other">Heng, Y. J. et al. Effect of testosterone therapy on breast tissue composition and mammographic breast density in trans masculine individuals. <italic toggle="yes">Breast Cancer Res</italic>. <bold>26</bold>, 109 (2024).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13058-024-01867-w</pub-id><pub-id pub-id-type="pmcid">PMC11221014</pub-id><pub-id pub-id-type="pmid">38956693</pub-id></mixed-citation></ref><ref id="CR96"><label>96.</label><mixed-citation publication-type="other">Di Lisa, F. S. et al. Breast and cervical cancer in transgender men: literature review and a case report. <italic toggle="yes">Ther. Adv. Med. Oncol.</italic><bold>16</bold>, 17588359241259466 (2024).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/17588359241259466</pub-id><pub-id pub-id-type="pmcid">PMC11316962</pub-id><pub-id pub-id-type="pmid">39131728</pub-id></mixed-citation></ref><ref id="CR97"><label>97.</label><citation-alternatives><element-citation id="ec-CR97" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Coelingh Bennink</surname><given-names>HJT</given-names></name><etal/></person-group><article-title>Progesterone from ovulatory menstrual cycles is an important cause of breast cancer</article-title><source>Breast Cancer Res.</source><year>2023</year><volume>25</volume><fpage>60</fpage><pub-id pub-id-type="doi">10.1186/s13058-023-01661-0</pub-id><pub-id pub-id-type="pmid">37254150</pub-id><pub-id pub-id-type="pmcid">PMC10228093</pub-id></element-citation><mixed-citation id="mc-CR97" publication-type="journal">Coelingh Bennink, H. J. T. et al. Progesterone from ovulatory menstrual cycles is an important cause of breast cancer. <italic toggle="yes">Breast Cancer Res.</italic><bold>25</bold>, 60 (2023).<pub-id pub-id-type="pmid">37254150</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13058-023-01661-0</pub-id><pub-id pub-id-type="pmcid">PMC10228093</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR98"><label>98.</label><citation-alternatives><element-citation id="ec-CR98" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>J-H</given-names></name><name name-style="western"><surname>Liu</surname><given-names>H</given-names></name><name name-style="western"><surname>Baek</surname><given-names>H-M</given-names></name><name name-style="western"><surname>Nalcioglu</surname><given-names>O</given-names></name><name name-style="western"><surname>Su</surname><given-names>M-Y</given-names></name></person-group><article-title>Magnetic resonance imaging features of fibrocystic change of the breast</article-title><source>Magn. Reson Imaging</source><year>2008</year><volume>26</volume><fpage>1207</fpage><lpage>1214</lpage><pub-id pub-id-type="doi">10.1016/j.mri.2008.02.004</pub-id><pub-id pub-id-type="pmid">18436406</pub-id><pub-id pub-id-type="pmcid">PMC2613187</pub-id></element-citation><mixed-citation id="mc-CR98" publication-type="journal">Chen, J.-H., Liu, H., Baek, H.-M., Nalcioglu, O. &amp; Su, M.-Y. Magnetic resonance imaging features of fibrocystic change of the breast. <italic toggle="yes">Magn. Reson Imaging</italic><bold>26</bold>, 1207&#8211;1214 (2008).<pub-id pub-id-type="pmid">18436406</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.mri.2008.02.004</pub-id><pub-id pub-id-type="pmcid">PMC2613187</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR99"><label>99.</label><mixed-citation publication-type="other">Zhu, Y. et al. Imaging manifestations of ductal adenoma of the breast: a case report. <italic toggle="yes">Open Life Sci.</italic><bold>19</bold>, 20220917 (2024).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1515/biol-2022-0917</pub-id><pub-id pub-id-type="pmcid">PMC11252727</pub-id><pub-id pub-id-type="pmid">39022161</pub-id></mixed-citation></ref><ref id="CR100"><label>100.</label><mixed-citation publication-type="other">Stachs, A., Stubert, J., Reimer, T. &amp; Hartmann, S. Benign breast disease in women. <italic toggle="yes">Dtsch. Arztebl. Int.</italic>10.3238/arztebl.2019.0565 (2019).<pub-id pub-id-type="doi" assigning-authority="pmc">10.3238/arztebl.2019.0565</pub-id><pub-id pub-id-type="pmcid">PMC6794703</pub-id><pub-id pub-id-type="pmid">31554551</pub-id></mixed-citation></ref><ref id="CR101"><label>101.</label><citation-alternatives><element-citation id="ec-CR101" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McDonald</surname><given-names>ES</given-names></name><name name-style="western"><surname>Clark</surname><given-names>AS</given-names></name><name name-style="western"><surname>Tchou</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>P</given-names></name><name name-style="western"><surname>Freedman</surname><given-names>GM</given-names></name></person-group><article-title>Clinical diagnosis and management of breast cancer</article-title><source>J. Nucl. Med.</source><year>2016</year><volume>57</volume><fpage>9S</fpage><lpage>16S</lpage><pub-id pub-id-type="doi">10.2967/jnumed.115.157834</pub-id><pub-id pub-id-type="pmid">26834110</pub-id></element-citation><mixed-citation id="mc-CR101" publication-type="journal">McDonald, E. S., Clark, A. S., Tchou, J., Zhang, P. &amp; Freedman, G. M. Clinical diagnosis and management of breast cancer. <italic toggle="yes">J. Nucl. Med.</italic><bold>57</bold>, 9S&#8211;16S (2016).<pub-id pub-id-type="pmid">26834110</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2967/jnumed.115.157834</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR102"><label>102.</label><citation-alternatives><element-citation id="ec-CR102" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cardoso</surname><given-names>F</given-names></name><etal/></person-group><article-title>Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up&#8224;</article-title><source>Ann. Oncol.</source><year>2019</year><volume>30</volume><fpage>1194</fpage><lpage>1220</lpage><pub-id pub-id-type="doi">10.1093/annonc/mdz173</pub-id><pub-id pub-id-type="pmid">31161190</pub-id></element-citation><mixed-citation id="mc-CR102" publication-type="journal">Cardoso, F. et al. Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up&#8224;. <italic toggle="yes">Ann. Oncol.</italic><bold>30</bold>, 1194&#8211;1220 (2019).<pub-id pub-id-type="pmid">31161190</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/annonc/mdz173</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR103"><label>103.</label><citation-alternatives><element-citation id="ec-CR103" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bleyer</surname><given-names>A</given-names></name><name name-style="western"><surname>Baines</surname><given-names>C</given-names></name><name name-style="western"><surname>Miller</surname><given-names>AB</given-names></name></person-group><article-title>Impact of screening mammography on breast cancer mortality</article-title><source>Int. J. Cancer</source><year>2016</year><volume>138</volume><fpage>2003</fpage><lpage>2012</lpage><pub-id pub-id-type="doi">10.1002/ijc.29925</pub-id><pub-id pub-id-type="pmid">26562826</pub-id></element-citation><mixed-citation id="mc-CR103" publication-type="journal">Bleyer, A., Baines, C. &amp; Miller, A. B. Impact of screening mammography on breast cancer mortality. <italic toggle="yes">Int. J. Cancer</italic><bold>138</bold>, 2003&#8211;2012 (2016).<pub-id pub-id-type="pmid">26562826</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/ijc.29925</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR104"><label>104.</label><citation-alternatives><element-citation id="ec-CR104" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Novack</surname><given-names>DV</given-names></name></person-group><article-title>Estrogen and bone: osteoclasts take center stage</article-title><source>Cell Metab.</source><year>2007</year><volume>6</volume><fpage>254</fpage><lpage>256</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2007.09.007</pub-id><pub-id pub-id-type="pmid">17908554</pub-id></element-citation><mixed-citation id="mc-CR104" publication-type="journal">Novack, D. V. Estrogen and bone: osteoclasts take center stage. <italic toggle="yes">Cell Metab.</italic><bold>6</bold>, 254&#8211;256 (2007).<pub-id pub-id-type="pmid">17908554</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cmet.2007.09.007</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR105"><label>105.</label><citation-alternatives><element-citation id="ec-CR105" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Y-Y</given-names></name><etal/></person-group><article-title>Insights and implications of sexual dimorphism in osteoporosis</article-title><source>Bone Res.</source><year>2024</year><volume>12</volume><fpage>8</fpage><pub-id pub-id-type="doi">10.1038/s41413-023-00306-4</pub-id><pub-id pub-id-type="pmid">38368422</pub-id><pub-id pub-id-type="pmcid">PMC10874461</pub-id></element-citation><mixed-citation id="mc-CR105" publication-type="journal">Zhang, Y.-Y. et al. Insights and implications of sexual dimorphism in osteoporosis. <italic toggle="yes">Bone Res.</italic><bold>12</bold>, 8 (2024).<pub-id pub-id-type="pmid">38368422</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41413-023-00306-4</pub-id><pub-id pub-id-type="pmcid">PMC10874461</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR106"><label>106.</label><mixed-citation publication-type="other">Krugh, M. &amp; Langaker, M. D. <italic toggle="yes">Dual-Energy X-Ray Absorptiometry</italic>. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK519042/">https://www.ncbi.nlm.nih.gov/books/NBK519042/</ext-link> (2024).<pub-id pub-id-type="pmid">30085584</pub-id></mixed-citation></ref><ref id="CR107"><label>107.</label><citation-alternatives><element-citation id="ec-CR107" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shah</surname><given-names>BA</given-names></name><name name-style="western"><surname>Mirchandani</surname><given-names>A</given-names></name><name name-style="western"><surname>Abrol</surname><given-names>S</given-names></name></person-group><article-title>Impact of same day screening mammogram results on women&#8217;s satisfaction and overall breast cancer screening experience: a quality improvement survey analysis</article-title><source>BMC Women&#8217;s Health</source><year>2022</year><volume>22</volume><fpage>338</fpage><pub-id pub-id-type="doi">10.1186/s12905-022-01919-3</pub-id><pub-id pub-id-type="pmid">35941606</pub-id><pub-id pub-id-type="pmcid">PMC9361536</pub-id></element-citation><mixed-citation id="mc-CR107" publication-type="journal">Shah, B. A., Mirchandani, A. &amp; Abrol, S. Impact of same day screening mammogram results on women&#8217;s satisfaction and overall breast cancer screening experience: a quality improvement survey analysis. <italic toggle="yes">BMC Women&#8217;s Health</italic><bold>22</bold>, 338 (2022).<pub-id pub-id-type="pmid">35941606</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12905-022-01919-3</pub-id><pub-id pub-id-type="pmcid">PMC9361536</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR108"><label>108.</label><citation-alternatives><element-citation id="ec-CR108" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ghomrawi</surname><given-names>HM</given-names></name><etal/></person-group><article-title>Clinicians&#8217; perspectives on wearable sensor technology as an alternative bedside monitoring tool in two West African countries</article-title><source>Int. J. Med. Inf.</source><year>2023</year><volume>175</volume><fpage>105046</fpage><pub-id pub-id-type="doi">10.1016/j.ijmedinf.2023.105046</pub-id><pub-id pub-id-type="pmid">37148867</pub-id></element-citation><mixed-citation id="mc-CR108" publication-type="journal">Ghomrawi, H. M. et al. Clinicians&#8217; perspectives on wearable sensor technology as an alternative bedside monitoring tool in two West African countries. <italic toggle="yes">Int. J. Med. Inf.</italic><bold>175</bold>, 105046 (2023).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ijmedinf.2023.105046</pub-id><pub-id pub-id-type="pmid">37148867</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR109"><label>109.</label><citation-alternatives><element-citation id="ec-CR109" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huhn</surname><given-names>S</given-names></name><etal/></person-group><article-title>The impact of wearable technologies in health research: scoping review</article-title><source>JMIR Mhealth Uhealth</source><year>2022</year><volume>10</volume><fpage>e34384</fpage><pub-id pub-id-type="doi">10.2196/34384</pub-id><pub-id pub-id-type="pmid">35076409</pub-id><pub-id pub-id-type="pmcid">PMC8826148</pub-id></element-citation><mixed-citation id="mc-CR109" publication-type="journal">Huhn, S. et al. The impact of wearable technologies in health research: scoping review. <italic toggle="yes">JMIR Mhealth Uhealth</italic><bold>10</bold>, e34384 (2022).<pub-id pub-id-type="pmid">35076409</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2196/34384</pub-id><pub-id pub-id-type="pmcid">PMC8826148</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR110"><label>110.</label><citation-alternatives><element-citation id="ec-CR110" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Setyati</surname><given-names>R</given-names></name><etal/></person-group><article-title>The importance of early detection in disease management</article-title><source>J. World Future Med.</source><year>2024</year><volume>2</volume><fpage>51</fpage><lpage>63</lpage></element-citation><mixed-citation id="mc-CR110" publication-type="journal">Setyati, R. et al. The importance of early detection in disease management. <italic toggle="yes">J. World Future Med.</italic><bold>2</bold>, 51&#8211;63 (2024).</mixed-citation></citation-alternatives></ref><ref id="CR111"><label>111.</label><mixed-citation publication-type="other">Spink, S. S. et al. High optode-density wearable diffuse optical probe for monitoring paced breathing hemodynamics in breast tissue. <italic toggle="yes">J. Biomed. Optics</italic><bold>26</bold>, 062708 10.1117/1.JBO.26.6.062708 (2021).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1117/1.JBO.26.6.062708</pub-id><pub-id pub-id-type="pmcid">PMC8170390</pub-id><pub-id pub-id-type="pmid">34080400</pub-id></mixed-citation></ref><ref id="CR112"><label>112.</label><citation-alternatives><element-citation id="ec-CR112" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mahmood</surname><given-names>SN</given-names></name><etal/></person-group><article-title>Full ground ultra-wideband wearable textile antenna for breast cancer and wireless body area network applications</article-title><source>Micromachines</source><year>2021</year><volume>12</volume><fpage>322</fpage><pub-id pub-id-type="doi">10.3390/mi12030322</pub-id><pub-id pub-id-type="pmid">33808523</pub-id><pub-id pub-id-type="pmcid">PMC8003189</pub-id></element-citation><mixed-citation id="mc-CR112" publication-type="journal">Mahmood, S. N. et al. Full ground ultra-wideband wearable textile antenna for breast cancer and wireless body area network applications. <italic toggle="yes">Micromachines</italic><bold>12</bold>, 322 (2021).<pub-id pub-id-type="pmid">33808523</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/mi12030322</pub-id><pub-id pub-id-type="pmcid">PMC8003189</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR113"><label>113.</label><citation-alternatives><element-citation id="ec-CR113" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rahman</surname><given-names>A</given-names></name><name name-style="western"><surname>Islam</surname><given-names>MT</given-names></name><name name-style="western"><surname>Singh</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Kibria</surname><given-names>S</given-names></name><name name-style="western"><surname>Akhtaruzzaman</surname><given-names>M</given-names></name></person-group><article-title>Electromagnetic performances analysis of an ultra-wideband and flexible material antenna in microwave breast imaging: to implement a wearable medical bra</article-title><source>Sci. Rep.</source><year>2016</year><volume>6</volume><fpage>38906</fpage><pub-id pub-id-type="doi">10.1038/srep38906</pub-id><pub-id pub-id-type="pmid">28008923</pub-id><pub-id pub-id-type="pmcid">PMC5180093</pub-id></element-citation><mixed-citation id="mc-CR113" publication-type="journal">Rahman, A., Islam, M. T., Singh, M. J., Kibria, S. &amp; Akhtaruzzaman, M. Electromagnetic performances analysis of an ultra-wideband and flexible material antenna in microwave breast imaging: to implement a wearable medical bra. <italic toggle="yes">Sci. Rep.</italic><bold>6</bold>, 38906 (2016).<pub-id pub-id-type="pmid">28008923</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/srep38906</pub-id><pub-id pub-id-type="pmcid">PMC5180093</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR114"><label>114.</label><citation-alternatives><element-citation id="ec-CR114" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Matiatou</surname><given-names>M</given-names></name><etal/></person-group><article-title>Complex refractive index of freshly excised human breast tissue as a marker of disease</article-title><source>Lasers Med. Sci.</source><year>2022</year><volume>37</volume><fpage>2597</fpage><lpage>2604</lpage><pub-id pub-id-type="doi">10.1007/s10103-022-03524-0</pub-id><pub-id pub-id-type="pmid">35301608</pub-id></element-citation><mixed-citation id="mc-CR114" publication-type="journal">Matiatou, M. et al. Complex refractive index of freshly excised human breast tissue as a marker of disease. <italic toggle="yes">Lasers Med. Sci.</italic><bold>37</bold>, 2597&#8211;2604 (2022).<pub-id pub-id-type="pmid">35301608</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10103-022-03524-0</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR115"><label>115.</label><mixed-citation publication-type="other">Du, W. et al. Conformable ultrasound breast patch for deep tissue scanning and imaging. <italic toggle="yes">Sci. Adv.</italic><bold>9</bold>, eadh5325 (2023).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/sciadv.adh5325</pub-id><pub-id pub-id-type="pmcid">PMC10382022</pub-id><pub-id pub-id-type="pmid">37506210</pub-id></mixed-citation></ref><ref id="CR116"><label>116.</label><citation-alternatives><element-citation id="ec-CR116" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pandian</surname><given-names>R</given-names></name><name name-style="western"><surname>Danasegaran</surname><given-names>SK</given-names></name><name name-style="western"><surname>Lalithakumari</surname><given-names>S</given-names></name><name name-style="western"><surname>Rajalakshmi</surname><given-names>G</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>GS</given-names></name></person-group><article-title>Photonic crystal based hour glass patch antenna for the detection of breast cancer</article-title><source>Opt. Quantum Electron</source><year>2024</year><volume>56</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1007/s11082-024-06657-4</pub-id></element-citation><mixed-citation id="mc-CR116" publication-type="journal">Pandian, R., Danasegaran, S. K., Lalithakumari, S., Rajalakshmi, G. &amp; Kumar, G. S. Photonic crystal based hour glass patch antenna for the detection of breast cancer. <italic toggle="yes">Opt. Quantum Electron</italic><bold>56</bold>, 1&#8211;11 (2024).</mixed-citation></citation-alternatives></ref><ref id="CR117"><label>117.</label><citation-alternatives><element-citation id="ec-CR117" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Satpathy</surname><given-names>S</given-names></name><name name-style="western"><surname>Khalaf</surname><given-names>OI</given-names></name><name name-style="western"><surname>Shukla</surname><given-names>DK</given-names></name><name name-style="western"><surname>Algburi</surname><given-names>S</given-names></name><name name-style="western"><surname>Hamam</surname><given-names>H</given-names></name></person-group><article-title>Consumer electronics based smart technologies for enhanced terahertz healthcare having an integration of split learning with medical imaging</article-title><source>Sci. Rep.</source><year>2024</year><volume>14</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1038/s41598-024-58741-0</pub-id><pub-id pub-id-type="pmid">38710744</pub-id><pub-id pub-id-type="pmcid">PMC11074303</pub-id></element-citation><mixed-citation id="mc-CR117" publication-type="journal">Satpathy, S., Khalaf, O. I., Shukla, D. K., Algburi, S. &amp; Hamam, H. Consumer electronics based smart technologies for enhanced terahertz healthcare having an integration of split learning with medical imaging. <italic toggle="yes">Sci. Rep.</italic><bold>14</bold>, 1&#8211;12 (2024).<pub-id pub-id-type="pmid">38710744</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-024-58741-0</pub-id><pub-id pub-id-type="pmcid">PMC11074303</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR118"><label>118.</label><citation-alternatives><element-citation id="ec-CR118" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Elsheakh</surname><given-names>DM</given-names></name><name name-style="western"><surname>Alsherif</surname><given-names>SA</given-names></name><name name-style="western"><surname>Eldamak</surname><given-names>AR</given-names></name></person-group><article-title>Textile monopole sensors for breast cancer detection</article-title><source>Telecommun. Syst.</source><year>2023</year><volume>82</volume><fpage>363</fpage><lpage>379</lpage><pub-id pub-id-type="doi">10.1007/s11235-023-00990-x</pub-id></element-citation><mixed-citation id="mc-CR118" publication-type="journal">Elsheakh, D. M., Alsherif, S. A. &amp; Eldamak, A. R. Textile monopole sensors for breast cancer detection. <italic toggle="yes">Telecommun. Syst.</italic><bold>82</bold>, 363&#8211;379 (2023).</mixed-citation></citation-alternatives></ref><ref id="CR119"><label>119.</label><citation-alternatives><element-citation id="ec-CR119" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Elsheakh</surname><given-names>DN</given-names></name><name name-style="western"><surname>Mohamed</surname><given-names>RA</given-names></name><name name-style="western"><surname>Fahmy</surname><given-names>OM</given-names></name><name name-style="western"><surname>Ezzat</surname><given-names>K</given-names></name><name name-style="western"><surname>Eldamak</surname><given-names>AR</given-names></name></person-group><article-title>Complete breast cancer detection and monitoring system by using microwave textile based antenna sensors</article-title><source>Biosensors</source><year>2023</year><volume>13</volume><fpage>87</fpage><pub-id pub-id-type="doi">10.3390/bios13010087</pub-id><pub-id pub-id-type="pmid">36671922</pub-id><pub-id pub-id-type="pmcid">PMC9855354</pub-id></element-citation><mixed-citation id="mc-CR119" publication-type="journal">Elsheakh, D. N., Mohamed, R. A., Fahmy, O. M., Ezzat, K. &amp; Eldamak, A. R. Complete breast cancer detection and monitoring system by using microwave textile based antenna sensors. <italic toggle="yes">Biosensors</italic><bold>13</bold>, 87 (2023).<pub-id pub-id-type="pmid">36671922</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/bios13010087</pub-id><pub-id pub-id-type="pmcid">PMC9855354</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR120"><label>120.</label><citation-alternatives><element-citation id="ec-CR120" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vijayakumari</surname><given-names>P</given-names></name><etal/></person-group><article-title>Wearable transceiver with composite test-beds for breast cancer diagnosis</article-title><source>Mater. Today Proc.</source><year>2021</year><volume>45</volume><fpage>3120</fpage><lpage>3123</lpage><pub-id pub-id-type="doi">10.1016/j.matpr.2020.12.206</pub-id></element-citation><mixed-citation id="mc-CR120" publication-type="journal">Vijayakumari, P. et al. Wearable transceiver with composite test-beds for breast cancer diagnosis. <italic toggle="yes">Mater. Today Proc.</italic><bold>45</bold>, 3120&#8211;3123 (2021).</mixed-citation></citation-alternatives></ref><ref id="CR121"><label>121.</label><citation-alternatives><element-citation id="ec-CR121" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mukai</surname><given-names>Y</given-names></name><name name-style="western"><surname>Suh</surname><given-names>M</given-names></name></person-group><article-title>Development of a conformal woven fabric antenna for wearable breast hyperthermia</article-title><source>Fash. Text.</source><year>2021</year><volume>8</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1186/s40691-020-00231-8</pub-id></element-citation><mixed-citation id="mc-CR121" publication-type="journal">Mukai, Y. &amp; Suh, M. Development of a conformal woven fabric antenna for wearable breast hyperthermia. <italic toggle="yes">Fash. Text.</italic><bold>8</bold>, 1&#8211;12 (2021).</mixed-citation></citation-alternatives></ref><ref id="CR122"><label>122.</label><mixed-citation publication-type="other">Elias, V., Rabih, A. &amp; Nassar, G. Early breast lump detection using the intelligent bra&#8221;IN-bra&#8221;. <italic toggle="yes">HAL Open Sci.</italic><bold>4</bold>, 43&#8211;49 (2022).</mixed-citation></ref><ref id="CR123"><label>123.</label><citation-alternatives><element-citation id="ec-CR123" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>L</given-names></name><name name-style="western"><surname>Webster</surname><given-names>TJ</given-names></name></person-group><article-title>In situ sensor advancements for osteoporosis prevention, diagnosis, and treatment</article-title><source>Curr. Osteoporos. Rep.</source><year>2016</year><volume>14</volume><fpage>386</fpage><lpage>395</lpage><pub-id pub-id-type="doi">10.1007/s11914-016-0339-7</pub-id><pub-id pub-id-type="pmid">27815807</pub-id></element-citation><mixed-citation id="mc-CR123" publication-type="journal">Liu, L. &amp; Webster, T. J. In situ sensor advancements for osteoporosis prevention, diagnosis, and treatment. <italic toggle="yes">Curr. Osteoporos. Rep.</italic><bold>14</bold>, 386&#8211;395 (2016).<pub-id pub-id-type="pmid">27815807</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11914-016-0339-7</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR124"><label>124.</label><mixed-citation publication-type="other">Amin, U., McPartland, A., O&#8217;Sullivan, M. &amp; Silke, C. An overview of the management of osteoporosis in the aging female population. <italic toggle="yes">Women&#8217;s Health</italic><bold>19</bold>, 17455057231176655 (2023).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/17455057231176655</pub-id><pub-id pub-id-type="pmcid">PMC10214060</pub-id><pub-id pub-id-type="pmid">37218715</pub-id></mixed-citation></ref><ref id="CR125"><label>125.</label><citation-alternatives><element-citation id="ec-CR125" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>JK</given-names></name><name name-style="western"><surname>Bae</surname><given-names>MN</given-names></name><name name-style="western"><surname>Lee</surname><given-names>K</given-names></name><name name-style="western"><surname>Kim</surname><given-names>JC</given-names></name><name name-style="western"><surname>Hong</surname><given-names>SG</given-names></name></person-group><article-title>Explainable artificial intelligence and wearable sensor-based gait analysis to identify patients with osteopenia and sarcopenia in daily life</article-title><source>Biosensors</source><year>2022</year><volume>12</volume><fpage>167</fpage><pub-id pub-id-type="doi">10.3390/bios12030167</pub-id><pub-id pub-id-type="pmid">35323437</pub-id><pub-id pub-id-type="pmcid">PMC8946270</pub-id></element-citation><mixed-citation id="mc-CR125" publication-type="journal">Kim, J. K., Bae, M. N., Lee, K., Kim, J. C. &amp; Hong, S. G. Explainable artificial intelligence and wearable sensor-based gait analysis to identify patients with osteopenia and sarcopenia in daily life. <italic toggle="yes">Biosensors</italic><bold>12</bold>, 167 (2022).<pub-id pub-id-type="pmid">35323437</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/bios12030167</pub-id><pub-id pub-id-type="pmcid">PMC8946270</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR126"><label>126.</label><citation-alternatives><element-citation id="ec-CR126" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kristoffersson</surname><given-names>A</given-names></name><name name-style="western"><surname>Lind&#233;n</surname><given-names>M</given-names></name></person-group><article-title>A systematic review on the use of wearable body sensors for health monitoring: a qualitative synthesis</article-title><source>Sensors</source><year>2020</year><volume>20</volume><fpage>1502</fpage><pub-id pub-id-type="doi">10.3390/s20051502</pub-id><pub-id pub-id-type="pmid">32182907</pub-id><pub-id pub-id-type="pmcid">PMC7085653</pub-id></element-citation><mixed-citation id="mc-CR126" publication-type="journal">Kristoffersson, A. &amp; Lind&#233;n, M. A systematic review on the use of wearable body sensors for health monitoring: a qualitative synthesis. <italic toggle="yes">Sensors</italic><bold>20</bold>, 1502 (2020).<pub-id pub-id-type="pmid">32182907</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/s20051502</pub-id><pub-id pub-id-type="pmcid">PMC7085653</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR127"><label>127.</label><citation-alternatives><element-citation id="ec-CR127" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aggelis</surname><given-names>DG</given-names></name><etal/></person-group><article-title>Fracture of human femur tissue monitored by acoustic emission sensors</article-title><source>Sensors</source><year>2015</year><volume>15</volume><fpage>5803</fpage><lpage>5819</lpage><pub-id pub-id-type="doi">10.3390/s150305803</pub-id><pub-id pub-id-type="pmid">25763648</pub-id><pub-id pub-id-type="pmcid">PMC4435197</pub-id></element-citation><mixed-citation id="mc-CR127" publication-type="journal">Aggelis, D. G. et al. Fracture of human femur tissue monitored by acoustic emission sensors. <italic toggle="yes">Sensors</italic><bold>15</bold>, 5803&#8211;5819 (2015).<pub-id pub-id-type="pmid">25763648</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/s150305803</pub-id><pub-id pub-id-type="pmcid">PMC4435197</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR128"><label>128.</label><citation-alternatives><element-citation id="ec-CR128" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Song</surname><given-names>Z</given-names></name><name name-style="western"><surname>Wang</surname><given-names>B</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Yu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Lin</surname><given-names>D</given-names></name></person-group><article-title>A highly flexible piezoelectric ultrasonic sensor for wearable bone density testing</article-title><source>Micromachines (Basel)</source><year>2023</year><volume>14</volume><fpage>1798</fpage><pub-id pub-id-type="doi">10.3390/mi14091798</pub-id><pub-id pub-id-type="pmid">37763961</pub-id><pub-id pub-id-type="pmcid">PMC10535184</pub-id></element-citation><mixed-citation id="mc-CR128" publication-type="journal">Song, Z., Wang, B., Zhang, Z., Yu, Y. &amp; Lin, D. A highly flexible piezoelectric ultrasonic sensor for wearable bone density testing. <italic toggle="yes">Micromachines (Basel)</italic><bold>14</bold>, 1798 (2023).<pub-id pub-id-type="pmid">37763961</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/mi14091798</pub-id><pub-id pub-id-type="pmcid">PMC10535184</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR129"><label>129.</label><citation-alternatives><element-citation id="ec-CR129" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gao</surname><given-names>H</given-names></name><etal/></person-group><article-title>Lower bone mineral density in patients with Parkinson&#8217;s disease: a cross-sectional study from Chinese Mainland</article-title><source>Front Aging Neurosci.</source><year>2015</year><volume>7</volume><fpage>162985</fpage><pub-id pub-id-type="doi">10.3389/fnagi.2015.00203</pub-id><pub-id pub-id-type="pmcid">PMC4621433</pub-id><pub-id pub-id-type="pmid">26578949</pub-id></element-citation><mixed-citation id="mc-CR129" publication-type="journal">Gao, H. et al. Lower bone mineral density in patients with Parkinson&#8217;s disease: a cross-sectional study from Chinese Mainland. <italic toggle="yes">Front Aging Neurosci.</italic><bold>7</bold>, 162985 (2015).<pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fnagi.2015.00203</pub-id><pub-id pub-id-type="pmcid">PMC4621433</pub-id><pub-id pub-id-type="pmid">26578949</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR130"><label>130.</label><citation-alternatives><element-citation id="ec-CR130" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stewart</surname><given-names>A</given-names></name><name name-style="western"><surname>Black</surname><given-names>A</given-names></name></person-group><article-title>Bone mineral density in osteoarthritis</article-title><source>Curr. Opin. Rheumatol.</source><year>2000</year><volume>12</volume><fpage>464</fpage><lpage>467</lpage><pub-id pub-id-type="doi">10.1097/00002281-200009000-00021</pub-id><pub-id pub-id-type="pmid">10990188</pub-id></element-citation><mixed-citation id="mc-CR130" publication-type="journal">Stewart, A. &amp; Black, A. Bone mineral density in osteoarthritis. <italic toggle="yes">Curr. Opin. Rheumatol.</italic><bold>12</bold>, 464&#8211;467 (2000).<pub-id pub-id-type="pmid">10990188</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/00002281-200009000-00021</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR131"><label>131.</label><citation-alternatives><element-citation id="ec-CR131" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lodder</surname><given-names>MC</given-names></name><etal/></person-group><article-title>Bone mineral density in patients with rheumatoid arthritis: relation between disease severity and low bone mineral density</article-title><source>Ann. Rheum. Dis.</source><year>2004</year><volume>63</volume><fpage>1576</fpage><lpage>1580</lpage><pub-id pub-id-type="doi">10.1136/ard.2003.016253</pub-id><pub-id pub-id-type="pmid">15547081</pub-id><pub-id pub-id-type="pmcid">PMC1754831</pub-id></element-citation><mixed-citation id="mc-CR131" publication-type="journal">Lodder, M. C. et al. Bone mineral density in patients with rheumatoid arthritis: relation between disease severity and low bone mineral density. <italic toggle="yes">Ann. Rheum. Dis.</italic><bold>63</bold>, 1576&#8211;1580 (2004).<pub-id pub-id-type="pmid">15547081</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/ard.2003.016253</pub-id><pub-id pub-id-type="pmcid">PMC1754831</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR132"><label>132.</label><citation-alternatives><element-citation id="ec-CR132" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Redelinghuys</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Geldenhuys</surname><given-names>J</given-names></name><name name-style="western"><surname>Jung</surname><given-names>H</given-names></name><name name-style="western"><surname>Kock</surname><given-names>MM</given-names></name></person-group><article-title>Bacterial vaginosis: current diagnostic avenues and future opportunities</article-title><source>Front Cell Infect. Microbiol.</source><year>2020</year><volume>10</volume><fpage>521070</fpage><pub-id pub-id-type="doi">10.3389/fcimb.2020.00354</pub-id><pub-id pub-id-type="pmcid">PMC7431474</pub-id><pub-id pub-id-type="pmid">32850469</pub-id></element-citation><mixed-citation id="mc-CR132" publication-type="journal">Redelinghuys, M. J., Geldenhuys, J., Jung, H. &amp; Kock, M. M. Bacterial vaginosis: current diagnostic avenues and future opportunities. <italic toggle="yes">Front Cell Infect. Microbiol.</italic><bold>10</bold>, 521070 (2020).<pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fcimb.2020.00354</pub-id><pub-id pub-id-type="pmcid">PMC7431474</pub-id><pub-id pub-id-type="pmid">32850469</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR133"><label>133.</label><citation-alternatives><element-citation id="ec-CR133" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eleut&#233;rio</surname><given-names>J</given-names></name><name name-style="western"><surname>Campaner</surname><given-names>AB</given-names></name><name name-style="western"><surname>de Carvalho</surname><given-names>NS</given-names></name></person-group><article-title>Diagnosis and treatment of infectious vaginitis: proposal for a new algorithm</article-title><source>Front Med. (Lausanne)</source><year>2023</year><volume>10</volume><fpage>1040072</fpage><pub-id pub-id-type="doi">10.3389/fmed.2023.1040072</pub-id><pub-id pub-id-type="pmid">36844222</pub-id><pub-id pub-id-type="pmcid">PMC9947655</pub-id></element-citation><mixed-citation id="mc-CR133" publication-type="journal">Eleut&#233;rio, J., Campaner, A. B. &amp; de Carvalho, N. S. Diagnosis and treatment of infectious vaginitis: proposal for a new algorithm. <italic toggle="yes">Front Med. (Lausanne)</italic><bold>10</bold>, 1040072 (2023).<pub-id pub-id-type="pmid">36844222</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fmed.2023.1040072</pub-id><pub-id pub-id-type="pmcid">PMC9947655</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR134"><label>134.</label><mixed-citation publication-type="other">Wilson, M. &amp; Wilson, P. J. K. Vaginitis. <italic toggle="yes">Close Encounters of the Microbial Kind</italic> 361&#8211;378 10.1007/978-3-030-56978-5_26 (2021).</mixed-citation></ref><ref id="CR135"><label>135.</label><citation-alternatives><element-citation id="ec-CR135" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rezk</surname><given-names>S</given-names></name><name name-style="western"><surname>Alqabbasi</surname><given-names>O</given-names></name></person-group><article-title>Bacterial vaginosis, vulvovaginal candidiasis, trichomonal vaginitis and aerobic vaginitis in women from Egypt</article-title><source>Germs</source><year>2023</year><volume>13</volume><fpage>130</fpage><pub-id pub-id-type="doi">10.18683/germs.2023.1376</pub-id><pub-id pub-id-type="pmid">38144250</pub-id><pub-id pub-id-type="pmcid">PMC10746338</pub-id></element-citation><mixed-citation id="mc-CR135" publication-type="journal">Rezk, S. &amp; Alqabbasi, O. Bacterial vaginosis, vulvovaginal candidiasis, trichomonal vaginitis and aerobic vaginitis in women from Egypt. <italic toggle="yes">Germs</italic><bold>13</bold>, 130 (2023).<pub-id pub-id-type="pmid">38144250</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.18683/germs.2023.1376</pub-id><pub-id pub-id-type="pmcid">PMC10746338</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR136"><label>136.</label><citation-alternatives><element-citation id="ec-CR136" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brown</surname><given-names>H</given-names></name><name name-style="western"><surname>Drexler</surname><given-names>M</given-names></name></person-group><article-title>Improving the diagnosis of vulvovaginitis: perspectives to align practice, guidelines, and awareness</article-title><source>Popul. Health Manag.</source><year>2020</year><volume>23</volume><fpage>S3</fpage><lpage>S12</lpage><pub-id pub-id-type="doi">10.1089/pop.2020.0265</pub-id><pub-id pub-id-type="pmid">32997581</pub-id><pub-id pub-id-type="pmcid">PMC7591372</pub-id></element-citation><mixed-citation id="mc-CR136" publication-type="journal">Brown, H. &amp; Drexler, M. Improving the diagnosis of vulvovaginitis: perspectives to align practice, guidelines, and awareness. <italic toggle="yes">Popul. Health Manag.</italic><bold>23</bold>, S3&#8211;S12 (2020).<pub-id pub-id-type="pmid">32997581</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1089/pop.2020.0265</pub-id><pub-id pub-id-type="pmcid">PMC7591372</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR137"><label>137.</label><citation-alternatives><element-citation id="ec-CR137" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jin</surname><given-names>X</given-names></name><etal/></person-group><article-title>An integrated and multi-target nucleic acid isothermal analysis system for rapid diagnosis of vulvovaginal candidiasis</article-title><source>Biosensors (Basel)</source><year>2023</year><volume>13</volume><fpage>559</fpage><pub-id pub-id-type="doi">10.3390/bios13050559</pub-id><pub-id pub-id-type="pmid">37232920</pub-id><pub-id pub-id-type="pmcid">PMC10216317</pub-id></element-citation><mixed-citation id="mc-CR137" publication-type="journal">Jin, X. et al. An integrated and multi-target nucleic acid isothermal analysis system for rapid diagnosis of vulvovaginal candidiasis. <italic toggle="yes">Biosensors (Basel)</italic><bold>13</bold>, 559 (2023).<pub-id pub-id-type="pmid">37232920</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/bios13050559</pub-id><pub-id pub-id-type="pmcid">PMC10216317</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR138"><label>138.</label><mixed-citation publication-type="other">Paghi, A. et al. Wireless and flexible optoelectronic system for in situ monitoring of vaginal pH using a bioresorbable fluorescence sensor. <italic toggle="yes">Adv. Mater. Technol.</italic><bold>8</bold>, 2201600 (2023).</mixed-citation></ref><ref id="CR139"><label>139.</label><mixed-citation publication-type="other">Alma - Wearable Biosensor for Monitoring Vaginal Discharge - Hackster.io. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.hackster.io/alma/alma-wearable-biosensor-for-monitoring-vaginal-discharge-b1022f">https://www.hackster.io/alma/alma-wearable-biosensor-for-monitoring-vaginal-discharge-b1022f</ext-link>.</mixed-citation></ref><ref id="CR140"><label>140.</label><mixed-citation publication-type="other">Pal, A., Nadiger, V. G., Goswami, D. &amp; Martinez, R. V. Conformal, waterproof electronic decals for wireless monitoring of sweat and vaginal pH at the point-of-care. <italic toggle="yes">Biosens. Bioelectron.</italic><bold>160</bold>, 112206 (2020).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bios.2020.112206</pub-id><pub-id pub-id-type="pmid">32339147</pub-id></mixed-citation></ref><ref id="CR141"><label>141.</label><citation-alternatives><element-citation id="ec-CR141" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Torres</surname><given-names>ML</given-names></name><etal/></person-group><article-title>Home-based electrochemical rapid sensor (HERS): a diagnostic tool for bacterial vaginosis</article-title><source>Sensors</source><year>2023</year><volume>23</volume><fpage>1891</fpage><pub-id pub-id-type="doi">10.3390/s23041891</pub-id><pub-id pub-id-type="pmid">36850490</pub-id><pub-id pub-id-type="pmcid">PMC9964842</pub-id></element-citation><mixed-citation id="mc-CR141" publication-type="journal">Torres, M. L. et al. Home-based electrochemical rapid sensor (HERS): a diagnostic tool for bacterial vaginosis. <italic toggle="yes">Sensors</italic><bold>23</bold>, 1891 (2023).<pub-id pub-id-type="pmid">36850490</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/s23041891</pub-id><pub-id pub-id-type="pmcid">PMC9964842</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR142"><label>142.</label><mixed-citation publication-type="other">Clack, K., Sallam, M., Matheson, C., Muyldermans, S. &amp; Nguyen, N.-T. Towards a Wearable Feminine Hygiene Platform for Detection of Invasive Fungal Pathogens via Gold Nanoparticle Aggregation. <italic toggle="yes">Micromachines (Basel)</italic><bold>15</bold>, 899 (2024).<pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/mi15070899</pub-id><pub-id pub-id-type="pmcid">PMC11278863</pub-id><pub-id pub-id-type="pmid">39064410</pub-id></mixed-citation></ref><ref id="CR143"><label>143.</label><citation-alternatives><element-citation id="ec-CR143" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vo</surname><given-names>D-K</given-names></name><name name-style="western"><surname>Trinh</surname><given-names>KTL</given-names></name></person-group><article-title>Advances in wearable biosensors for healthcare: current trends, applications, and future perspectives</article-title><source>Biosensors (Basel)</source><year>2024</year><volume>14</volume><fpage>560</fpage><pub-id pub-id-type="doi">10.3390/bios14110560</pub-id><pub-id pub-id-type="pmid">39590019</pub-id><pub-id pub-id-type="pmcid">PMC11592256</pub-id></element-citation><mixed-citation id="mc-CR143" publication-type="journal">Vo, D.-K. &amp; Trinh, K. T. L. Advances in wearable biosensors for healthcare: current trends, applications, and future perspectives. <italic toggle="yes">Biosensors (Basel)</italic><bold>14</bold>, 560 (2024).<pub-id pub-id-type="pmid">39590019</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/bios14110560</pub-id><pub-id pub-id-type="pmcid">PMC11592256</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR144"><label>144.</label><mixed-citation publication-type="other">World Health Organization. Point-of-Care Diagnostic Tests (POCTs) for Sexually Transmitted Infections (STIs). <italic toggle="yes">World Health Organization</italic><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.who.int/teams/sexual-and-reproductive-health-and-research-(srh)/areas-of-work/sexual-health/sexually-transmitted-infections/point-of-care-tests#:~:text=Background%20and%20rationale,professional%20and%20lay%20health%20workers">https://www.who.int/teams/sexual-and-reproductive-health-and-research-(srh)/areas-of-work/sexual-health/sexually-transmitted-infections/point-of-care-tests#:~:text=Background%20and%20rationale,professional%20and%20lay%20health%20workers</ext-link>.</mixed-citation></ref><ref id="CR145"><label>145.</label><citation-alternatives><element-citation id="ec-CR145" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Adamson</surname><given-names>PC</given-names></name><name name-style="western"><surname>Loeffelholz</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Klausner</surname><given-names>JD</given-names></name></person-group><article-title>Point-of-care testing for sexually transmitted infections a review of recent developments</article-title><source>Arch. Pathol. Lab. Med.</source><year>2020</year><volume>144</volume><fpage>1344</fpage><pub-id pub-id-type="doi">10.5858/arpa.2020-0118-RA</pub-id><pub-id pub-id-type="pmid">32810868</pub-id><pub-id pub-id-type="pmcid">PMC7606737</pub-id></element-citation><mixed-citation id="mc-CR145" publication-type="journal">Adamson, P. C., Loeffelholz, M. J. &amp; Klausner, J. D. Point-of-care testing for sexually transmitted infections a review of recent developments. <italic toggle="yes">Arch. Pathol. Lab. Med.</italic><bold>144</bold>, 1344 (2020).<pub-id pub-id-type="pmid">32810868</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.5858/arpa.2020-0118-RA</pub-id><pub-id pub-id-type="pmcid">PMC7606737</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR146"><label>146.</label><mixed-citation publication-type="other">Chen, L., Li, J. &amp; Xiao, B. The role of sialidases in the pathogenesis of bacterial vaginosis and their use as a promising pharmacological target in bacterial vaginosis. <italic toggle="yes">Front. Cell. Infection Microbiol.</italic><bold>14</bold>, 1367233 (2024).<pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fcimb.2024.1367233</pub-id><pub-id pub-id-type="pmcid">PMC10940449</pub-id><pub-id pub-id-type="pmid">38495652</pub-id></mixed-citation></ref><ref id="CR147"><label>147.</label><mixed-citation publication-type="other">Wu, S. et al. A biochemiluminescent sialidase assay for diagnosis of bacterial vaginosis. <italic toggle="yes">Sci. Rep.</italic><bold>9</bold>, 20024 (2019).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-019-56371-5</pub-id><pub-id pub-id-type="pmcid">PMC6934538</pub-id><pub-id pub-id-type="pmid">31882933</pub-id></mixed-citation></ref><ref id="CR148"><label>148.</label><citation-alternatives><element-citation id="ec-CR148" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rodr&#237;guez-Nava</surname><given-names>C</given-names></name><etal/></person-group><article-title>Nanophotonic sialidase immunoassay for bacterial vaginosis diagnosis</article-title><source>ACS Pharm. Transl. Sci.</source><year>2021</year><volume>4</volume><fpage>365</fpage><lpage>371</lpage><pub-id pub-id-type="doi">10.1021/acsptsci.0c00211</pub-id><pub-id pub-id-type="pmcid">PMC7887842</pub-id><pub-id pub-id-type="pmid">33615186</pub-id></element-citation><mixed-citation id="mc-CR148" publication-type="journal">Rodr&#237;guez-Nava, C. et al. Nanophotonic sialidase immunoassay for bacterial vaginosis diagnosis. <italic toggle="yes">ACS Pharm. Transl. Sci.</italic><bold>4</bold>, 365&#8211;371 (2021).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acsptsci.0c00211</pub-id><pub-id pub-id-type="pmcid">PMC7887842</pub-id><pub-id pub-id-type="pmid">33615186</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR149"><label>149.</label><mixed-citation publication-type="other">Ng, S. et al. Large-scale characterisation of the pregnancy vaginal microbiome and sialidase activity in a low-risk Chinese population. <italic toggle="yes">NPJ Biofilms Microbiomes</italic><bold>7</bold>, 89 (2021).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41522-021-00261-0</pub-id><pub-id pub-id-type="pmcid">PMC8688454</pub-id><pub-id pub-id-type="pmid">34930922</pub-id></mixed-citation></ref><ref id="CR150"><label>150.</label><citation-alternatives><element-citation id="ec-CR150" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Rochefort</surname><given-names>D</given-names></name></person-group><article-title>Fast and effective paper based sensor for self-diagnosis of bacterial vaginosis</article-title><source>Anal. Chim. Acta</source><year>2013</year><volume>800</volume><fpage>87</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1016/j.aca.2013.09.032</pub-id><pub-id pub-id-type="pmid">24120172</pub-id></element-citation><mixed-citation id="mc-CR150" publication-type="journal">Zhang, Y. &amp; Rochefort, D. Fast and effective paper based sensor for self-diagnosis of bacterial vaginosis. <italic toggle="yes">Anal. Chim. Acta</italic><bold>800</bold>, 87&#8211;94 (2013).<pub-id pub-id-type="pmid">24120172</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.aca.2013.09.032</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR151"><label>151.</label><citation-alternatives><element-citation id="ec-CR151" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Reukov</surname><given-names>V</given-names></name><etal/></person-group><article-title>Fabrication of nanocoated fibers for self-diagnosis of bacterial vaginosis</article-title><source>Mater. Sci. Eng. C</source><year>2009</year><volume>29</volume><fpage>669</fpage><lpage>673</lpage><pub-id pub-id-type="doi">10.1016/j.msec.2008.11.016</pub-id></element-citation><mixed-citation id="mc-CR151" publication-type="journal">Reukov, V. et al. Fabrication of nanocoated fibers for self-diagnosis of bacterial vaginosis. <italic toggle="yes">Mater. Sci. Eng. C</italic><bold>29</bold>, 669&#8211;673 (2009).</mixed-citation></citation-alternatives></ref><ref id="CR152"><label>152.</label><citation-alternatives><element-citation id="ec-CR152" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Avila-Huerta</surname><given-names>MD</given-names></name><etal/></person-group><article-title>Disposable device for bacterial vaginosis detection</article-title><source>ACS Meas. Sci. Au.</source><year>2023</year><volume>3</volume><fpage>355</fpage><lpage>360</lpage><pub-id pub-id-type="doi">10.1021/acsmeasuresciau.3c00007</pub-id><pub-id pub-id-type="pmid">37868361</pub-id><pub-id pub-id-type="pmcid">PMC10588930</pub-id></element-citation><mixed-citation id="mc-CR152" publication-type="journal">Avila-Huerta, M. D. et al. Disposable device for bacterial vaginosis detection. <italic toggle="yes">ACS Meas. Sci. Au.</italic><bold>3</bold>, 355&#8211;360 (2023).<pub-id pub-id-type="pmid">37868361</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acsmeasuresciau.3c00007</pub-id><pub-id pub-id-type="pmcid">PMC10588930</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR153"><label>153.</label><mixed-citation publication-type="other">Li, M. et al. Loop-mediated isothermal amplification (LAMP): potential point-of-care testing for vulvovaginal candidiasis. <italic toggle="yes">J. Fungi</italic><bold>9</bold>, 1159 (2023).<pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/jof9121159</pub-id><pub-id pub-id-type="pmcid">PMC10744362</pub-id><pub-id pub-id-type="pmid">38132760</pub-id></mixed-citation></ref><ref id="CR154"><label>154.</label><citation-alternatives><element-citation id="ec-CR154" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mosley</surname><given-names>GL</given-names></name><etal/></person-group><article-title>Improved lateral-flow immunoassays for chlamydia and immunoglobulin M by sequential rehydration of two-phase system components within a paper-based diagnostic</article-title><source>Microchim. Acta</source><year>2017</year><volume>184</volume><fpage>4055</fpage><lpage>4064</lpage><pub-id pub-id-type="doi">10.1007/s00604-017-2434-6</pub-id></element-citation><mixed-citation id="mc-CR154" publication-type="journal">Mosley, G. L. et al. Improved lateral-flow immunoassays for chlamydia and immunoglobulin M by sequential rehydration of two-phase system components within a paper-based diagnostic. <italic toggle="yes">Microchim. Acta</italic><bold>184</bold>, 4055&#8211;4064 (2017).</mixed-citation></citation-alternatives></ref><ref id="CR155"><label>155.</label><mixed-citation publication-type="other">Yang, J. et al. Leak-proof probe for accurate detection of Neisseria gonorrhoeae by recombinase polymerase amplification-mediated lateral flow strip. <italic toggle="yes">Anal. Chim. Acta</italic><bold>1258</bold>, 341176 (2023).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.aca.2023.341176</pub-id><pub-id pub-id-type="pmid">37087294</pub-id></mixed-citation></ref><ref id="CR156"><label>156.</label><mixed-citation publication-type="other">Ji, T. et al. Establishment and application of a rapid visual diagnostic method for Streptococcus agalactiae based on recombinase polymerase amplification and lateral flow strips. <italic toggle="yes">Sci. Rep.</italic><bold>14</bold>, 10064 (2024).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-024-56138-7</pub-id><pub-id pub-id-type="pmcid">PMC11066032</pub-id><pub-id pub-id-type="pmid">38698011</pub-id></mixed-citation></ref><ref id="CR157"><label>157.</label><mixed-citation publication-type="other">Dighe, K. et al. Highly-specific single-stranded oligonucleotides and functional nanoprobes for clinical determination of chlamydia trachomatis and neisseria gonorrhoeae infections. <italic toggle="yes">Adv. Sci.</italic><bold>10</bold>, 2304009 (2023).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/advs.202304009</pub-id><pub-id pub-id-type="pmcid">PMC10754082</pub-id><pub-id pub-id-type="pmid">37870167</pub-id></mixed-citation></ref><ref id="CR158"><label>158.</label><citation-alternatives><element-citation id="ec-CR158" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>X</given-names></name><etal/></person-group><article-title>Nanoparticle-based lateral flow biosensor integrated with loop-mediated isothermal amplification for rapid and visual identification of chlamydia trachomatis for point-of-care use</article-title><source>Front. Microbiol.</source><year>2022</year><volume>13</volume><fpage>914620</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2022.914620</pub-id><pub-id pub-id-type="pmid">35903464</pub-id><pub-id pub-id-type="pmcid">PMC9318599</pub-id></element-citation><mixed-citation id="mc-CR158" publication-type="journal">Chen, X. et al. Nanoparticle-based lateral flow biosensor integrated with loop-mediated isothermal amplification for rapid and visual identification of chlamydia trachomatis for point-of-care use. <italic toggle="yes">Front. Microbiol.</italic><bold>13</bold>, 914620 (2022).<pub-id pub-id-type="pmid">35903464</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fmicb.2022.914620</pub-id><pub-id pub-id-type="pmcid">PMC9318599</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR159"><label>159.</label><citation-alternatives><element-citation id="ec-CR159" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>X</given-names></name><etal/></person-group><article-title>Visual and rapid identification of Chlamydia trachomatis and Neisseria gonorrhoeae using multiplex loop-mediated isothermal amplification and a gold nanoparticle-based lateral flow biosensor</article-title><source>Front Cell Infect. Microbiol.</source><year>2023</year><volume>13</volume><fpage>1067554</fpage><pub-id pub-id-type="doi">10.3389/fcimb.2023.1067554</pub-id><pub-id pub-id-type="pmid">36926514</pub-id><pub-id pub-id-type="pmcid">PMC10011439</pub-id></element-citation><mixed-citation id="mc-CR159" publication-type="journal">Chen, X. et al. Visual and rapid identification of Chlamydia trachomatis and Neisseria gonorrhoeae using multiplex loop-mediated isothermal amplification and a gold nanoparticle-based lateral flow biosensor. <italic toggle="yes">Front Cell Infect. Microbiol.</italic><bold>13</bold>, 1067554 (2023).<pub-id pub-id-type="pmid">36926514</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fcimb.2023.1067554</pub-id><pub-id pub-id-type="pmcid">PMC10011439</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR160"><label>160.</label><mixed-citation publication-type="other">Shivaram, K. B., Bhatt, P., Verma, M. S., Clase, K. &amp; Simsek, H. Bacteriophage-based biosensors for detection of pathogenic microbes in wastewater. <italic toggle="yes">Sci. Total Environ.</italic><bold>901</bold>, 165859 (2023).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.scitotenv.2023.165859</pub-id><pub-id pub-id-type="pmid">37516175</pub-id></mixed-citation></ref><ref id="CR161"><label>161.</label><citation-alternatives><element-citation id="ec-CR161" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Patel</surname><given-names>D</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ramasamy</surname><given-names>RP</given-names></name></person-group><article-title>A bacteriophage-based electrochemical biosensor for detection of methicillin-resistant staphylococcus aureus</article-title><source>J. Electrochem. Soc.</source><year>2021</year><volume>168</volume><fpage>057523</fpage><pub-id pub-id-type="doi">10.1149/1945-7111/abef85</pub-id></element-citation><mixed-citation id="mc-CR161" publication-type="journal">Patel, D., Zhou, Y. &amp; Ramasamy, R. P. A bacteriophage-based electrochemical biosensor for detection of methicillin-resistant staphylococcus aureus. <italic toggle="yes">J. Electrochem. Soc.</italic><bold>168</bold>, 057523 (2021).</mixed-citation></citation-alternatives></ref><ref id="CR162"><label>162.</label><mixed-citation publication-type="other">Panhwar, S., Keerio, H. A., Ilhan, H., Boyac&#305;, I. H. &amp; Tamer, U. Principles, methods, and real-time applications of bacteriophage-based pathogen detection. <italic toggle="yes">Mol. Biotechnol. 2023</italic> 1&#8211;18 10.1007/S12033-023-00926-5 (2023).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s12033-023-00926-5</pub-id><pub-id pub-id-type="pmid">37914863</pub-id></mixed-citation></ref><ref id="CR163"><label>163.</label><citation-alternatives><element-citation id="ec-CR163" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>L</given-names></name><etal/></person-group><article-title>Multiplexed detection of bacterial pathogens based on a cocktail of dual-modified phages</article-title><source>Anal. Chim. Acta</source><year>2021</year><volume>1166</volume><fpage>338596</fpage><pub-id pub-id-type="doi">10.1016/j.aca.2021.338596</pub-id><pub-id pub-id-type="pmid">34023003</pub-id></element-citation><mixed-citation id="mc-CR163" publication-type="journal">Wu, L. et al. Multiplexed detection of bacterial pathogens based on a cocktail of dual-modified phages. <italic toggle="yes">Anal. Chim. Acta</italic><bold>1166</bold>, 338596 (2021).<pub-id pub-id-type="pmid">34023003</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.aca.2021.338596</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR164"><label>164.</label><mixed-citation publication-type="other">Fitzgerald, R. C., Antoniou, A. C., Fruk, L. &amp; Rosenfeld, N. The future of early cancer detection. <italic toggle="yes">Nat. Med.</italic><bold>28</bold>, 666&#8211;677 (2022).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41591-022-01746-x</pub-id><pub-id pub-id-type="pmid">35440720</pub-id></mixed-citation></ref><ref id="CR165"><label>165.</label><mixed-citation publication-type="other">Guerra, C. E., Sharma, P. V. &amp; Castillo, B. S. Annual Review of Medicine Multi-Cancer Early Detection: The New Frontier in Cancer Early Detection. 10.1146/annurev-med-050522 (2023).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1146/annurev-med-050522-033624</pub-id><pub-id pub-id-type="pmid">37729031</pub-id></mixed-citation></ref><ref id="CR166"><label>166.</label><mixed-citation publication-type="other">Pink, R. C., Beaman, E. M., Samuel, P., Brooks, S. A. &amp; Carter, D. R. F. Utilising extracellular vesicles for early cancer diagnostics: benefits, challenges and recommendations for the future. <italic toggle="yes">Br J Cancer</italic><bold>126</bold>, 323&#8211;330 (2022).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41416-021-01668-4</pub-id><pub-id pub-id-type="pmcid">PMC8810954</pub-id><pub-id pub-id-type="pmid">35013578</pub-id></mixed-citation></ref><ref id="CR167"><label>167.</label><mixed-citation publication-type="other">Aziz, N. B. et al. MicroRNAs in ovarian cancer and recent advances in the development of microRNA-based biosensors. <italic toggle="yes">Analyst</italic><bold>145</bold>, 2038&#8211;2057 (2020).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1039/c9an02263e</pub-id><pub-id pub-id-type="pmid">32016203</pub-id></mixed-citation></ref><ref id="CR168"><label>168.</label><mixed-citation publication-type="other">Giampaolino, P. et al. Role of biomarkers for early detection of ovarian cancer recurrence. <italic toggle="yes">Gland Surg.</italic><bold>9</bold>, 1102&#8211;1111 (2020).<pub-id pub-id-type="doi" assigning-authority="pmc">10.21037/gs-20-544</pub-id><pub-id pub-id-type="pmcid">PMC7475347</pub-id><pub-id pub-id-type="pmid">32953625</pub-id></mixed-citation></ref><ref id="CR169"><label>169.</label><mixed-citation publication-type="other">Trinidad, C. V., Tetlow, A. L., Bantis, L. E. &amp; Godwin, A. K. Reducing ovarian cancer mortality through early detection: approaches using circulating biomarkers. <italic toggle="yes">Cancer Prev. Res.</italic><bold>13</bold>, 241&#8211;252 (2020).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1158/1940-6207.CAPR-19-0184</pub-id><pub-id pub-id-type="pmcid">PMC7080297</pub-id><pub-id pub-id-type="pmid">32132118</pub-id></mixed-citation></ref><ref id="CR170"><label>170.</label><mixed-citation publication-type="other">Lone, S. N. et al. Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments. <italic toggle="yes">Mol. Cancer</italic><bold>21</bold>, 79 (2022).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12943-022-01543-7</pub-id><pub-id pub-id-type="pmcid">PMC8932066</pub-id><pub-id pub-id-type="pmid">35303879</pub-id></mixed-citation></ref><ref id="CR171"><label>171.</label><mixed-citation publication-type="other">Belotti, Y. &amp; Lim, C. T. Microfluidics for liquid biopsies: recent advances, current challenges, and future directions. <italic toggle="yes">Anal. Chem.</italic><bold>93</bold>, 4727&#8211;4738 (2021).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acs.analchem.1c00410</pub-id><pub-id pub-id-type="pmid">33683116</pub-id></mixed-citation></ref><ref id="CR172"><label>172.</label><mixed-citation publication-type="other">Lin, B. et al. Microfluidic-based exosome analysis for liquid biopsy. <italic toggle="yes">Small Methods</italic><bold>5</bold>, 2001131 (2021).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/smtd.202001131</pub-id><pub-id pub-id-type="pmid">34927834</pub-id></mixed-citation></ref><ref id="CR173"><label>173.</label><citation-alternatives><element-citation id="ec-CR173" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Poudineh</surname><given-names>M</given-names></name><etal/></person-group><article-title>Tracking the dynamics of circulating tumour cell phenotypes using nanoparticle-mediated magnetic ranking</article-title><source>Nat. Nanotechnol.</source><year>2017</year><volume>12</volume><fpage>274</fpage><lpage>281</lpage><pub-id pub-id-type="doi">10.1038/nnano.2016.239</pub-id><pub-id pub-id-type="pmid">27870841</pub-id></element-citation><mixed-citation id="mc-CR173" publication-type="journal">Poudineh, M. et al. Tracking the dynamics of circulating tumour cell phenotypes using nanoparticle-mediated magnetic ranking. <italic toggle="yes">Nat. Nanotechnol.</italic><bold>12</bold>, 274&#8211;281 (2017).<pub-id pub-id-type="pmid">27870841</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nnano.2016.239</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR174"><label>174.</label><mixed-citation publication-type="other">Poudineh, M., Sargent, E. H., Pantel, K. &amp; Kelley, S. O. Profiling circulating tumour cells and other biomarkers of invasive cancers. <italic toggle="yes">Nat. Biomed. Eng.</italic><bold>2</bold>, 72&#8211;84 (2018).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41551-018-0190-5</pub-id><pub-id pub-id-type="pmid">31015625</pub-id></mixed-citation></ref><ref id="CR175"><label>175.</label><citation-alternatives><element-citation id="ec-CR175" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gardner</surname><given-names>L</given-names></name><name name-style="western"><surname>Kostarelos</surname><given-names>K</given-names></name><name name-style="western"><surname>Mallick</surname><given-names>P</given-names></name><name name-style="western"><surname>Dive</surname><given-names>C</given-names></name><name name-style="western"><surname>Hadjidemetriou</surname><given-names>M</given-names></name></person-group><article-title>Nano-omics: nanotechnology-based multidimensional harvesting of the blood-circulating cancerome</article-title><source>Nat. Rev. Clin. Oncol.</source><year>2022</year><volume>19</volume><fpage>551</fpage><lpage>561</lpage><pub-id pub-id-type="doi">10.1038/s41571-022-00645-x</pub-id><pub-id pub-id-type="pmid">35739399</pub-id></element-citation><mixed-citation id="mc-CR175" publication-type="journal">Gardner, L., Kostarelos, K., Mallick, P., Dive, C. &amp; Hadjidemetriou, M. Nano-omics: nanotechnology-based multidimensional harvesting of the blood-circulating cancerome. <italic toggle="yes">Nat. Rev. Clin. Oncol.</italic><bold>19</bold>, 551&#8211;561 (2022).<pub-id pub-id-type="pmid">35739399</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41571-022-00645-x</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR176"><label>176.</label><citation-alternatives><element-citation id="ec-CR176" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>Z</given-names></name><name name-style="western"><surname>Yang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>Y</given-names></name><name name-style="western"><surname>He</surname><given-names>M</given-names></name></person-group><article-title>A microfluidic ExoSearch chip for multiplexed exosome detection towards blood-based ovarian cancer diagnosis</article-title><source>Lab Chip</source><year>2016</year><volume>16</volume><fpage>489</fpage><lpage>496</lpage><pub-id pub-id-type="doi">10.1039/C5LC01117E</pub-id><pub-id pub-id-type="pmid">26645590</pub-id><pub-id pub-id-type="pmcid">PMC4729647</pub-id></element-citation><mixed-citation id="mc-CR176" publication-type="journal">Zhao, Z., Yang, Y., Zeng, Y. &amp; He, M. A microfluidic ExoSearch chip for multiplexed exosome detection towards blood-based ovarian cancer diagnosis. <italic toggle="yes">Lab Chip</italic><bold>16</bold>, 489&#8211;496 (2016).<pub-id pub-id-type="pmid">26645590</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1039/c5lc01117e</pub-id><pub-id pub-id-type="pmcid">PMC4729647</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR177"><label>177.</label><mixed-citation publication-type="other">Sinawang, P. D., Soto, F., Ozen, M. O., Akin, D. &amp; Demirci, U. Progress and challenges in biomarker enrichment for cancer early detection. <italic toggle="yes">Progr. Biomed. Eng.</italic><bold>3</bold>, 043001 (2021).</mixed-citation></ref><ref id="CR178"><label>178.</label><citation-alternatives><element-citation id="ec-CR178" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Labib</surname><given-names>M</given-names></name><etal/></person-group><article-title>Tracking the expression of therapeutic protein targets in rare cells by antibody-mediated nanoparticle labelling and magnetic sorting</article-title><source>Nat. Biomed. Eng.</source><year>2021</year><volume>5</volume><fpage>41</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1038/s41551-020-0590-1</pub-id><pub-id pub-id-type="pmid">32719513</pub-id><pub-id pub-id-type="pmcid">PMC8436965</pub-id></element-citation><mixed-citation id="mc-CR178" publication-type="journal">Labib, M. et al. Tracking the expression of therapeutic protein targets in rare cells by antibody-mediated nanoparticle labelling and magnetic sorting. <italic toggle="yes">Nat. Biomed. Eng.</italic><bold>5</bold>, 41&#8211;52 (2021).<pub-id pub-id-type="pmid">32719513</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41551-020-0590-1</pub-id><pub-id pub-id-type="pmcid">PMC8436965</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR179"><label>179.</label><citation-alternatives><element-citation id="ec-CR179" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>F</given-names></name><name name-style="western"><surname>Yang</surname><given-names>G</given-names></name><name name-style="western"><surname>Aguilar</surname><given-names>ZP</given-names></name><name name-style="western"><surname>Xiong</surname><given-names>Y</given-names></name><name name-style="western"><surname>Xu</surname><given-names>H</given-names></name></person-group><article-title>Affordable and simple method for separating and detecting ovarian cancer circulating tumor cells using BSA coated magnetic nanoprobes modified with folic acid</article-title><source>Sens Actuators B Chem.</source><year>2018</year><volume>262</volume><fpage>611</fpage><lpage>618</lpage><pub-id pub-id-type="doi">10.1016/j.snb.2018.02.038</pub-id></element-citation><mixed-citation id="mc-CR179" publication-type="journal">Li, F., Yang, G., Aguilar, Z. P., Xiong, Y. &amp; Xu, H. Affordable and simple method for separating and detecting ovarian cancer circulating tumor cells using BSA coated magnetic nanoprobes modified with folic acid. <italic toggle="yes">Sens Actuators B Chem.</italic><bold>262</bold>, 611&#8211;618 (2018).</mixed-citation></citation-alternatives></ref><ref id="CR180"><label>180.</label><citation-alternatives><element-citation id="ec-CR180" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ma</surname><given-names>J</given-names></name><etal/></person-group><article-title>Purification of circulating tumor cells based on multiantibody-modified magnetic nanoparticles and molecular analysis toward epithelial ovarian cancer detection</article-title><source>ACS Sens.</source><year>2023</year><volume>8</volume><fpage>3744</fpage><lpage>3753</lpage><pub-id pub-id-type="doi">10.1021/acssensors.3c01063</pub-id><pub-id pub-id-type="pmid">37773014</pub-id></element-citation><mixed-citation id="mc-CR180" publication-type="journal">Ma, J. et al. Purification of circulating tumor cells based on multiantibody-modified magnetic nanoparticles and molecular analysis toward epithelial ovarian cancer detection. <italic toggle="yes">ACS Sens.</italic><bold>8</bold>, 3744&#8211;3753 (2023).<pub-id pub-id-type="pmid">37773014</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acssensors.3c01063</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR181"><label>181.</label><mixed-citation publication-type="other">Gurudatt, N. G. et al. Separation detection of different circulating tumor cells in the blood using an electrochemical microfluidic channel modified with a lipid-bonded conducting polymer. <italic toggle="yes">Biosens. Bioelectron.</italic><bold>146</bold>, 111746 (2019).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bios.2019.111746</pub-id><pub-id pub-id-type="pmid">31586761</pub-id></mixed-citation></ref><ref id="CR182"><label>182.</label><mixed-citation publication-type="other">Descamps, L., Le Roy, D. &amp; Deman, A. L. Microfluidic-based technologies for CTC isolation: a review of 10 years of intense efforts towards liquid biopsy. <italic toggle="yes">Int. J. Mol. Sci</italic>. <bold>23</bold>, 1981 (2022).<pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms23041981</pub-id><pub-id pub-id-type="pmcid">PMC8875744</pub-id><pub-id pub-id-type="pmid">35216097</pub-id></mixed-citation></ref><ref id="CR183"><label>183.</label><citation-alternatives><element-citation id="ec-CR183" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Karabacak</surname><given-names>NM</given-names></name><etal/></person-group><article-title>Microfluidic, marker-free isolation of circulating tumor cells from blood samples</article-title><source>Nat. Protoc.</source><year>2014</year><volume>9</volume><fpage>694</fpage><lpage>710</lpage><pub-id pub-id-type="doi">10.1038/nprot.2014.044</pub-id><pub-id pub-id-type="pmid">24577360</pub-id><pub-id pub-id-type="pmcid">PMC4179254</pub-id></element-citation><mixed-citation id="mc-CR183" publication-type="journal">Karabacak, N. M. et al. Microfluidic, marker-free isolation of circulating tumor cells from blood samples. <italic toggle="yes">Nat. Protoc.</italic><bold>9</bold>, 694&#8211;710 (2014).<pub-id pub-id-type="pmid">24577360</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nprot.2014.044</pub-id><pub-id pub-id-type="pmcid">PMC4179254</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR184"><label>184.</label><mixed-citation publication-type="other">Fang, S. et al. Clinical application of a microfluidic chip for immunocapture and quantification of circulating exosomes to assist breast cancer diagnosis and molecular classification. <italic toggle="yes">PLoS One</italic><bold>12</bold>, e0175050 (2017).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0175050</pub-id><pub-id pub-id-type="pmcid">PMC5378374</pub-id><pub-id pub-id-type="pmid">28369094</pub-id></mixed-citation></ref><ref id="CR185"><label>185.</label><mixed-citation publication-type="other">Gwak, H. et al. Microfluidic chip for rapid and selective isolation of tumor-derived extracellular vesicles for early diagnosis and metastatic risk evaluation of breast cancer. <italic toggle="yes">Biosens. Bioelectron.</italic><bold>192</bold>, 113495 (2021).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bios.2021.113495</pub-id><pub-id pub-id-type="pmid">34273737</pub-id></mixed-citation></ref><ref id="CR186"><label>186.</label><citation-alternatives><element-citation id="ec-CR186" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>W</given-names></name><etal/></person-group><article-title>Simple and fast isolation of circulating exosomes with a chitosan modified shuttle flow microchip for breast cancer diagnosis</article-title><source>Lab Chip</source><year>2021</year><volume>21</volume><fpage>1759</fpage><lpage>1770</lpage><pub-id pub-id-type="doi">10.1039/D0LC01311K</pub-id><pub-id pub-id-type="pmid">33710183</pub-id></element-citation><mixed-citation id="mc-CR186" publication-type="journal">Chen, W. et al. Simple and fast isolation of circulating exosomes with a chitosan modified shuttle flow microchip for breast cancer diagnosis. <italic toggle="yes">Lab Chip</italic><bold>21</bold>, 1759&#8211;1770 (2021).<pub-id pub-id-type="pmid">33710183</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1039/d0lc01311k</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR187"><label>187.</label><mixed-citation publication-type="other">Gumus, E., Bingol, H. &amp; Zor, E. Lateral flow assays for detection of disease biomarkers. <italic toggle="yes">J. Pharm. Biomed. Anal.</italic><bold>225</bold>, 115206 (2023).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jpba.2022.115206</pub-id><pub-id pub-id-type="pmid">36586382</pub-id></mixed-citation></ref><ref id="CR188"><label>188.</label><citation-alternatives><element-citation id="ec-CR188" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ren</surname><given-names>W</given-names></name><name name-style="western"><surname>Mohammed</surname><given-names>SI</given-names></name><name name-style="western"><surname>Wereley</surname><given-names>S</given-names></name><name name-style="western"><surname>Irudayaraj</surname><given-names>J</given-names></name></person-group><article-title>Magnetic focus lateral flow sensor for detection of cervical cancer biomarkers</article-title><source>Anal. Chem.</source><year>2019</year><volume>91</volume><fpage>2876</fpage><lpage>2884</lpage><pub-id pub-id-type="doi">10.1021/acs.analchem.8b04848</pub-id><pub-id pub-id-type="pmid">30632735</pub-id></element-citation><mixed-citation id="mc-CR188" publication-type="journal">Ren, W., Mohammed, S. I., Wereley, S. &amp; Irudayaraj, J. Magnetic focus lateral flow sensor for detection of cervical cancer biomarkers. <italic toggle="yes">Anal. Chem.</italic><bold>91</bold>, 2876&#8211;2884 (2019).<pub-id pub-id-type="pmid">30632735</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acs.analchem.8b04848</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR189"><label>189.</label><mixed-citation publication-type="other">Ekman, M. et al. Spectrally separated dual-label upconversion luminescence lateral flow assay for cancer-specific STn-glycosylation in CA125 and CA15-3. <italic toggle="yes">Anal. Bioanal. Chem.</italic><bold>13</bold>, 3251&#8211;3260 (2024).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00216-024-05275-z</pub-id><pub-id pub-id-type="pmcid">PMC11068694</pub-id><pub-id pub-id-type="pmid">38584178</pub-id></mixed-citation></ref><ref id="CR190"><label>190.</label><mixed-citation publication-type="other">Chen, J. et al. Accurate and portable tumor exosomes detection based on manganese dioxide and aptamer-functionalized fluorescent microspheres mediated dual-mode lateral flow assay. <italic toggle="yes">Sens. Actuators B Chem.</italic><bold>409</bold>, 135614 (2024).</mixed-citation></ref><ref id="CR191"><label>191.</label><citation-alternatives><element-citation id="ec-CR191" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>B</given-names></name><etal/></person-group><article-title>Fluorescence quenching-based signal amplification on immunochromatography test strips for dual-mode sensing of two biomarkers of breast cancer</article-title><source>Nanoscale</source><year>2017</year><volume>9</volume><fpage>18711</fpage><lpage>18722</lpage><pub-id pub-id-type="doi">10.1039/C7NR06781J</pub-id><pub-id pub-id-type="pmid">29165496</pub-id></element-citation><mixed-citation id="mc-CR191" publication-type="journal">Zhang, B. et al. Fluorescence quenching-based signal amplification on immunochromatography test strips for dual-mode sensing of two biomarkers of breast cancer. <italic toggle="yes">Nanoscale</italic><bold>9</bold>, 18711&#8211;18722 (2017).<pub-id pub-id-type="pmid">29165496</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1039/c7nr06781j</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR192"><label>192.</label><citation-alternatives><element-citation id="ec-CR192" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guo</surname><given-names>S</given-names></name><etal/></person-group><article-title>All-in-one detection of breast cancer-derived exosomal miRNA on a pen-based paper chip</article-title><source>Analyst</source><year>2024</year><volume>149</volume><fpage>1250</fpage><lpage>1261</lpage><pub-id pub-id-type="doi">10.1039/D3AN02032K</pub-id><pub-id pub-id-type="pmid">38225883</pub-id></element-citation><mixed-citation id="mc-CR192" publication-type="journal">Guo, S. et al. All-in-one detection of breast cancer-derived exosomal miRNA on a pen-based paper chip. <italic toggle="yes">Analyst</italic><bold>149</bold>, 1250&#8211;1261 (2024).<pub-id pub-id-type="pmid">38225883</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1039/d3an02032k</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR193"><label>193.</label><mixed-citation publication-type="other">Liu, H., Cao, J. &amp; Ding, S. N. Simultaneous detection of two ovarian cancer biomarkers in human serums with biotin-enriched dendritic mesoporous silica nanoparticles-labeled multiplex lateral flow immunoassay. <italic toggle="yes">Sens. Actuators B Chem.</italic><bold>371</bold>, 132597 (2022).</mixed-citation></ref><ref id="CR194"><label>194.</label><citation-alternatives><element-citation id="ec-CR194" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Szymanska</surname><given-names>B</given-names></name><name name-style="western"><surname>Lukaszewski</surname><given-names>Z</given-names></name><name name-style="western"><surname>Hermanowicz-Szamatowicz</surname><given-names>K</given-names></name><name name-style="western"><surname>Gorodkiewicz</surname><given-names>E</given-names></name></person-group><article-title>A Multiple-array SPRi biosensor as a tool for detection of gynecological&#8211;oncological diseases</article-title><source>Biosensors (Basel)</source><year>2023</year><volume>13</volume><fpage>279</fpage><pub-id pub-id-type="doi">10.3390/bios13020279</pub-id><pub-id pub-id-type="pmid">36832045</pub-id><pub-id pub-id-type="pmcid">PMC9954693</pub-id></element-citation><mixed-citation id="mc-CR194" publication-type="journal">Szymanska, B., Lukaszewski, Z., Hermanowicz-Szamatowicz, K. &amp; Gorodkiewicz, E. A Multiple-array SPRi biosensor as a tool for detection of gynecological&#8211;oncological diseases. <italic toggle="yes">Biosensors (Basel)</italic><bold>13</bold>, 279 (2023).<pub-id pub-id-type="pmid">36832045</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/bios13020279</pub-id><pub-id pub-id-type="pmcid">PMC9954693</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR195"><label>195.</label><citation-alternatives><element-citation id="ec-CR195" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kight</surname><given-names>EC</given-names></name><name name-style="western"><surname>Hussain</surname><given-names>I</given-names></name><name name-style="western"><surname>Bowden</surname><given-names>AK</given-names></name><name name-style="western"><surname>Haselton</surname><given-names>FR</given-names></name></person-group><article-title>Recurrence monitoring for ovarian cancer using a cell phone-integrated paper device to measure the ovarian cancer biomarker HE4/CRE ratio in urine</article-title><source>Sci. Rep.</source><year>2021</year><volume>11</volume><fpage>21945</fpage><pub-id pub-id-type="doi">10.1038/s41598-021-01544-4</pub-id><pub-id pub-id-type="pmid">34754053</pub-id><pub-id pub-id-type="pmcid">PMC8578327</pub-id></element-citation><mixed-citation id="mc-CR195" publication-type="journal">Kight, E. C., Hussain, I., Bowden, A. K. &amp; Haselton, F. R. Recurrence monitoring for ovarian cancer using a cell phone-integrated paper device to measure the ovarian cancer biomarker HE4/CRE ratio in urine. <italic toggle="yes">Sci. Rep.</italic><bold>11</bold>, 21945 (2021).<pub-id pub-id-type="pmid">34754053</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-021-01544-4</pub-id><pub-id pub-id-type="pmcid">PMC8578327</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR196"><label>196.</label><mixed-citation publication-type="other">Tellez-Gabriel, M., Knutsen, E. &amp; Perander, M. Current status of circulating tumor cells, circulating tumor DNA, and exosomes in breast cancer liquid biopsies. <italic toggle="yes">Int. J. Mol. Sci.</italic><bold>21</bold>, 1&#8211;23 (2020).<pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms21249457</pub-id><pub-id pub-id-type="pmcid">PMC7763984</pub-id><pub-id pub-id-type="pmid">33322643</pub-id></mixed-citation></ref><ref id="CR197"><label>197.</label><citation-alternatives><element-citation id="ec-CR197" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jordan</surname><given-names>NV</given-names></name><etal/></person-group><article-title>HER2 expression identifies dynamic functional states within circulating breast cancer cells</article-title><source>Nature</source><year>2016</year><volume>537</volume><fpage>102</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.1038/nature19328</pub-id><pub-id pub-id-type="pmid">27556950</pub-id><pub-id pub-id-type="pmcid">PMC5161614</pub-id></element-citation><mixed-citation id="mc-CR197" publication-type="journal">Jordan, N. V. et al. HER2 expression identifies dynamic functional states within circulating breast cancer cells. <italic toggle="yes">Nature</italic><bold>537</bold>, 102&#8211;106 (2016).<pub-id pub-id-type="pmid">27556950</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature19328</pub-id><pub-id pub-id-type="pmcid">PMC5161614</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR198"><label>198.</label><mixed-citation publication-type="other">Meng, S. et al. Surface-enhanced Raman scattering holography chip for rapid, sensitive and multiplexed detection of human breast cancer-associated MicroRNAs in clinical samples. <italic toggle="yes">Biosens. Bioelectron.</italic> 190, 113470 (2021).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bios.2021.113470</pub-id><pub-id pub-id-type="pmid">34229191</pub-id></mixed-citation></ref><ref id="CR199"><label>199.</label><mixed-citation publication-type="other">Yoon, J. et al. Flexible electrochemical biosensors for healthcare monitoring. <italic toggle="yes">J. Mater. Chem. B</italic><bold>8</bold>, 7303&#8211;7318 (2020).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1039/d0tb01325k</pub-id><pub-id pub-id-type="pmid">32647855</pub-id></mixed-citation></ref><ref id="CR200"><label>200.</label><mixed-citation publication-type="other">Kucherenko, I. S., Soldatkin, O. O., Kucherenko, D. Y., Soldatkina, O. V. &amp; Dzyadevych, S. V. Advances in nanomaterial application in enzyme-based electrochemical biosensors: a review. <italic toggle="yes">Nanoscale Adv.</italic><bold>1</bold>, 4560&#8211;4577 (2019).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1039/c9na00491b</pub-id><pub-id pub-id-type="pmcid">PMC9417062</pub-id><pub-id pub-id-type="pmid">36133111</pub-id></mixed-citation></ref><ref id="CR201"><label>201.</label><citation-alternatives><element-citation id="ec-CR201" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Xia</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>F</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>B</given-names></name></person-group><article-title>Simultaneous detection of ovarian cancer-concerned HE4 and CA125 markers based on Cu single-atom-triggered CdS QDs and Eu MOF@Isoluminol ECL</article-title><source>Anal. Chem.</source><year>2023</year><volume>95</volume><fpage>4795</fpage><lpage>4802</lpage><pub-id pub-id-type="doi">10.1021/acs.analchem.3c00273</pub-id><pub-id pub-id-type="pmid">36867090</pub-id></element-citation><mixed-citation id="mc-CR201" publication-type="journal">Tang, Y., Liu, Y., Xia, Y., Zhao, F. &amp; Zeng, B. Simultaneous detection of ovarian cancer-concerned HE4 and CA125 markers based on Cu single-atom-triggered CdS QDs and Eu MOF@Isoluminol ECL. <italic toggle="yes">Anal. Chem.</italic><bold>95</bold>, 4795&#8211;4802 (2023).<pub-id pub-id-type="pmid">36867090</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acs.analchem.3c00273</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR202"><label>202.</label><citation-alternatives><element-citation id="ec-CR202" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barr</surname><given-names>CE</given-names></name><name name-style="western"><surname>Njoku</surname><given-names>K</given-names></name><name name-style="western"><surname>Owens</surname><given-names>GL</given-names></name><name name-style="western"><surname>Crosbie</surname><given-names>EJ</given-names></name></person-group><article-title>Urine CA125 and HE4 for the detection of ovarian cancer in symptomatic women</article-title><source>Cancers (Basel)</source><year>2023</year><volume>15</volume><fpage>1256</fpage><pub-id pub-id-type="doi">10.3390/cancers15041256</pub-id><pub-id pub-id-type="pmid">36831601</pub-id><pub-id pub-id-type="pmcid">PMC9953976</pub-id></element-citation><mixed-citation id="mc-CR202" publication-type="journal">Barr, C. E., Njoku, K., Owens, G. L. &amp; Crosbie, E. J. Urine CA125 and HE4 for the detection of ovarian cancer in symptomatic women. <italic toggle="yes">Cancers (Basel)</italic><bold>15</bold>, 1256 (2023).<pub-id pub-id-type="pmid">36831601</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/cancers15041256</pub-id><pub-id pub-id-type="pmcid">PMC9953976</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR203"><label>203.</label><citation-alternatives><element-citation id="ec-CR203" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ross</surname><given-names>GMS</given-names></name><name name-style="western"><surname>Filippini</surname><given-names>D</given-names></name><name name-style="western"><surname>Nielen</surname><given-names>MWF</given-names></name><name name-style="western"><surname>Salentijn</surname><given-names>GIJ</given-names></name></person-group><article-title>Unraveling the Hook effect: a comprehensive study of high antigen concentration effects in sandwich lateral flow immunoassays</article-title><source>Anal. Chem.</source><year>2020</year><volume>92</volume><fpage>15587</fpage><lpage>15595</lpage><pub-id pub-id-type="doi">10.1021/acs.analchem.0c03740</pub-id><pub-id pub-id-type="pmid">33185097</pub-id><pub-id pub-id-type="pmcid">PMC7711776</pub-id></element-citation><mixed-citation id="mc-CR203" publication-type="journal">Ross, G. M. S., Filippini, D., Nielen, M. W. F. &amp; Salentijn, G. I. J. Unraveling the Hook effect: a comprehensive study of high antigen concentration effects in sandwich lateral flow immunoassays. <italic toggle="yes">Anal. Chem.</italic><bold>92</bold>, 15587&#8211;15595 (2020).<pub-id pub-id-type="pmid">33185097</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acs.analchem.0c03740</pub-id><pub-id pub-id-type="pmcid">PMC7711776</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR204"><label>204.</label><citation-alternatives><element-citation id="ec-CR204" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Su</surname><given-names>X</given-names></name><etal/></person-group><article-title>Integrated SERS-vertical flow biosensor enabling multiplexed quantitative profiling of serological exosomal proteins in patients for accurate breast cancer subtyping</article-title><source>ACS Nano</source><year>2023</year><volume>17</volume><fpage>4077</fpage><lpage>4088</lpage><pub-id pub-id-type="doi">10.1021/acsnano.3c00449</pub-id><pub-id pub-id-type="pmid">36758150</pub-id></element-citation><mixed-citation id="mc-CR204" publication-type="journal">Su, X. et al. Integrated SERS-vertical flow biosensor enabling multiplexed quantitative profiling of serological exosomal proteins in patients for accurate breast cancer subtyping. <italic toggle="yes">ACS Nano</italic><bold>17</bold>, 4077&#8211;4088 (2023).<pub-id pub-id-type="pmid">36758150</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acsnano.3c00449</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR205"><label>205.</label><citation-alternatives><element-citation id="ec-CR205" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Warty</surname><given-names>RR</given-names></name><name name-style="western"><surname>Smith</surname><given-names>V</given-names></name><name name-style="western"><surname>Patabendige</surname><given-names>M</given-names></name><name name-style="western"><surname>Fox</surname><given-names>D</given-names></name><name name-style="western"><surname>Mol</surname><given-names>B</given-names></name></person-group><article-title>Clarifying the unmet clinical need during medical device innovation in women&#8217;s health&#8212;a narrative review</article-title><source>Health Care Women Int.</source><year>2023</year><volume>45</volume><fpage>1</fpage><lpage>29</lpage><pub-id pub-id-type="pmid">37000043</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/07399332.2023.2190983</pub-id></element-citation><mixed-citation id="mc-CR205" publication-type="journal">Warty, R. R., Smith, V., Patabendige, M., Fox, D. &amp; Mol, B. Clarifying the unmet clinical need during medical device innovation in women&#8217;s health&#8212;a narrative review. <italic toggle="yes">Health Care Women Int.</italic><bold>45</bold>, 1&#8211;29 (2023).<pub-id pub-id-type="pmid">37000043</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/07399332.2023.2190983</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR206"><label>206.</label><citation-alternatives><element-citation id="ec-CR206" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Regidor</surname><given-names>PA</given-names></name><name name-style="western"><surname>Kaczmarczyk</surname><given-names>M</given-names></name><name name-style="western"><surname>Schiweck</surname><given-names>E</given-names></name><name name-style="western"><surname>Goeckenjan-Festag</surname><given-names>M</given-names></name><name name-style="western"><surname>Alexander</surname><given-names>H</given-names></name></person-group><article-title>Identification and prediction of the fertile window with a new web-based medical device using a vaginal biosensor for measuring the circadian and circamensual core body temperature</article-title><source>Gynecol. Endocrinol.</source><year>2018</year><volume>34</volume><fpage>256</fpage><lpage>260</lpage><pub-id pub-id-type="doi">10.1080/09513590.2017.1390737</pub-id><pub-id pub-id-type="pmid">29082805</pub-id></element-citation><mixed-citation id="mc-CR206" publication-type="journal">Regidor, P. A., Kaczmarczyk, M., Schiweck, E., Goeckenjan-Festag, M. &amp; Alexander, H. Identification and prediction of the fertile window with a new web-based medical device using a vaginal biosensor for measuring the circadian and circamensual core body temperature. <italic toggle="yes">Gynecol. Endocrinol.</italic><bold>34</bold>, 256&#8211;260 (2018).<pub-id pub-id-type="pmid">29082805</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/09513590.2017.1390737</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR207"><label>207.</label><citation-alternatives><element-citation id="ec-CR207" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>TY</given-names></name><etal/></person-group><article-title>The accuracy of wrist skin temperature in detecting ovulation compared to basal body temperature: prospective comparative diagnostic accuracy study</article-title><source>J. Med. Internet Res.</source><year>2021</year><volume>23</volume><fpage>e20710</fpage><pub-id pub-id-type="doi">10.2196/20710</pub-id><pub-id pub-id-type="pmid">34100763</pub-id><pub-id pub-id-type="pmcid">PMC8238491</pub-id></element-citation><mixed-citation id="mc-CR207" publication-type="journal">Zhu, T. Y. et al. The accuracy of wrist skin temperature in detecting ovulation compared to basal body temperature: prospective comparative diagnostic accuracy study. <italic toggle="yes">J. Med. Internet Res.</italic><bold>23</bold>, e20710 (2021).<pub-id pub-id-type="pmid">34100763</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2196/20710</pub-id><pub-id pub-id-type="pmcid">PMC8238491</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR208"><label>208.</label><mixed-citation publication-type="other">Hicks, J. L. et al. Best practices for analyzing large-scale health data from wearables and smartphone apps. <italic toggle="yes">npj Digit. Med.</italic><bold>2</bold>, 45 (2019).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41746-019-0121-1</pub-id><pub-id pub-id-type="pmcid">PMC6550237</pub-id><pub-id pub-id-type="pmid">31304391</pub-id></mixed-citation></ref><ref id="CR209"><label>209.</label><mixed-citation publication-type="other">Walter, J. R., Xu, S. &amp; Rogers, J. A. From lab to life: how wearable devices can improve health equity. <italic toggle="yes">Nat. Commun.</italic><bold>15</bold>, 123 (2024).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-023-44634-9</pub-id><pub-id pub-id-type="pmcid">PMC10761710</pub-id><pub-id pub-id-type="pmid">38167483</pub-id></mixed-citation></ref><ref id="CR210"><label>210.</label><mixed-citation publication-type="other">Mihan, A. &amp; Van Spall, H. G. C. Interventions to enhance digital health equity in cardiovascular care. <italic toggle="yes">Nat. Med.</italic><bold>30</bold>, 628&#8211;630 (2024).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41591-024-02815-z</pub-id><pub-id pub-id-type="pmid">38355972</pub-id></mixed-citation></ref><ref id="CR211"><label>211.</label><mixed-citation publication-type="other">Dexcom. Manage your diabetes with confidence. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.dexcom.com/en-CA">https://www.dexcom.com/en-CA</ext-link>.</mixed-citation></ref><ref id="CR212"><label>212.</label><mixed-citation publication-type="other">FreeStyle. What is FreeStyle Libre? <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.freestyle.abbott/en-ca/products/what-is-free-style-libre.html?utm_source=google&amp;utm_medium=cpc&amp;utm_campaign=FSL_Brand&amp;utm_content=106128906887&amp;utm_term=freestyle%20libre&amp;gad_source=1&amp;gad_campaignid=10263421839&amp;gbraid=0AAAAADbRZUNt21gagBE8nuAAfu9mqYO2N&amp;gclid=CjwKCAjw6NrBBhB6EiwAvnT_ruv0vdiuV0kBMFf1LsZoi-AhRfDc7RXwy5nUtJTzE-c6iMCJaZ-DGxoCNIkQAvD_BwE">https://www.freestyle.abbott/en-ca/products/what-is-free-style-libre.html?utm_source=google&amp;utm_medium=cpc&amp;utm_campaign=FSL_Brand&amp;utm_content=106128906887&amp;utm_term=freestyle%20libre&amp;gad_source=1&amp;gad_campaignid=10263421839&amp;gbraid=0AAAAADbRZUNt21gagBE8nuAAfu9mqYO2N&amp;gclid=CjwKCAjw6NrBBhB6EiwAvnT_ruv0vdiuV0kBMFf1LsZoi-AhRfDc7RXwy5nUtJTzE-c6iMCJaZ-DGxoCNIkQAvD_BwE</ext-link>.</mixed-citation></ref><ref id="CR213"><label>213.</label><citation-alternatives><element-citation id="ec-CR213" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Doshi</surname><given-names>KB</given-names></name><name name-style="western"><surname>Moon</surname><given-names>SH</given-names></name><name name-style="western"><surname>Whitaker</surname><given-names>MD</given-names></name><name name-style="western"><surname>Lockhart</surname><given-names>TE</given-names></name></person-group><article-title>Assessment of gait and posture characteristics using a smartphone wearable system for persons with osteoporosis with and without falls</article-title><source>Sci. Rep.</source><year>2023</year><volume>13</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1038/s41598-023-27788-w</pub-id><pub-id pub-id-type="pmid">36631544</pub-id><pub-id pub-id-type="pmcid">PMC9834330</pub-id></element-citation><mixed-citation id="mc-CR213" publication-type="journal">Doshi, K. B., Moon, S. H., Whitaker, M. D. &amp; Lockhart, T. E. Assessment of gait and posture characteristics using a smartphone wearable system for persons with osteoporosis with and without falls. <italic toggle="yes">Sci. Rep.</italic><bold>13</bold>, 1&#8211;9 (2023).<pub-id pub-id-type="pmid">36631544</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-023-27788-w</pub-id><pub-id pub-id-type="pmcid">PMC9834330</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR214"><label>214.</label><citation-alternatives><element-citation id="ec-CR214" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huberty</surname><given-names>J</given-names></name><name name-style="western"><surname>Ehlers</surname><given-names>DK</given-names></name><name name-style="western"><surname>Kurka</surname><given-names>J</given-names></name><name name-style="western"><surname>Ainsworth</surname><given-names>B</given-names></name><name name-style="western"><surname>Buman</surname><given-names>M</given-names></name></person-group><article-title>Feasibility of three wearable sensors for 24 hour monitoring in middle-aged women</article-title><source>BMC Women&#8217;s Health</source><year>2015</year><volume>15</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1186/s12905-015-0212-3</pub-id><pub-id pub-id-type="pmid">26223521</pub-id><pub-id pub-id-type="pmcid">PMC4518514</pub-id></element-citation><mixed-citation id="mc-CR214" publication-type="journal">Huberty, J., Ehlers, D. K., Kurka, J., Ainsworth, B. &amp; Buman, M. Feasibility of three wearable sensors for 24 hour monitoring in middle-aged women. <italic toggle="yes">BMC Women&#8217;s Health</italic><bold>15</bold>, 1&#8211;9 (2015).<pub-id pub-id-type="pmid">26223521</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12905-015-0212-3</pub-id><pub-id pub-id-type="pmcid">PMC4518514</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR215"><label>215.</label><citation-alternatives><element-citation id="ec-CR215" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sanchez-Trigo</surname><given-names>H</given-names></name><name name-style="western"><surname>Maher</surname><given-names>C</given-names></name><name name-style="western"><surname>Godino</surname><given-names>JG</given-names></name><name name-style="western"><surname>Sa&#241;udo</surname><given-names>B</given-names></name></person-group><article-title>Effects of an mHealth physical activity intervention to prevent osteoporosis in premenopausal women. A randomized controlled trial</article-title><source>J. Sci. Med. Sport</source><year>2023</year><volume>26</volume><fpage>545</fpage><lpage>552</lpage><pub-id pub-id-type="doi">10.1016/j.jsams.2023.09.004</pub-id><pub-id pub-id-type="pmid">37739855</pub-id></element-citation><mixed-citation id="mc-CR215" publication-type="journal">Sanchez-Trigo, H., Maher, C., Godino, J. G. &amp; Sa&#241;udo, B. Effects of an mHealth physical activity intervention to prevent osteoporosis in premenopausal women. A randomized controlled trial. <italic toggle="yes">J. Sci. Med. Sport</italic><bold>26</bold>, 545&#8211;552 (2023).<pub-id pub-id-type="pmid">37739855</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jsams.2023.09.004</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR216"><label>216.</label><citation-alternatives><element-citation id="ec-CR216" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>S&#225;nchez-Trigo</surname><given-names>H</given-names></name><name name-style="western"><surname>Sanchez-Oliver</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Abt</surname><given-names>G</given-names></name><name name-style="western"><surname>Sa&#241;udo</surname><given-names>B</given-names></name></person-group><article-title>Validation of a Wearable accelerometer-based activity monitor for use in future osteoporosis prevention programs</article-title><source>Sustainability</source><year>2020</year><volume>12</volume><fpage>2187</fpage><pub-id pub-id-type="doi">10.3390/su12062187</pub-id></element-citation><mixed-citation id="mc-CR216" publication-type="journal">S&#225;nchez-Trigo, H., Sanchez-Oliver, A. J., Abt, G. &amp; Sa&#241;udo, B. Validation of a Wearable accelerometer-based activity monitor for use in future osteoporosis prevention programs. <italic toggle="yes">Sustainability</italic><bold>12</bold>, 2187 (2020).</mixed-citation></citation-alternatives></ref><ref id="CR217"><label>217.</label><citation-alternatives><element-citation id="ec-CR217" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Navalta</surname><given-names>JW</given-names></name><name name-style="western"><surname>Ramirez</surname><given-names>GG</given-names></name><name name-style="western"><surname>Maxwell</surname><given-names>C</given-names></name><name name-style="western"><surname>Radzak</surname><given-names>KN</given-names></name><name name-style="western"><surname>McGinnis</surname><given-names>GR</given-names></name></person-group><article-title>Validity and reliability of three commercially available smart sports bras during treadmill walking and running</article-title><source>Sci. Rep.</source><year>2020</year><volume>10</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1038/s41598-020-64185-z</pub-id><pub-id pub-id-type="pmid">32355249</pub-id><pub-id pub-id-type="pmcid">PMC7192924</pub-id></element-citation><mixed-citation id="mc-CR217" publication-type="journal">Navalta, J. W., Ramirez, G. G., Maxwell, C., Radzak, K. N. &amp; McGinnis, G. R. Validity and reliability of three commercially available smart sports bras during treadmill walking and running. <italic toggle="yes">Sci. Rep.</italic><bold>10</bold>, 1&#8211;9 (2020).<pub-id pub-id-type="pmid">32355249</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-020-64185-z</pub-id><pub-id pub-id-type="pmcid">PMC7192924</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR218"><label>218.</label><citation-alternatives><element-citation id="ec-CR218" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arcarisi</surname><given-names>L</given-names></name><etal/></person-group><article-title>Palpreast&#8212;a new wearable device for breast self-examination</article-title><source>Appl. Sci.</source><year>2019</year><volume>9</volume><fpage>381</fpage><pub-id pub-id-type="doi">10.3390/app9030381</pub-id></element-citation><mixed-citation id="mc-CR218" publication-type="journal">Arcarisi, L. et al. Palpreast&#8212;a new wearable device for breast self-examination. <italic toggle="yes">Appl. Sci.</italic><bold>9</bold>, 381 (2019).</mixed-citation></citation-alternatives></ref><ref id="CR219"><label>219.</label><citation-alternatives><element-citation id="ec-CR219" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Park</surname><given-names>CKS</given-names></name><etal/></person-group><article-title>Cost-effective, portable, patient-dedicated three-dimensional automated breast ultrasound for point-of-care breast cancer screening</article-title><source>Sci. Rep.</source><year>2023</year><volume>13</volume><fpage>1</fpage><lpage>16</lpage><pub-id pub-id-type="pmid">37658125</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-023-41424-7</pub-id><pub-id pub-id-type="pmcid">PMC10474273</pub-id></element-citation><mixed-citation id="mc-CR219" publication-type="journal">Park, C. K. S. et al. Cost-effective, portable, patient-dedicated three-dimensional automated breast ultrasound for point-of-care breast cancer screening. <italic toggle="yes">Sci. Rep.</italic><bold>13</bold>, 1&#8211;16 (2023).<pub-id pub-id-type="pmid">37658125</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-023-41424-7</pub-id><pub-id pub-id-type="pmcid">PMC10474273</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR220"><label>220.</label><citation-alternatives><element-citation id="ec-CR220" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Broach</surname><given-names>RB</given-names></name><etal/></person-group><article-title>A cost-effective handheld breast scanner for use in low-resource environments: a validation study</article-title><source>World J. Surg. Oncol.</source><year>2016</year><volume>14</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1186/s12957-016-1022-2</pub-id><pub-id pub-id-type="pmid">27793162</pub-id><pub-id pub-id-type="pmcid">PMC5084434</pub-id></element-citation><mixed-citation id="mc-CR220" publication-type="journal">Broach, R. B. et al. A cost-effective handheld breast scanner for use in low-resource environments: a validation study. <italic toggle="yes">World J. Surg. Oncol.</italic><bold>14</bold>, 1&#8211;6 (2016).<pub-id pub-id-type="pmid">27793162</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12957-016-1022-2</pub-id><pub-id pub-id-type="pmcid">PMC5084434</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR221"><label>221.</label><mixed-citation publication-type="other">Fertility Test Market by Product (Ovulation Predictor Kits, Fertility Monitors (Urine, Saliva, Blood)), Mode of Purchase (OTC, Prescription, Online), Application (Female, Male), End User (Home care, Fertility clinics, hospitals) &amp; Region - Global Forecast to 2025. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.marketsandmarkets.com/Market-Reports/fertility-testing-devices-market-139945432.html#:~:text=Market%20Growth%20Outlook%20Summary,both%20developed%20and%20developing%20countries">https://www.marketsandmarkets.com/Market-Reports/fertility-testing-devices-market-139945432.html#:~:text=Market%20Growth%20Outlook%20Summary,both%20developed%20and%20developing%20countries</ext-link>.</mixed-citation></ref><ref id="CR222"><label>222.</label><mixed-citation publication-type="other">Gestational Diabetes Market Size And Share Analysis - Growth Trends And Forecasts (2025-2032). <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.coherentmi.com/industry-reports/gestational-diabetes-market">https://www.coherentmi.com/industry-reports/gestational-diabetes-market</ext-link>.</mixed-citation></ref><ref id="CR223"><label>223.</label><mixed-citation publication-type="other">Patenting products for women. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.taylorwessing.com/en/insights-and-events/insights/2024/06/patenting-products-for-women">https://www.taylorwessing.com/en/insights-and-events/insights/2024/06/patenting-products-for-women</ext-link>.</mixed-citation></ref><ref id="CR224"><label>224.</label><citation-alternatives><element-citation id="ec-CR224" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mshelia</surname><given-names>YU</given-names></name><name name-style="western"><surname>Elei</surname><given-names>FO</given-names></name><name name-style="western"><surname>Ikerionwu</surname><given-names>CO</given-names></name><name name-style="western"><surname>Erike</surname><given-names>AI</given-names></name><name name-style="western"><surname>Mshelia</surname><given-names>YU</given-names></name></person-group><article-title>Transition to Value-Based Care IoT Wearable Devices in Maternity Healthcare for Low-Resource Countries</article-title><source>Int. J. Sci. Res. Comput. Sci. Eng.</source><year>2023</year><volume>11</volume><fpage>8</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.26438/ijsrcse/v11i4.814</pub-id></element-citation><mixed-citation id="mc-CR224" publication-type="journal">Mshelia, Y. U., Elei, F. O., Ikerionwu, C. O., Erike, A. I. &amp; Mshelia, Y. U. Transition to Value-Based Care IoT Wearable Devices in Maternity Healthcare for Low-Resource Countries. <italic toggle="yes">Int. J. Sci. Res. Comput. Sci. Eng.</italic><bold>11</bold>, 8&#8211;14 (2023).</mixed-citation></citation-alternatives></ref><ref id="CR225"><label>225.</label><citation-alternatives><element-citation id="ec-CR225" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Godfrey</surname><given-names>A</given-names></name><etal/></person-group><article-title>Wearables beyond borders: a case study of barriers to gait assessment in low-resource settings</article-title><source>Maturitas</source><year>2020</year><volume>137</volume><fpage>7</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1016/j.maturitas.2020.04.013</pub-id><pub-id pub-id-type="pmid">32498939</pub-id></element-citation><mixed-citation id="mc-CR225" publication-type="journal">Godfrey, A. et al. Wearables beyond borders: a case study of barriers to gait assessment in low-resource settings. <italic toggle="yes">Maturitas</italic><bold>137</bold>, 7&#8211;10 (2020).<pub-id pub-id-type="pmid">32498939</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.maturitas.2020.04.013</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR226"><label>226.</label><citation-alternatives><element-citation id="ec-CR226" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Paolillo</surname><given-names>EW</given-names></name><etal/></person-group><article-title>Wearable use in an observational study among older adults: adherence, feasibility, and effects of clinicodemographic factors</article-title><source>Front Digit Health</source><year>2022</year><volume>4</volume><fpage>884208</fpage><pub-id pub-id-type="doi">10.3389/fdgth.2022.884208</pub-id><pub-id pub-id-type="pmid">35754462</pub-id><pub-id pub-id-type="pmcid">PMC9231611</pub-id></element-citation><mixed-citation id="mc-CR226" publication-type="journal">Paolillo, E. W. et al. Wearable use in an observational study among older adults: adherence, feasibility, and effects of clinicodemographic factors. <italic toggle="yes">Front Digit Health</italic><bold>4</bold>, 884208 (2022).<pub-id pub-id-type="pmid">35754462</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fdgth.2022.884208</pub-id><pub-id pub-id-type="pmcid">PMC9231611</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR227"><label>227.</label><citation-alternatives><element-citation id="ec-CR227" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>J</given-names></name><name name-style="western"><surname>Ma</surname><given-names>Q</given-names></name><name name-style="western"><surname>Chan</surname><given-names>AH</given-names></name><name name-style="western"><surname>Man</surname><given-names>SS</given-names></name></person-group><article-title>Health monitoring through wearable technologies for older adults: smart wearables acceptance model</article-title><source>Appl. Erg.</source><year>2019</year><volume>75</volume><fpage>162</fpage><lpage>169</lpage><pub-id pub-id-type="doi">10.1016/j.apergo.2018.10.006</pub-id><pub-id pub-id-type="pmid">30509522</pub-id></element-citation><mixed-citation id="mc-CR227" publication-type="journal">Li, J., Ma, Q., Chan, A. H. &amp; Man, S. S. Health monitoring through wearable technologies for older adults: smart wearables acceptance model. <italic toggle="yes">Appl. Erg.</italic><bold>75</bold>, 162&#8211;169 (2019).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.apergo.2018.10.006</pub-id><pub-id pub-id-type="pmid">30509522</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR228"><label>228.</label><citation-alternatives><element-citation id="ec-CR228" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tikkanen</surname><given-names>H</given-names></name><name name-style="western"><surname>Heinonen</surname><given-names>K</given-names></name><name name-style="western"><surname>Ravald</surname><given-names>A</given-names></name></person-group><article-title>Smart wearable technologies as resources for consumer agency in well-being</article-title><source>J. Interact. Mark.</source><year>2023</year><volume>58</volume><fpage>136</fpage><lpage>150</lpage><pub-id pub-id-type="doi">10.1177/10949968221143351</pub-id></element-citation><mixed-citation id="mc-CR228" publication-type="journal">Tikkanen, H., Heinonen, K. &amp; Ravald, A. Smart wearable technologies as resources for consumer agency in well-being. <italic toggle="yes">J. Interact. Mark.</italic><bold>58</bold>, 136&#8211;150 (2023).</mixed-citation></citation-alternatives></ref><ref id="CR229"><label>229.</label><citation-alternatives><element-citation id="ec-CR229" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yao</surname><given-names>R</given-names></name><etal/></person-group><article-title>Inequities in health care services caused by the adoption of digital health technologies: scoping review</article-title><source>J. Med. Internet Res.</source><year>2022</year><volume>24</volume><fpage>e34144</fpage><pub-id pub-id-type="doi">10.2196/34144</pub-id><pub-id pub-id-type="pmid">35311682</pub-id><pub-id pub-id-type="pmcid">PMC8981004</pub-id></element-citation><mixed-citation id="mc-CR229" publication-type="journal">Yao, R. et al. Inequities in health care services caused by the adoption of digital health technologies: scoping review. <italic toggle="yes">J. Med. Internet Res.</italic><bold>24</bold>, e34144 (2022).<pub-id pub-id-type="pmid">35311682</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2196/34144</pub-id><pub-id pub-id-type="pmcid">PMC8981004</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR230"><label>230.</label><mixed-citation publication-type="other">Biga, R., Nottebaum, S., Kozlakidis, Z. &amp; Psomiadis, S. Digitalization of Healthcare in LMICs: Digital Health and the Digital Divide Based on Technological Availability and Development. In 185&#8211;193. 10.1007/978-3-031-62332-5_18 (2024).</mixed-citation></ref><ref id="CR231"><label>231.</label><mixed-citation publication-type="other">Borges do Nascimento, I. J. et al. Transforming women&#8217;s health, empowerment, and gender equality with digital health: evidence-based policy and practice. <italic toggle="yes">Lancet Digit. Health</italic>10.1016/j.landig.2025.01.014 (2025).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.landig.2025.01.014</pub-id><pub-id pub-id-type="pmcid">PMC12208921</pub-id><pub-id pub-id-type="pmid">40368744</pub-id></mixed-citation></ref><ref id="CR232"><label>232.</label><mixed-citation publication-type="other">Berrian, K., Exsted, M. D., Lampe, N. M., Pease, S. L. &amp; Akr&#233;, E. L. Barriers to quality healthcare among transgender and gender nonconforming adults. <italic toggle="yes">Health Serv. Res.</italic><bold>60</bold>, e14362 (2025).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/1475-6773.14362</pub-id><pub-id pub-id-type="pmcid">PMC11782051</pub-id><pub-id pub-id-type="pmid">38988141</pub-id></mixed-citation></ref><ref id="CR233"><label>233.</label><mixed-citation publication-type="other">Renner, J. et al. Barriers to accessing health care in rural regions by transgender, non-binary, and gender diverse people: a case-based scoping review. <italic toggle="yes">Front. Endocrinol. (Lausanne)</italic><bold>12</bold>, 717821 (2021).<pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fendo.2021.717821</pub-id><pub-id pub-id-type="pmcid">PMC8637736</pub-id><pub-id pub-id-type="pmid">34867775</pub-id></mixed-citation></ref><ref id="CR234"><label>234.</label><mixed-citation publication-type="other">Safer, J. D. &amp; Chan, K. J. Review of medical, socioeconomic, and systemic barriers to transgender care. In 25&#8211;38. 10.1007/978-3-030-05683-4_2 (2019).</mixed-citation></ref><ref id="CR235"><label>235.</label><mixed-citation publication-type="other">Cook, R. Women&#8217;s Health and Human Rights The Promotion and Protection of Women&#8217;s Health through International Human Rights law. <italic toggle="yes">World Health Organization Geneva.</italic><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://iris.who.int/bitstream/handle/10665/39354/9241561661_eng.pdf;jsessionid=314C6EB3C086C">https://iris.who.int/bitstream/handle/10665/39354/9241561661_eng.pdf;jsessionid=314C6EB3C086C</ext-link> (1994).</mixed-citation></ref><ref id="CR236"><label>236.</label><mixed-citation publication-type="other">Women&#8217;s autonomy, equality and reproductive health | OHCHR. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.ohchr.org/en/special-procedures/wg-women-and-girls/womens-autonomy-equality-and-reproductive-health">https://www.ohchr.org/en/special-procedures/wg-women-and-girls/womens-autonomy-equality-and-reproductive-health</ext-link>.</mixed-citation></ref><ref id="CR237"><label>237.</label><mixed-citation publication-type="other">2024 &#8211; Women&#8217;s Health Manifesto &#8211; Eurohealth. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://eurohealth.ie/2023/05/29/2024-womens_health_manifesto/">https://eurohealth.ie/2023/05/29/2024-womens_health_manifesto/</ext-link>.</mixed-citation></ref><ref id="CR238"><label>238.</label><citation-alternatives><element-citation id="ec-CR238" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Daniel</surname><given-names>H</given-names></name><etal/></person-group><article-title>Women&#8217;s health policy in the united states: an american college of physicians position paper</article-title><source>Ann. Intern Med.</source><year>2018</year><volume>168</volume><fpage>874</fpage><lpage>875</lpage><pub-id pub-id-type="doi">10.7326/M17-3344</pub-id><pub-id pub-id-type="pmid">29809243</pub-id></element-citation><mixed-citation id="mc-CR238" publication-type="journal">Daniel, H. et al. Women&#8217;s health policy in the united states: an american college of physicians position paper. <italic toggle="yes">Ann. Intern Med.</italic><bold>168</bold>, 874&#8211;875 (2018).<pub-id pub-id-type="pmid">29809243</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7326/M17-3344</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR239"><label>239.</label><mixed-citation publication-type="other">Women&#8217;s health and well-being in Europe: beyond the mortality advantage. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.who.int/europe/publications/i/item/9789289051910">https://www.who.int/europe/publications/i/item/9789289051910</ext-link> (2016).</mixed-citation></ref><ref id="CR240"><label>240.</label><mixed-citation publication-type="other">Women&#8217;s Health Initiative (WHI) | NHLBI, NIH. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.nhlbi.nih.gov/science/womens-health-initiative-whi">https://www.nhlbi.nih.gov/science/womens-health-initiative-whi</ext-link>.</mixed-citation></ref><ref id="CR241"><label>241.</label><mixed-citation publication-type="other">National Women&#8217;s Health Strategy (2020-2030) - Australian Women&#8217;s Health Alliance. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://australianwomenshealth.org/resource/national-womens-health-strategy/">https://australianwomenshealth.org/resource/national-womens-health-strategy/</ext-link>.</mixed-citation></ref><ref id="CR242"><label>242.</label><mixed-citation publication-type="other">United Nations. United Nations Population Fund. <italic toggle="yes">United Nations</italic>. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.unfpa.org/donate/EmergencyBirthKit/b?utm_source=google&amp;utm_medium=cpc&amp;utm_campaign=UNFPA_DLV_GAdsP_Search_Brand_Alpha_Tier1_EN&amp;utm_content=Evergreen&amp;gad_source=1&amp;gad_campaignid=22480363807&amp;gbraid=0AAAAAoaU5jLKIgEPYbRPuycqhN2wHuvDE&amp;gclid=EAIaIQobChMI3L35tt26jwMVW1N_AB3W6TrWEAAYASAAEgKmavD_BwE">https://www.unfpa.org/donate/EmergencyBirthKit/b?utm_source=google&amp;utm_medium=cpc&amp;utm_campaign=UNFPA_DLV_GAdsP_Search_Brand_Alpha_Tier1_EN&amp;utm_content=Evergreen&amp;gad_source=1&amp;gad_campaignid=22480363807&amp;gbraid=0AAAAAoaU5jLKIgEPYbRPuycqhN2wHuvDE&amp;gclid=EAIaIQobChMI3L35tt26jwMVW1N_AB3W6TrWEAAYASAAEgKmavD_BwE</ext-link>.</mixed-citation></ref><ref id="CR243"><label>243.</label><mixed-citation publication-type="other">World Health Organization. Global Strategy for Women&#8217;s, Children&#8217;s and Adolescents&#8217; Health Data Portal. <italic toggle="yes">World Health Organization</italic>. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://platform.who.int/data/maternal-newborn-child-adolescent-ageing/global-strategy-data">https://platform.who.int/data/maternal-newborn-child-adolescent-ageing/global-strategy-data</ext-link>.</mixed-citation></ref><ref id="CR244"><label>244.</label><mixed-citation publication-type="other">Ye, J., Hai, J., Song, J. &amp; Wang, Z. The role of artificial intelligence in the application of the integrated electronic health records and patient-generated health data. <italic toggle="yes">medRxiv</italic> 2024.05.01.24306690 10.1101/2024.05.01.24306690 (2024).</mixed-citation></ref><ref id="CR245"><label>245.</label><mixed-citation publication-type="other">Wang, Z. et al. AI-assisted diagnosis of vulvovaginal candidiasis using cascaded neural networks. <italic toggle="yes">Microbiol. Spectr.</italic><bold>13</bold>, e01691&#8211;24 (2025).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/spectrum.01691-24</pub-id><pub-id pub-id-type="pmcid">PMC11705804</pub-id><pub-id pub-id-type="pmid">39576103</pub-id></mixed-citation></ref><ref id="CR246"><label>246.</label><mixed-citation publication-type="other">Mennickent, D. et al. Machine learning applied in maternal and fetal health: a narrative review focused on pregnancy diseases and complications. <italic toggle="yes">Front. Endocrinol. (Lausanne)</italic><bold>14</bold>, 1130139 (2023).<pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fendo.2023.1130139</pub-id><pub-id pub-id-type="pmcid">PMC10235786</pub-id><pub-id pub-id-type="pmid">37274341</pub-id></mixed-citation></ref><ref id="CR247"><label>247.</label><citation-alternatives><element-citation id="ec-CR247" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Machine learning prediction models for gestational diabetes mellitus: meta-analysis</article-title><source>J. Med. Internet Res.</source><year>2022</year><volume>24</volume><fpage>e26634</fpage><pub-id pub-id-type="doi">10.2196/26634</pub-id><pub-id pub-id-type="pmid">35294369</pub-id><pub-id pub-id-type="pmcid">PMC8968560</pub-id></element-citation><mixed-citation id="mc-CR247" publication-type="journal">Zhang, Z. et al. Machine learning prediction models for gestational diabetes mellitus: meta-analysis. <italic toggle="yes">J. Med. Internet Res.</italic><bold>24</bold>, e26634 (2022).<pub-id pub-id-type="pmid">35294369</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2196/26634</pub-id><pub-id pub-id-type="pmcid">PMC8968560</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR248"><label>248.</label><mixed-citation publication-type="other">Foschi, C. et al. Potential use of artificial intelligence for vaginal swab analysis in the assessment of common genital disorders: a pilot study. <italic toggle="yes">New Microbiol.</italic><bold>45</bold>, 291 (2022).<pub-id pub-id-type="pmid">36190372</pub-id></mixed-citation></ref><ref id="CR249"><label>249.</label><citation-alternatives><element-citation id="ec-CR249" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>X</given-names></name><etal/></person-group><article-title>Cervical cancer screening aided by artificial intelligence, China</article-title><source>Bull. World Health Organ.</source><year>2023</year><volume>101</volume><fpage>381</fpage><pub-id pub-id-type="doi">10.2471/BLT.22.289061</pub-id><pub-id pub-id-type="pmid">37265676</pub-id><pub-id pub-id-type="pmcid">PMC10225939</pub-id></element-citation><mixed-citation id="mc-CR249" publication-type="journal">Zhu, X. et al. Cervical cancer screening aided by artificial intelligence, China. <italic toggle="yes">Bull. World Health Organ.</italic><bold>101</bold>, 381 (2023).<pub-id pub-id-type="pmid">37265676</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2471/BLT.22.289061</pub-id><pub-id pub-id-type="pmcid">PMC10225939</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR250"><label>250.</label><citation-alternatives><element-citation id="ec-CR250" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McKinney</surname><given-names>SM</given-names></name><etal/></person-group><article-title>International evaluation of an AI system for breast cancer screening</article-title><source>Nature</source><year>2020</year><volume>577</volume><fpage>89</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-1799-6</pub-id><pub-id pub-id-type="pmid">31894144</pub-id></element-citation><mixed-citation id="mc-CR250" publication-type="journal">McKinney, S. M. et al. International evaluation of an AI system for breast cancer screening. <italic toggle="yes">Nature</italic><bold>577</bold>, 89&#8211;94 (2020).<pub-id pub-id-type="pmid">31894144</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41586-019-1799-6</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR251"><label>251.</label><citation-alternatives><element-citation id="ec-CR251" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ng</surname><given-names>AY</given-names></name><etal/></person-group><article-title>Prospective implementation of AI-assisted screen reading to improve early detection of breast cancer</article-title><source>Nat. Med.</source><year>2023</year><volume>29</volume><fpage>3044</fpage><lpage>3049</lpage><pub-id pub-id-type="doi">10.1038/s41591-023-02625-9</pub-id><pub-id pub-id-type="pmid">37973948</pub-id><pub-id pub-id-type="pmcid">PMC10719086</pub-id></element-citation><mixed-citation id="mc-CR251" publication-type="journal">Ng, A. Y. et al. Prospective implementation of AI-assisted screen reading to improve early detection of breast cancer. <italic toggle="yes">Nat. Med.</italic><bold>29</bold>, 3044&#8211;3049 (2023).<pub-id pub-id-type="pmid">37973948</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41591-023-02625-9</pub-id><pub-id pub-id-type="pmcid">PMC10719086</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR252"><label>252.</label><mixed-citation publication-type="other">Salim, M. et al. AI-based selection of individuals for supplemental MRI in population-based breast cancer screening: the randomized ScreenTrustMRI trial. <italic toggle="yes">Nat. Med.</italic>10.1038/s41591-024-03093-5 (2024).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41591-024-03093-5</pub-id><pub-id pub-id-type="pmcid">PMC11405258</pub-id><pub-id pub-id-type="pmid">38977914</pub-id></mixed-citation></ref><ref id="CR253"><label>253.</label><citation-alternatives><element-citation id="ec-CR253" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Dooijeweert</surname><given-names>C</given-names></name><etal/></person-group><article-title>Clinical implementation of artificial-intelligence-assisted detection of breast cancer metastases in sentinel lymph nodes: the CONFIDENT-B single-center, non-randomized clinical trial</article-title><source>Nat. Cancer</source><year>2024</year><volume>5</volume><fpage>1195</fpage><lpage>1205</lpage><pub-id pub-id-type="doi">10.1038/s43018-024-00788-z</pub-id><pub-id pub-id-type="pmid">38937624</pub-id><pub-id pub-id-type="pmcid">PMC11358151</pub-id></element-citation><mixed-citation id="mc-CR253" publication-type="journal">van Dooijeweert, C. et al. Clinical implementation of artificial-intelligence-assisted detection of breast cancer metastases in sentinel lymph nodes: the CONFIDENT-B single-center, non-randomized clinical trial. <italic toggle="yes">Nat. Cancer</italic><bold>5</bold>, 1195&#8211;1205 (2024).<pub-id pub-id-type="pmid">38937624</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s43018-024-00788-z</pub-id><pub-id pub-id-type="pmcid">PMC11358151</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR254"><label>254.</label><citation-alternatives><element-citation id="ec-CR254" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lotter</surname><given-names>W</given-names></name><etal/></person-group><article-title>Robust breast cancer detection in mammography and digital breast tomosynthesis using an annotation-efficient deep learning approach</article-title><source>Nat. Med.</source><year>2021</year><volume>27</volume><fpage>244</fpage><lpage>249</lpage><pub-id pub-id-type="doi">10.1038/s41591-020-01174-9</pub-id><pub-id pub-id-type="pmid">33432172</pub-id><pub-id pub-id-type="pmcid">PMC9426656</pub-id></element-citation><mixed-citation id="mc-CR254" publication-type="journal">Lotter, W. et al. Robust breast cancer detection in mammography and digital breast tomosynthesis using an annotation-efficient deep learning approach. <italic toggle="yes">Nat. Med.</italic><bold>27</bold>, 244&#8211;249 (2021).<pub-id pub-id-type="pmid">33432172</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41591-020-01174-9</pub-id><pub-id pub-id-type="pmcid">PMC9426656</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR255"><label>255.</label><citation-alternatives><element-citation id="ec-CR255" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Burks</surname><given-names>JH</given-names></name><etal/></person-group><article-title>General feature selection technique supporting sex-debiasing in chronic illness algorithms validated using wearable device data</article-title><source>npj Women&#8217;s Health</source><year>2024</year><volume>2</volume><fpage>37</fpage><pub-id pub-id-type="doi">10.1038/s44294-024-00041-z</pub-id></element-citation><mixed-citation id="mc-CR255" publication-type="journal">Burks, J. H. et al. General feature selection technique supporting sex-debiasing in chronic illness algorithms validated using wearable device data. <italic toggle="yes">npj Women&#8217;s Health</italic><bold>2</bold>, 37 (2024).</mixed-citation></citation-alternatives></ref><ref id="CR256"><label>256.</label><citation-alternatives><element-citation id="ec-CR256" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Simms</surname><given-names>KT</given-names></name><etal/></person-group><article-title>Benefits, harms and cost-effectiveness of cervical screening, triage and treatment strategies for women in the general population</article-title><source>Nat. Med.</source><year>2023</year><volume>29</volume><fpage>3050</fpage><lpage>3058</lpage><pub-id pub-id-type="doi">10.1038/s41591-023-02600-4</pub-id><pub-id pub-id-type="pmid">38087115</pub-id><pub-id pub-id-type="pmcid">PMC10719104</pub-id></element-citation><mixed-citation id="mc-CR256" publication-type="journal">Simms, K. T. et al. Benefits, harms and cost-effectiveness of cervical screening, triage and treatment strategies for women in the general population. <italic toggle="yes">Nat. Med.</italic><bold>29</bold>, 3050&#8211;3058 (2023).<pub-id pub-id-type="pmid">38087115</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41591-023-02600-4</pub-id><pub-id pub-id-type="pmcid">PMC10719104</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR257"><label>257.</label><mixed-citation publication-type="other">Endo, P. T. Artificial intelligence for women and child healthcare: is AI able to change the beginning of a new story? A perspective. <italic toggle="yes">Health Sci. Rep.</italic><bold>8</bold>, e70779 (2025).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/hsr2.70779</pub-id><pub-id pub-id-type="pmcid">PMC12053047</pub-id><pub-id pub-id-type="pmid">40330751</pub-id></mixed-citation></ref><ref id="CR258"><label>258.</label><mixed-citation publication-type="other">Massachusetts General Hospital. Are you pregnant? Do you own a smartphone? <italic toggle="yes">MGH&#8217;s Center for Women&#8217;s Mental Health</italic>. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://rally.massgeneralbrigham.org/study/mghpdsmobileapp">https://rally.massgeneralbrigham.org/study/mghpdsmobileapp</ext-link> (2025).</mixed-citation></ref><ref id="CR259"><label>259.</label><citation-alternatives><element-citation id="ec-CR259" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pearlstein</surname><given-names>T</given-names></name><name name-style="western"><surname>Howard</surname><given-names>M</given-names></name><name name-style="western"><surname>Salisbury</surname><given-names>A</given-names></name><name name-style="western"><surname>Zlotnick</surname><given-names>C</given-names></name></person-group><article-title>Postpartum depression</article-title><source>Am. J. Obstet. Gynecol.</source><year>2009</year><volume>200</volume><fpage>357</fpage><lpage>364</lpage><pub-id pub-id-type="doi">10.1016/j.ajog.2008.11.033</pub-id><pub-id pub-id-type="pmid">19318144</pub-id><pub-id pub-id-type="pmcid">PMC3918890</pub-id></element-citation><mixed-citation id="mc-CR259" publication-type="journal">Pearlstein, T., Howard, M., Salisbury, A. &amp; Zlotnick, C. Postpartum depression. <italic toggle="yes">Am. J. Obstet. Gynecol.</italic><bold>200</bold>, 357&#8211;364 (2009).<pub-id pub-id-type="pmid">19318144</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ajog.2008.11.033</pub-id><pub-id pub-id-type="pmcid">PMC3918890</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR260"><label>260.</label><mixed-citation publication-type="other">Davidson, L. &amp; Boland, M. R. Towards deep phenotyping pregnancy: a systematic review on artificial intelligence and machine learning methods to improve pregnancy outcomes. <italic toggle="yes">Brief Bioinform.</italic><bold>22</bold>, bbaa369 (2021).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/bib/bbaa369</pub-id><pub-id pub-id-type="pmcid">PMC8424395</pub-id><pub-id pub-id-type="pmid">33406530</pub-id></mixed-citation></ref><ref id="CR261"><label>261.</label><mixed-citation publication-type="other">OvuFirst Wearable Fertility Tracker. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.hellovio.com/en_ca/about-ovufirst/">https://www.hellovio.com/en_ca/about-ovufirst/</ext-link>.</mixed-citation></ref><ref id="CR262"><label>262.</label><mixed-citation publication-type="other">GE HealthCare (United States). Invenia Abus Breast Imaging Ultrasound. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.gehealthcare.com/products/ultrasound/breast-ultrasound/invenia-abus">https://www.gehealthcare.com/products/ultrasound/breast-ultrasound/invenia-abus</ext-link>.</mixed-citation></ref><ref id="CR263"><label>263.</label><citation-alternatives><element-citation id="ec-CR263" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Futoma</surname><given-names>J</given-names></name><name name-style="western"><surname>Simons</surname><given-names>M</given-names></name><name name-style="western"><surname>Panch</surname><given-names>T</given-names></name><name name-style="western"><surname>Doshi-Velez</surname><given-names>F</given-names></name><name name-style="western"><surname>Celi</surname><given-names>LA</given-names></name></person-group><article-title>The myth of generalisability in clinical research and machine learning in health care</article-title><source>Lancet Digit Health</source><year>2020</year><volume>2</volume><fpage>e489</fpage><lpage>e492</lpage><pub-id pub-id-type="doi">10.1016/S2589-7500(20)30186-2</pub-id><pub-id pub-id-type="pmid">32864600</pub-id><pub-id pub-id-type="pmcid">PMC7444947</pub-id></element-citation><mixed-citation id="mc-CR263" publication-type="journal">Futoma, J., Simons, M., Panch, T., Doshi-Velez, F. &amp; Celi, L. A. The myth of generalisability in clinical research and machine learning in health care. <italic toggle="yes">Lancet Digit Health</italic><bold>2</bold>, e489&#8211;e492 (2020).<pub-id pub-id-type="pmid">32864600</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S2589-7500(20)30186-2</pub-id><pub-id pub-id-type="pmcid">PMC7444947</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR264"><label>264.</label><citation-alternatives><element-citation id="ec-CR264" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Achtari</surname><given-names>M</given-names></name><etal/></person-group><article-title>Gender bias in AI&#8217;s perception of cardiovascular risk</article-title><source>J. Med. Internet Res.</source><year>2024</year><volume>26</volume><fpage>e54242</fpage><pub-id pub-id-type="doi">10.2196/54242</pub-id><pub-id pub-id-type="pmid">39437384</pub-id><pub-id pub-id-type="pmcid">PMC11538872</pub-id></element-citation><mixed-citation id="mc-CR264" publication-type="journal">Achtari, M. et al. Gender bias in AI&#8217;s perception of cardiovascular risk. <italic toggle="yes">J. Med. Internet Res.</italic><bold>26</bold>, e54242 (2024).<pub-id pub-id-type="pmid">39437384</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2196/54242</pub-id><pub-id pub-id-type="pmcid">PMC11538872</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR265"><label>265.</label><citation-alternatives><element-citation id="ec-CR265" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bruce</surname><given-names>LK</given-names></name><etal/></person-group><article-title>Variability of temperature measurements recorded by a wearable device by biological sex</article-title><source>Biol. Sex. Differ.</source><year>2023</year><volume>14</volume><fpage>76</fpage><pub-id pub-id-type="doi">10.1186/s13293-023-00558-z</pub-id><pub-id pub-id-type="pmid">37915069</pub-id><pub-id pub-id-type="pmcid">PMC10619297</pub-id></element-citation><mixed-citation id="mc-CR265" publication-type="journal">Bruce, L. K. et al. Variability of temperature measurements recorded by a wearable device by biological sex. <italic toggle="yes">Biol. Sex. Differ.</italic><bold>14</bold>, 76 (2023).<pub-id pub-id-type="pmid">37915069</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13293-023-00558-z</pub-id><pub-id pub-id-type="pmcid">PMC10619297</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR266"><label>266.</label><mixed-citation publication-type="other">Smarr, B. L. AI for precision medicine must keep non-random complexity in mind to support equity in outcomes. In <italic toggle="yes">2024 IEEE 20th International Conference on e-Science (e-Science)</italic> 1&#8211;7 (IEEE, 2024). 10.1109/e-Science62913.2024.10678664.</mixed-citation></ref><ref id="CR267"><label>267.</label><citation-alternatives><element-citation id="ec-CR267" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cirillo</surname><given-names>D</given-names></name><etal/></person-group><article-title>Sex and gender differences and biases in artificial intelligence for biomedicine and healthcare</article-title><source>NPJ Digit Med.</source><year>2020</year><volume>3</volume><fpage>81</fpage><pub-id pub-id-type="doi">10.1038/s41746-020-0288-5</pub-id><pub-id pub-id-type="pmid">32529043</pub-id><pub-id pub-id-type="pmcid">PMC7264169</pub-id></element-citation><mixed-citation id="mc-CR267" publication-type="journal">Cirillo, D. et al. Sex and gender differences and biases in artificial intelligence for biomedicine and healthcare. <italic toggle="yes">NPJ Digit Med.</italic><bold>3</bold>, 81 (2020).<pub-id pub-id-type="pmid">32529043</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41746-020-0288-5</pub-id><pub-id pub-id-type="pmcid">PMC7264169</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR268"><label>268.</label><mixed-citation publication-type="other">Murrin, E. M., Saad, A. F., Sullivan, S., Millo, Y. &amp; Miodovnik, M. Innovations in diabetes management for pregnant women: artificial intelligence and the internet of medical things. <italic toggle="yes">Am. J. Perinatol.</italic>10.1055/a-2489-4462 (2024).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1055/a-2489-4462</pub-id><pub-id pub-id-type="pmid">39592107</pub-id></mixed-citation></ref><ref id="CR269"><label>269.</label><citation-alternatives><element-citation id="ec-CR269" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abu-El-Ruz</surname><given-names>R</given-names></name><etal/></person-group><article-title>Artificial intelligence in bacterial infections control: a scoping review</article-title><source>Antibiotics</source><year>2025</year><volume>14</volume><fpage>256</fpage><pub-id pub-id-type="doi">10.3390/antibiotics14030256</pub-id><pub-id pub-id-type="pmid">40149067</pub-id><pub-id pub-id-type="pmcid">PMC11939793</pub-id></element-citation><mixed-citation id="mc-CR269" publication-type="journal">Abu-El-Ruz, R. et al. Artificial intelligence in bacterial infections control: a scoping review. <italic toggle="yes">Antibiotics</italic><bold>14</bold>, 256 (2025).<pub-id pub-id-type="pmid">40149067</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/antibiotics14030256</pub-id><pub-id pub-id-type="pmcid">PMC11939793</pub-id></mixed-citation></citation-alternatives></ref></ref-list></back></article></pmc-articleset>